[go: up one dir, main page]

US20030092097A1 - Cellulase variants - Google Patents

Cellulase variants Download PDF

Info

Publication number
US20030092097A1
US20030092097A1 US09/261,329 US26132999A US2003092097A1 US 20030092097 A1 US20030092097 A1 US 20030092097A1 US 26132999 A US26132999 A US 26132999A US 2003092097 A1 US2003092097 A1 US 2003092097A1
Authority
US
United States
Prior art keywords
holds
cellulase
variant
amino acid
humicola insolens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/261,329
Inventor
Kim Vilbour Andersen
Martin Schulein
Lars Christiansen
Bo Damgaard
Claus von der Osten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Assigned to NOVO NORDISK A/S reassignment NOVO NORDISK A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DAMGAARD, BO, VON DER OSTEN, CLAUS, CHRISTIANSEN, LARS, SCHULEIN, MARTIN, ANDERSON, KIM VILBOUR
Assigned to NOVOZYMES A/S reassignment NOVOZYMES A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOVO NORDISK A/S
Publication of US20030092097A1 publication Critical patent/US20030092097A1/en
Priority to US10/919,195 priority Critical patent/US20050009166A1/en
Priority to US11/830,063 priority patent/US8017372B2/en
Priority to US12/394,202 priority patent/US7993898B2/en
Priority to US13/162,636 priority patent/US20110250674A1/en
Priority to US13/471,757 priority patent/US20120289450A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase

Definitions

  • the present invention relates to cellulase variants, i.e. endo- ⁇ -1,4-glucanase variants, derived from a parental cellulase, i.e. endo- ⁇ -1,4-glucanase, by substitution, insertion and/or deletion, which variant has a catalytic core domain, in which the variant at position 5 holds an alanine residue (A), a serine residue (S), or a threonine residue (T); at position 8 holds a phenylalanine residue (F), or a tyrosine residue (Y); at position 9 holds a phenylalanine residue (F), a tryptophan residue (W), or a tyrosine residue (Y); at position 10 holds an aspartic acid residue (D); and at position 121 holds an aspartic acid residue (D).
  • A alanine residue
  • S serine residue
  • T threonine residue
  • T a threonine residue
  • Cellulases or cellulolytic enzymes are enzymes involved in hydrolyses of cellulose.
  • cellobiohydrolase (1,4- ⁇ -D-glucan cellobiohydrolase, EC 3.2.1.91)
  • endo- ⁇ -1,4-glucanase endo-1,4- ⁇ -D-glucan 4-glucanohydrolase
  • ⁇ -glucosidase EC 3.2.1.21
  • endo- ⁇ -1,4-glucanases (EC No. 3.2.1.4) constitute an interesting group of hydrolases for the mentioned industrial uses.
  • Endoglucanases catalyses endo hydrolysis of 1,4- ⁇ -D-glycosidic linkages in cellulose, cellulose derivatives (such as carboxy methyl cellulose and hydroxy ethyl cellulose), lichenin, ⁇ -1,4 bonds in mixed ⁇ -1,3 glucans such as cereal ⁇ -D-glucans or xyloglucans and other plant material containing cellulosic parts.
  • endo-1,4- ⁇ -D-glucan 4-glucano hydrolase endo-1,4- ⁇ -D-glucan 4-glucano hydrolase, but the abbreviated term endoglucanase is used in the present specification.
  • T.- M. Enveri “Microbial Cellulases” in W. M. Fogarty, Microbial Enzymes and Biotechnology, Applied Sciences Publishers, p. 183-224 (1983); Methods in Enzymology, (1988) Vol. 160, p. 200-391 (edited by Wood, W. A. and Kellogg, S. T.); Béguin, P., “Molecular Biology of Cellulose Degradation”, Annu. Rev. Microbiol. (1990), Vol. 44, pp. 219-248; Béguin, P.
  • Cellulases are synthesized by a large number of microorganisms which include fungi, actinomycetes, myxobacteria and true bacteria but also by plants. Especially endoglucanases of a wide variety of specificities have been identified
  • a very important industrial use or cellulolytic enzymes is the use for treatment of cellulosic textile or fabric, e.g. as ingredients in detergent compositions or fabric softener compositions, for bio-polishing of new fabric (garment finishing), and for obtaining a “stone-washed” look of cellulose-containing fabric, especially denim, and several methods for such treatment have been suggested, e.g. in GB-A-1 368 599, EP-A-0 307 564 and EP-A-0 435 876, WO 91/17243, WO 91/10732, WO 91/17244, PCT/DK95/000108 and PCT/DK95/00132.
  • Another important industrial use of cellulolytic enzymes is the use for treatment of paper pulp, e.g. for improving the drainage or for deinking of recycled paper.
  • CBD cellulose binding domain
  • Fungi and bacteria produces a spectrum of cellulolytic enzymes (cellulases) which, on the basis of sequence similarities (hydrophobic cluster analysis), can be classified into different families of glycosyl hydrolases [Henrissat B & Bairoch A; Biochem. J. 1993 293 781-788]. At present are known cellulases belonging to the families 5, 6, 7, 8, 9, 10, 12, 26, 44, 45, 48, 60, and 61 of glycosyl hydrolases.
  • the present invention provides a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of:
  • the invention provides cellulase variants improved with respect to altered (increased or decreased) catalytic activity; and/or altered sensitivity to anionic tensides; and/or altered pH optimum and pH profile activity-wise as well as stability-wise.
  • the invention provides a cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion, which variant has a catalytic core domain, in which the variant
  • At position 5 holds an alanine residue (A), a serine residue (S), or a threonine residue (T);
  • the present invention provides new cellulase variants derived from a parental cellulase by substitution, insertion and/or deletion.
  • a cellulase variant of this invention is a cellulase variant or mutated cellulase, having an amino acid sequence not found in nature.
  • the cellulase variants of the invention show improved performance, in particular with respect to increased catalytic activity; and/or altered sensitivity to anionic tensides; and/or altered pH optimum; and/or altered thermostability.
  • the cellulase variant or mutated cellulase of this invention may be regarded a functional derivative of a parental cellulase (i.e. the native or wild-type enzyme), and may be obtained by alteration of a DNA nucleotide sequence of the parental gene or its derivatives, encoding the parental enzyme.
  • the cellulase variant or mutated cellulase may be expressed and produced when the DNA nucleotide sequence encoding the cellulase variant is inserted into a suitable vector in a suitable host organism.
  • the host organism is not necessarily identical to the organism from which the parental gene originated.
  • enzyme variants have also been referred to as mutants or muteins.
  • the cellulases (a-i) are described in WO 96/29397, (j) is described in GeneBank under the accession number G45498, and (k) is described in GeneBank under the accession number S81598 and in Biol. Chem. Hoppe-Seyler 1995 376 (10) 617-625.
  • Amino acid residues which represent insertions in relation to the amino acid sequence of the cellulase from Humicola insolens are numbered by the addition of letters in alphabetical order to the preceding cellulase number, such as e.g. position *21aV for the “inserted” valine (V), where no amino acid residue is present, between lysine at position 21 and alanine at position 22 of the amino acid sequence of the cellulase from Humicola insolens , cf. Table 1.
  • P49* Deletion of a proline (P) at position 49 in the amino acid sequence of the cellulase from Humicola insolens is indicated as P49*.
  • cellulose numbering refers to the cellulase numbers described above, and are determined relative to the amino acid sequence of the cellulase derived from Humicola insolens , cf. Table 1, (a). TABLE 1 Amino Acid Sequence Alignment; Cellulase Numbering of Selected Cellulases of Different Microbial Origin (a) Humicola insolens ; (b) Acremonium sp.
  • the present invention relates to cellulase variants. More specifically the present invention provides cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion, which variant has a catalytic core domain, in which the variant
  • At position 5 holds an alanine residue (A), a serine residue (S), or a threonine residue (T);
  • the endoglucanase of the invention may comprise a cellulose binding domain (CBD) existing as an integral part of the enzyme, or a CBD from another origin may be introduced into the endoglucanase thus creating an enzyme hybride.
  • CBD cellulose binding domain
  • the term “cellulose-binding domain” is intended to be understood as defined by Peter Tomme et al. “Cellulose-Binding Domains: Classification and Properties” in “Enzymatic Degradation of Insoluble Carbohydrates”, John N. Saddler and Michael H. Penner (Eds.), ACS Symposium Series, No. 618, 1996.
  • CBDs are found in various enzymes such as cellulases, xylanases, mannanases, arabinofuranosidases, acetyl (esterases and chitinases.
  • CBDs have also been found in algae, e.g. the red alga Porphyra purpurea as a non-hydrolytic polysaccharide-binding protein, see Tomme et al., op.cit.
  • most of the CBDs are from cellulases and xylanases, CBDs are found at the N and C termini of proteins or are internal.
  • Enzyme hybrids are known in the art, see e.g. WO 90/00609 and WO 95/16782, and may be prepared by transforming into a host cell a DNA construct comprising at least a fragment of DNA encoding the cellulose-binding domain ligated, with or without a linker, to a DNA sequence encoding the endoglucanase and growing the host cell to express the fused gene.
  • Enzyme hybrids may be described by the following formula:
  • CBD is the N-terminal or the C-terminal region of an amino acid sequence corresponding to at least the cellulose-binding domain
  • MR is the middle region (the linker), and may be a bond, or a short linking group preferably of from about 2 to about 100 carbon atoms, more preferably of from 2 to 40 carbon atoms; or is preferably from about 2 to about 100 amino acids, more preferably of from 2 to 40 amino acids
  • X is an N-terminal or C-terminal region of the enzyme according to the invention.
  • the present invention relates to a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of:
  • Step f. of the method is preferably carried out by choosing positions which, as a result of the alignment of step a., carry the same amino acid residue in a majority of the aligned sequences; more preferably in at least 63% of the aligned sequences; even more preferably positions which, in the aligned sequences, carries different amino acid residues, cf. below.
  • the specific activity of the cellulase can be improved, preferably by carrying out a substition, deletion or insertion at amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 ⁇ , more preferably not more than 3 ⁇ , even more preferably not more than 2.5 ⁇ . It is believed that residues present in a distance of not more than 2.5 ⁇ are capable of being in direct contact with the substrate.
  • the pH activity profile, the pH activity optimum, the pH stability profile, or the pH stability optimum of the cellulase can be altered, preferably by carrying out a substitution, deletion or insertion at amino acid residue positions present either in a distance from the substrate binding cleft of not more than 5 ⁇ , more preferably not more than 3 ⁇ , even more preferably not more than 2.5 ⁇ ; or at surface-exposed amino acid residue positions of the enzyme, thereby altering the electrostatic environment either locally or globally. It is preferred to perform a substitution involving a charged or potentially charged residue, this residue either being the original residue or the replacement residue. In the present context, charged or potentially charged residues are meant to include: Arg, Lys, His, Cys (if not part of a disulfide bridge), Tyr, Glu, Asp.
  • the stability of the cellulase in the presence of an anionic tenside or anionic detergent component can be altered, preferably by carrying out a substitution, deletion or insertion at surface-exposed amino acid residue positions of the enzyme, thereby altering the electrostatic environment either locally or globally. It is preferred to perform a substitution involving a charged or potentially charged residue, this residue either being the original residue or the replacement residue.
  • charged or potentially charged residues are meant to include: Arg, Lys, His, Cys (if not part of a disulfide bridge), Tyr, Glu, Asp.
  • Mutations towards a more negatively charged aa residue result in improved stability of the cellulase in the presence of an anionic tenside, whereas mutations towards a more positively charged aa residue decreases the stability of the cellulase towards anionic tensides.
  • cellulase variants comprising any combination of two or more of the amino acid substitutions, deletions or insertions disclosed herein are also within the scope of the present invention, cf. the exemplified variants.
  • the multiple sequence alignment is performed using the Pileup algorithm as implemented in the Wisconsin Sequence Analysis Package version 8.1-UNIX (GCG, Genetics Computer Group, Inc.). The method used is similar to the method described by Higgens and Sharp (CARBIOS 1989 5 151-153). A gap creation penalty of 3.0 and a gap extension penalty of 0.1 is used together with a scoring matrix as described in Nucl. Acids Res. 1986 14 (16) 6745-6763 (Dayhoff table (Schwartz, R. M. and Dayhoff, M. O.; Atlas of Protein Sequence and Structure (Dayhoff, M. O. Ed.); National Biomedical Research Foundation, Washington D.C.
  • a pair-wise sequence alignment is performed using the algorithm described by Needleman & Wunsch ( J. Mol. Biol. 1970 48 443-453), as implemented in the GAP routine in the Wisconsin Sequence Analysis Package (GCG).
  • GCG Wisconsin Sequence Analysis Package
  • a pair-wise sequence alignment with forced pairing of residues is performed using the algorithm described by Needleman & Wunsch ( J. Mol. Biol. 1970 48 443-453), as implemented in the GAP routine in the Wisconsin Sequence Analysis Package (GCG).
  • GCG Wisconsin Sequence Analysis Package
  • the parameters used for the GAP routine are the same as mentioned for the Pileup routine earlier, where the scoring matrix is modified to incorporate a residue named X which symbolize the residues to be paired.
  • the diagonal value for X paired with X is set to 9.0 and all off diagonal values involving X is set to 0.
  • SCRs Structurally conserveed Regions
  • the known X-ray structure of the Humicola insolens EGV cellulase will in the following be termed the reference structure.
  • the structure to be modeled will be termed the model structure.
  • Ad 1 The approximate extent of the core part of the enzyme is determined by a multiple sequence alignment including many known cellulase sequences. Since the reference structure only contain atomic coordinates for the core part of the enzyme only the residues in the sequence to be modeled which align with the core part of the reference structure can be included in the model building. This alignment also determines the alignment of the cysteine. The multiple sequence alignment is performed using the Pileup algorithm as described earlier.
  • Ad 2 A pair-wise sequence alignment is performed as described earlier. If the cysteine in the conserved disulfide bridges and/or the active site residues (D10 and D121) does not align, a pair-wise sequence alignment using forced pairing of the cysteines in the conserved disulfide bridges and/or the active site residues is performed as described earlier. The main purpose of the sequence alignment is to define SCRs (see later) to be used for a model structure generation.
  • Ad 3 Based on the sequence alignment Structurally conserveed Regions (SCRs) are defined as continuous regions of overlapping sequence with no insertions or deletions.
  • Ad 4 Using the computer program Homology 95.0 (Homology User Guide, October 1995. San Diego: Biosym/MSI, 1995.) atomic coordinates in the model structure can be generated from the atomic coordinates of the reference structure using the command AssignCoords Sequences.
  • Ad 5 Using the computer program Homology 95.0 possible conformations for the remaining regions, named Variable Regions (VRs) are found by a search in the loop structure database included in Homology 95.0. This procedure is performed for each VR.
  • VRs Variable Regions
  • Ad 6 If the VR length is smaller than six residues the first loop structure in the database search result is selected for coordinate generation. In cases where longer loops are generated the first solution in the list which does not have severe atomic overlap are selected. The degree of atomic overlap can be analyzed using the Bump Monitor Add Intra command in the computer program Insight II 95.0 (Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.) a parameter of 0.25 for the Bump command will show the severe overlap. If more than ten bumps exists between the inserted loop region and the remaining part of the protein the next solution is tested. If no solution is found with these parameters, the solution with the fewest bumps is selected. The coordinates for the VR regions are generated using the command AssignCoords Loops in the program Homology 95.0.
  • Ad 7 The disulfide bonds are created using the Bond Create command in the Biopolymer module of Insight II 95.0 and the protonation state is set to match pH 8.0 with charged caps using the Hydrogens command. Finally the active proton donor (the residue equivalent to D121 in the reference structure) is protonated using the residue replace ⁇ D121 residue name> ASP L command. To finalize the data of the model the appropriate forcefield template is applied using the CVFF forcefield through the command Potentials Fix.
  • Ad 8 Finally the modeled structure is subjected to 500 cycles energy minimization using the molecular mechanics program Discover 95.0/3.0.1 (Discover 95.0/3.0.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.).
  • the output from the above described procedure is atomic coordinates describing a structural model for the core domain of a new cellulase based on sequence homology to the Humicola insolens EGV cellulase.
  • [0115] 2) Perform pair-wise sequence alignment of each sequence with the Humicola insolens EGV cellulase core domain (residues 1-201). If the cysteines in the conserved disulfide bridges does not align at the same positions and/or if the two active site residues (D10 and D121) does not align at the same positions then use the pair-wise sequence alignment of cellulases with forced pairing method. Include only residues in the sequences overlapping with the core domain (residues 1-201) of the Humicola insolens EGV cellulase;
  • [0122] 2) Perform pair-wise sequence alignment of each sequence with the Humicola insolens EGV cellulase core domain (residues 1-201). If the cysteines in the conserved disulfide bridges does not align at the same positions and/or if the two active site residues (D10 and D121) does not align at the same positions then use the pair-wise sequence alignment of cellulases with forced pairing method. Include only residues in the sequences overlapping with the core domain (residues 1-201) of the Humicola insolens EGV cellulase;
  • Disulfide bridges i.e. Cys-Cys bridges stabilize the structure of the enzyme. It is believed that a certain number of stabilizing disulfide bridges are necessary to maintain the a proper stability of the enzyme. However, it is also contemplated that disulfide bridges can be removed from the protein structure resulting in an enzyme variant which is less stable, especially less thermostable, but which still has significant activity.
  • the invention provides a cellulase variant which variant holds 4 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering).
  • the variant of the invention holds 5 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering).
  • the variant of the invention holds 6 or more of the following disulfide bridges: C11-C135; C12-C47; C16- ⁇ -C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering).
  • the invention provides a cellulase variant in which cysteine has been replaced by another natural amino acid at one or more of the positions 16, 86, 87, 89, 189, and/or 199 (cellulase numbering).
  • the invention provides a cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion at one or more amino acid residues located in the substrate binding cleft. Mutations introduced at positions close to the substrate affect the enzyme-substrate interactive bindings.
  • An appropriate way of determining the residues interacting with a potential substrate in a structure is to partitionate the structure in “shells”.
  • the shells are defined as: 1st shell are residues directly interacting with the substrate, i.e. closest inter atomic distance between substrate and residue both including hydrogen atoms are smaller than 2.5 ⁇ which will include all direct interaction via hydrogen bonds and other non bonded interactions.
  • the subsequent (2nd, 3rd e.t.c.) shells are defined in the same way, as the residues with inter atomic distances smaller than 2.5 ⁇ to the substrate or all previously determined shells. In this way the structure will be partitioned in shells.
  • the routine “subset zone” in the program Insight II 95.0 Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.
  • Insight II 95.0 Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.
  • the amino acid residue contemplated according to this invention is located in the substrate binding cleft at a distance of up to 5 ⁇ from the substrate.
  • the invention provides a cellulase variant which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of these acid residues.
  • the cellulase variant is derived from one of the cellulases identified in Table 2 ((a) Humicola insolens ; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis ), by substitution, insertion and/or deletion at one or more of the positions identified in Table 2 for these cellulases.
  • the amino acid residue contemplated according to this invention is located in the substrate binding cleft at a distance of up to 3 ⁇ from the substrate.
  • the invention provides a cellulase variant which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of these acid residues.
  • the cellulase variant is derived from one of the cellulases identified in Table 3 ((a) Humicola insolens; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis ), by substitution, insertion and/or deletion at one or more of the positions identified in Table 3 for these cellulases.
  • a “partly conserved amino acid residue” is an amino acid residue identified according to Table 1, at a position at which position between 7 to 10 amino acid residues of the 11 residues (i.e. more than 63%) indicated in Table 1 for that position, are identical.
  • the invention further provides a cellulase variant, in which variant an amino acid residue has been changed into a conserved amino acid residue at one or more positions according to Table 1, at which position(s) between 7 and 10 amino acid residues of the 11 residues identified in Table 1, are identical.
  • the invention provides a cellulase variant, which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 13, 14, 15, 20, 21, 22, 24, 28, 32, 34, 45, 48, 50, 53, 54, 62, 63, 64, 65, 6E6, 68, 69, 70, 71, 72, 73, 74, 75, 79, 85, 88, 90, 92, 93, 95, 96, 97, 98, 99, 104, 106, 110, 111, 113, 115, 116, 118, 119, 131, 134, 138, 140, 146, 152, 153, 163, 166, 169, 170, 171, 172, 173, 174, 174, 177, 178, 179, 180, 193, 196, and/or 197 (cellulase numbering).
  • the invention provides a cellulase variant that has been subjected to substitutions, insertions and/or deletions, so as to comprise one or more of the amino acid residues at the positions identified in Table 4, below.
  • the positions in Table 4 reflects the “partly conserved amino acid residue positions” as well as the non-conserved positions present within 5 ⁇ of the substrate in binding cleft all of which indeed are present in the aligned sequences in Table 1.
  • the invention provides a cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion at one or more amino acid residues as indicated in Tables 5-6, below.
  • the cellulase variant may be derived from any parental cellulase holding the amino acid residue stated at the position indicated.
  • the parental cellulase may be a Humicola insolens cellulase; an Acremonium sp.
  • Cellulase a Volutella collectotrichoides cellulase; a Sordaria fimicola cellulase; a Thielavia terrestris cellulase; a Fusariuim oxysporum cellulase; a Myceliophthora thermophila cellulase; a Crinipellis scabella cellulase; a Macrophomina phaseolina cellulase; a Pseudomonas fluorescens cellulase; or a Ustilago maydis cellulase.
  • the cellulase variant may be characterized by having improved performance, in particular with respect to
  • anionic tensides are products frequently incorporated into detergent compositions. Sometimes cellulolytic enzymes having an increased stability towards anionic tensides is a desire, and sometimes cellulolytic enzymes having an increased sensitivity are preferred. In a further aspect the invention provides cellulase variants of an altered anionic tenside sensitivity.
  • a cellulase variant of the invention of altered anionic tenside sensitivity is a cellulase variant which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 2, 4, 7, 8, 10, 13, 15, 19, 20, 21, 25, 26, 29, 32, 33, 34, 35, 37, 40, 42, 42a, 43, 44, 48, 53, 54, 55, 58, 59, 63, 64, 65, 66, 67, 70, 72, 76, 79, 80, 82, 84, 86, 88, 90, 91, 93, 95, 95d, 95h, 95j, 97, 100, 101, 102, 103, 113, 114, 117, 119, 121, 133, 136, 137, 138, 139, 140a, 141, 143a, 145, 146, 147, 150e, 150j, 151, 152, 153, 154, 155,
  • the cellulase variant is derived from one of the cellulases identified in Table 7, below, ((a) Humicola insolens; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis), by substitution, insertion and/or deletion at one or more of the positions identified in Table 7 for these cellulases.
  • the present invention relates to an enzyme composition comprising an enzyme exhibiting cellulolytic activity as described above.
  • the enzyme composition of the invention may, in addition to the cellulase of the invention, comprise one or more other enzyme types, for instance hemi-cellulase such as xylanase and mannanase, other cellulase components, chitinase, lipase, esterase, pectinase, cutinase, phytase, oxidoreductase, peroxidase, laccase, oxidase, pactinmethylesterase, polygalacturonase, protease, or amylase.
  • hemi-cellulase such as xylanase and mannanase
  • other cellulase components such as xylanase and mannanase
  • chitinase such as xylanase and mannanase
  • lipase such as xylanase and mannanase
  • the enzyme composition may be prepared in accordance with methods known in the art and may be in the form of a liquid or a dry composition.
  • the enzyme composition may be in the form of a granulate or a microgranulate.
  • the enzyme to be included in the composition may be stabilized in accordance with methods known in the art.
  • the enzyme composition according to the invention may be useful for at least one of the following purposes.
  • de-pilling denotes removing of pills from the fabric surface.
  • soaking liquor denotes an aqueous liquor in which laundry may be immersed prior to being subjected to a conventional washing process.
  • the soaking liquor may contain one or more ingredients conventionally used in a washing or laundering process.
  • washing liquor denotes an aqueous liquor in which laundry is subjected to a washing process, i.e. usually a combined chemical and mechanical action either manually or in a washing machine.
  • the washing liquor is an aqueous solution of a powder or liquid detergent composition.
  • rinsing liquor denotes an aqueous liquor in which laundry is immersed and treated, conventionally immediately after being subjected to a washing process, in order to rinse the laundry, i.e. essentially remove the detergent solution from the laundry.
  • the rinsing liquor may contain a fabric conditioning or softening composition.
  • the laundry subjected to the method of the present invention may be conventional washable laundry.
  • the major part of the laundry is sewn or un-sewn fabrics, including knits, wovens, denims, yarns, and toweling, made from cotton, cotton blends or natural or manmade cellulosics (e.g. originating from xylan-containing cellulose fibers such as from wood pulp) or blends thereof.
  • blends are blends of cotton or rayon/viscose with one or more companion material such as wool, synthetic fibers (e.g.
  • polyamide fibers acrylic fibers, polyester fibers, polyvinyl alcohol fibers, polyvinyl chloride fibers, polyvinylidene chloride fibers, polyurethane fibers, polyurea fibers, aramid fibers), and cellulose-containing fibers (e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fibers, lyocell).
  • cellulose-containing fibers e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fibers, lyocell.
  • the detergent compositions according to the present invention comprise a surfactant system, wherein the surfactant can be selected from nonionic and/or anionic and/or cationic and/or ampholytic and/or zwitterionic and/or semi-polar surfactants.
  • the surfactant is typically present at a level from 0.1% to 60% by weight.
  • the surfactant is preferably formulated to be compatible with enzyme components present in the composition.
  • the surfactant is most preferably formulated in such a way that it promotes, or at least does not degrade, the stability of any enzyme in these compositions.
  • Preferred systems to be used according to the present invention comprise as a surfactant one or more of the nonionic and/or anionic surfactants described herein.
  • Polyethylene, polypropylene, and polybutylene oxide condensates of alkyl phenols are suitable for use as the nonionic surfactant of the surfactant systems of the present invention, with the polyethylene oxide condensates being preferred.
  • These compounds include the condensation products of alkyl phenols having an alkyl group containing from about 6 to about 14 carbon atoms, preferably from about 8 to about 14 carbon atoms, in either a straight chain or branched-chain configuration with the alkylene oxide.
  • the ethylene oxide is present in an amount: equal to from about 2 to about 25 moles, more preferably from about 3 to about 15 moles, of ethylene oxide per mole of alkyl phenol.
  • nonionic surfactants of this type include IgepalTM CO-630, marketed by the GAF Corporation; and TritonTM X-45, X-114, X-100 and X-102, all marketed by the Rohm & Haas Company. These surfactants are commonly referred to as alkylphenol alkoxylates (e.g., alkyl phenol ethoxylat(es).
  • the condensation products of primary and secondary aliphatic alcohols with about 1 to about 25 moles of ethylene oxide are suitable for use as the nonionic surfactant of the nonionic surfactant systems of the present invention.
  • the alkyl chain of the aliphatic alcohol can either be straight or branched, primary or secondary, and generally contains from about 8 to about 22 carbon atoms.
  • About 2 to about 7 moles of ethylene oxide and most preferably from 2 to 5 moles of ethylene oxide per mole of alcohol are present in said condensation products.
  • nonionic surfactants of this type include TergitolTM 15-S-9 (The condensation product of C11-C15 linear alcohol with 9 moles ethylene oxide), TergitolTM 24-L-6 NMW (the condensation product of C12-C14 primary alcohol with 6 moles ethylene oxide with a narrow molecular weight distribution), both marketed by Union Carbide Corporation; NeodolTM 45-9 (the condensation product of C14-C15 linear alcohol with 9 moles of ethylene oxide), NeodolTM 23-3 (the condensation product of C12-C13 linear alcohol with 3.0 moles of ethylene oxide), NeodolTM 45-7 (the condensation product of C14-C15 linear alcohol with 7 moles of ethylene oxide), NeodolTM 45-5 (the condensation product of C14-C15 linear alcohol with 5 moles of ethylene oxide) marketed by Shell Chemical Company, KyroTM EOB (the condensation product of C13-C15 alcohol with 9 moles ethylene oxide), marketed by The Procter & Gamble Company, and Genapol
  • alkylpolysaccharides disclosed in U.S. Pat. No. 4,565,647, having a hydrophobic group containing from about 6 to about 30 carbon atoms, preferably from about 10 to about 16 carbon atoms and a polysaccharide, e.g. a polyglycoside, hydrophilic group containing from about 1.3 to about 10, preferably from about 1.3 to about 3, most preferably from about 1.3 to about 2.7 saccharide units.
  • Any reducing saccharide containing 5 or 6 carbon atoms can be used, e.g., glucose, galactose and galactosyl moieties can be substituted for the glucosyl moieties (optionally the hydrophobic group is attached at the 2-, 3-, 4-, etc. positions thus giving a glucose or galactose as opposed to a glucoside or galactoside).
  • the intersaccharide bonds can be, e.g., between the one position of the additional saccharide units and the 2-, 3-, 4-, and/or 6- positions on the preceding saccharide units.
  • R2 is selected from the group consisting of alkyl, alkylphenyl, hydroxyalkyl, hydroxyalkylphenyl, and mixtures thereof in which the alkyl groups contain from about 10 to about 18, preferably from about 12 to about 14, carbon atoms; n is 2 or 3, preferably 2; t is from 0 to about 10, preferably 0; and x is from about 1.3 to about 10, preferably from about 1.3 to about 3, most preferably from about 1.3 to about 2.7.
  • the glycosyl is preferably derived from glucose. To prepare these compounds, the alcohol or alkylpolyethoxy alcohol is formed first and then reacted with glucose, or a source of glucose, to form the glucoside (attachment at the 1-position). The additional glycosyl units can then be attached between their 1-position and the preceding glycosyl units 2-, 3-, 4-, and/or 6-position, preferably predominantly the 2-position.
  • the condensation products of ethylene oxide with a hydrophobic base formed by the condensation of propylene oxide with propylene glycol are also suitable for use as the additional nonionic surfactant systems of the present invention.
  • the hydrophobic portion of these compounds will preferably have a molecular weight from about 1500 to about 1800 and will exhibit water insolubility.
  • the addition of polyoxyethylene moieties to this hydrophobic portion tends to increase the water solubility of the molecule as a whole, and the liquid character of the product is retained up to the point where the polyoxyethylene content is about 50% of the total weight of the condensation product, which corresponds to condensation with up to about 40 moles of ethylene oxide.
  • Examples of compounds of this type include certain of the commercially available PluronicTM surfactants, marketed by BASF.
  • nonionic surfactant of the nonionic surfactant system of the present invention are the condensation products of ethylene oxide with the product resulting from the reaction of propylene oxide and ethylenediamine.
  • the hydrophobic moiety of these products consists of the reaction product of ethylenediamine and excess propylene oxide, and generally has a molecular weight of from about 2500 to about 3000.
  • This hydrophobic moiety is condensed with ethylene oxide to the extent that the condensation product contains from about 40% to about 80% by weight of polyoxyethylene and has a molecular weight of from about 5,000 to about 11,000.
  • this type of nonionic surfactant include certain of the commercially available TetronicTM compounds, marketed by BASF.
  • Preferred for use as the nonionic surfactant of the surfactant systems of the present invention are polyethylene oxide condensates of alkyl phenols, condensation products of primary and secondary aliphatic alcohols with from about 1 to about 25 moles of ethyleneoxide, alkylpolysaccharides, and mixtures hereof. Most preferred are C8-C14 alkyl phenol ethoxylates having from 3 to 15 ethoxy groups and C8-C18 alcohol ethoxylates (preferably C10 avg.) having from 2 to 10 ethoxy groups, and mixtures thereof.
  • Highly preferred nonionic surfactants are polyhydroxy fatty acid amide surfactants of the formula
  • R1 is H, or R1 is C1-4 hydrocarbyl, 2-hydroxyethyl, 2-hydroxypropyl or a mixture thereof, R2 is C5-31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative thereof.
  • R1 is methyl
  • R2 is straight C11-15 alkyl or C16-18 alkyl or alkenyl chain such as coconut alkyl or mixtures thereof
  • Z is derived from a reducing sugar such as glucose, fructose, maltose or lactose, in a reductive amination reaction.
  • Highly preferred anionic surfactants include alkyl alkoxylated sulfate surfactants.
  • Examples hereof are water soluble salts or acids of the formula RO(A)mSO3M wherein R is an unsubstituted C10-C-24 alkyl or hydroxyalkyl group having a C10-C24 alkyl component, preferably a C12-C20 alkyl or hydroxyalkyl, more preferably C12-C18 alkyl or hydroxyalkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically between about 0.5 and about 6, more preferably between about 0.5 and about 3, and M is H or a cation which can be, for example, a metal cation (e.g., sodium, potassium, lithium, calcium, magnesium, etc.), ammonium or substituted-ammonium cation.
  • R is an unsubstituted C10-C-24 alkyl or hydroxyalkyl group having a C10-C24 alky
  • Alkyl ethoxylated sulfates as well as alkyl propoxylated sulfates are contemplated herein.
  • Specific examples of substituted ammonium cations include methyl-, dimethyl, trimethyl-ammonium cations and quaternary ammonium cations such as tetramethyl-ammonium and dimethyl piperdinium cations and those derived from alkylamines; such as ethylamine, diethylamine, triethylamine, mixtures thereof, and the like.
  • Exemplary surfactants are C12-C18 alkyl polyethoxylate (1.0) sulfate (C12-C18E(1.0)M), C12-C18 alkyl polyethoxylate (2.25) sulfate (C12-C18(2.25)M, and C12-C18 alkyl polyethoxylate (3.0) sulfate (C12-C18E(3.0)M), and C12-C18 alkyl polyethoxylate (4.0) sulfate (C12-C18E(4.0)M), wherein M is conveniently selected from sodium and potassium.
  • Suitable anionic surfactants to be used are alkyl ester sulfonate surfactants including linear esters of C8-C20 carboxylic acids (i.e., fatty acids) which are sulfonated with gaseous SO3 according to “The Journal of the American Oil Chemists Society”, 52 (1975), pp. 323-329.
  • Suitable starting materials would include natural fatty substances as derived from tallow, palm oil, etc.
  • alkyl ester sulfonate surfactant especially for laundry applications, comprise alkyl ester sulfonate surfactants of the structural formula:
  • R3 is a C8-C20 hydrocarbyl, preferably an alkyl, or combination thereof
  • R4 is a C1-C6 hydrocarbyl, preferably an alkyl, or combination thereof
  • M is a cation which forms a water soluble salt with the alkyl ester sulfonate.
  • Suitable salt-forming cations include metals such as sodium, potassium, and lithium, and substituted or unsubstituted ammonium cations, such as monoethanolamine, diethonolamine, and triethanolamine.
  • R3 is C10-C16 alkyl
  • R4 is methyl, ethyl or isopropyl.
  • the methyl ester sulfonates wherein R3 is C10-C16 alkyl.
  • alkyl sulfate surfactants which are water soluble salts or acids of the formula ROSO3M wherein R preferably is a C10-C24 hydrocarbyl, preferably an alkyl or hydroxyalkyl having a C10-C20 alkyl component, more preferably a C12-C18 alkyl or hydroxyalkyl, and M is H or a cation, e.g., an alkali metal cation (e.g. sodium, potassium, lithium), or ammonium or substituted ammonium (e.g.
  • R preferably is a C10-C24 hydrocarbyl, preferably an alkyl or hydroxyalkyl having a C10-C20 alkyl component, more preferably a C12-C18 alkyl or hydroxyalkyl
  • M is H or a cation, e.g., an alkali metal cation (e.g. sodium, potassium, lithium), or ammonium or substituted ammonium (e.g
  • alkylamines such as ethylamine, diethylamine, triethylamine, and mixtures thereof, and the like.
  • alkyl chains of C12-C16 are preferred for lower wash temperatures (e.g. below about 50° C.) and C16-C18 alkyl chains are preferred for higher wash temperatures (e.g. above about 50° C.).
  • anionic surfactants useful for detersive purposes can also be included in the laundry detergent compositions of the present invention. Theses can include salts (including, for example, sodium, potassium, ammonium, and substituted ammonium salts such as mono- di- and triethanolamine salts) of soap, C8-C22 primary or secondary alkanesulfonates, C8-C24 olefinsulfonates, sulfonated polycarboxylic acids prepared by sulfonation of the pyrolyzed product of alkaline earth metal citrates, e.g., as described in British patent specification No.
  • salts including, for example, sodium, potassium, ammonium, and substituted ammonium salts such as mono- di- and triethanolamine salts
  • C8-C22 primary or secondary alkanesulfonates C8-C24 olefinsulfonates
  • sulfonated polycarboxylic acids prepared by sulfonation of the pyrolyzed product of
  • alkylpolyglycolethersulfates (containing up to 10 moles of ethylene oxide); alkyl glycerol sulfonates, fatty acyl glycerol sulfonates, fatty oleyl glycerol sulfates, alkyl phenol ethylene oxide ether sulfates, paraffin sulfonates, alkyl phosphates, isethionates such as the acyl isethionates, N-acyl taurates, alkyl succinamates and sulfosuccinates, monoesters of sulfosuccinates (especially saturated and unsaturated C12-C18 monoesters) and diesters of sulfosuccinates (especially saturated and unsaturated C6-C12 diesters), acyl sarcosinates, sulfates of alkylpolysaccharides such as the sulfates of
  • Alkylbenzene sulfonates are highly preferred. Especially preferred are linear (straight-chain) alkyl benzene sulfonates (LAS) wherein the alkyl group preferably contains from 10 to 18 carbon atoms.
  • LAS linear (straight-chain) alkyl benzene sulfonates
  • the laundry detergent compositions of the present invention typically comprise from about 1% to about 40%, preferably from about 3% to about 20% by weight of such anionic surfactants.
  • the laundry detergent compositions of the present invention may also contain cationic, ampholytic, zwitterionic, and semi-polar surfactants, as well as the nonionic and/or anionic surfactants other than those already described herein.
  • Cationic detersive surfactants suitable for use in the laundry detergent compositions of the present invention are those having one long-chain hydrocarbyl group.
  • cationic surfactants include the ammonium surfactants such as alkyltrimethylammonium halogenides, and those surfactants having the formula:
  • R2 is an alkyl or alkyl benzyl group having from about 8 to about 18 carbon atoms in the alkyl chain
  • each R3 is selected form the group consisting of —CH2CH2—, —CH2CH(CH3)—, —CH2CH(CH20H)—, —CH2CH2CH2—, and mixtures thereof
  • each R4 is selected from the group consisting of C1-C4 alkyl, C1-C4 hydroxyalkyl, benzyl ring structures formed by joining the two R4 groups, —CH2CHOHCHOHCOR6CHOHCH2OH, wherein R6 is any hexose or hexose polymer having a molecular weight less than about 1000, and hydrogen when y is not 0
  • R5 is the same as R4 or is an alkyl chain, wherein the total number of carbon atoms or R2 plus R5 is not more than about 18
  • each y is from 0 to about 10, and the sum of
  • Highly preferred cationic surfactants are the water soluble quaternary ammonium compounds useful in the present composition having the formula:
  • R1 is C8-C16 alkyl
  • each of R2, R3 and R4 is independently C1-C4 alkyl, C1-C4 hydroxy alkyl, benzyl, and —(C2H40)xH where x has a value from 2 to 5, and X is an anion.
  • R2, R3 or R4 should be benzyl.
  • the preferred alkyl chain length for R1 is C12-C15, particularly where the alkyl group is a mixture of chain lengths derived from coconut or palm kernel fat or is derived synthetically by olefin build up or OXO alcohols synthesis.
  • Preferred groups for R2R3 and R4 are methyl and hydroxyethyl groups and the anion X may be selected from halide, methosulphate, acetate and phosphate ions.
  • coconut trimethyl ammonium chloride or bromide coconut trimethyl ammonium chloride or bromide
  • choline esters compounds of formula (i) wherein R1 is CH2—CH2—O—C—C12-14 alkyl and R2R3R4 are methyl).
  • the laundry detergent compositions of the present invention typically comprise from 0.2% to about 25%, preferably from about 1% to about 8% by weight of such cationic surfactants.
  • Ampholytic surfactants are also suitable for use in the laundry detergent compositions of the present invention. These surfactants can be broadly described as aliphatic derivatives of secondary or tertiary amines, or aliphatic derivatives of heterocyclic secondary and tertiary amines in which the aliphatic radical can be straight- or branched-chain.
  • One of the aliphatic substituents contains at least about 8 carbon atoms, typically from about 8 to about 18 carbon atoms, and at least one contains an anionic water-solubilizing group, e.g. carboxy, sulfonate, sulfate. See U.S. Pat. No. 3,929,678 (column 19, lines 18-35) for examples of ampholytic surfactants.
  • the laundry detergent compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such ampholytic surfactants.
  • Zwitterionic surfactants are also suitable for use in laundry detergent compositions. These surfactants can be broadly described as derivatives of secondary and tertiary amines, derivatives of heterocyclic secondary and tertiary amines, or derivatives of quaternary ammonium, quaternary phosphonium or tertiary sulfonium compounds. See U.S. Pat. No. 3,929,678 (column 19, line 38 through column 22, line 48) for examples of zwitterionic surfactants.
  • the laundry detergent compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such zwitterionic surfactants.
  • Semi-polar nonionic surfactants are a special category of nonionic surfactants which include water-soluble amine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms and 2 moieties selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; water soluble phosphine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms and 2 moieties selected from the group consisting of is alkyl groups and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; and water-soluble sulfoxides containing one alkyl moiety from about 10 to about 18 carbon atoms and a moiety selected from the group consisting of alkyl and hydroxyalkyl moieties of from about 1 to about 3 carbon atoms.
  • Semi-polar nonionic detergent surfactants include the amine oxide surfactants having the formula:
  • R3 is an alkyl, hydroxyalkyl, or alkyl phenyl group or mixtures thereof containing from about 8 to about 22 carbon atoms
  • R4 is an alkylene or hydroxyalkylene group containing from about 2 to about 3 carbon atoms or mixtures thereof
  • x is from 0 to about 3
  • each R5 is an alkyl or hydroxyalkyl group containing from about 1 to about 3 carbon atoms or a polyethylene oxide group containing from about 1 to about 3 ethylene oxide groups.
  • the R5 groups can be attached to each other, e.g., through an oxygen or nitrogen atom, to form a ring structure.
  • amine oxide surfactants in particular include C10-C18 alkyl dimethyl amine oxides and C8-C12 alkoxy ethyl dihydroxy ethyl amine oxides.
  • the laundry detergent compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such semi-polar nonionic surfactants.
  • compositions according to the present invention may further comprise a builder system.
  • a builder system Any conventional builder system is suitable for use herein including aluminosilicate materials, silicates, polycarboxylates and fatty acids, materials such as ethylenediamine tetraacetate, metal ion sequestrants such as aminopolyphosphonates, particularly ethylenediamine tetramethylene phosphonic acid and diethylene triamine pentamethylenephosphonic acid.
  • phosphate builders can also be used herein.
  • Suitable builders can be an inorganic ion exchange material, commonly an inorganic hydrated aluminosilicate material, more particularly a hydrated synthetic zeolite such as hydrated zeolite A, X, B, HS or MAP.
  • inorganic ion exchange material commonly an inorganic hydrated aluminosilicate material, more particularly a hydrated synthetic zeolite such as hydrated zeolite A, X, B, HS or MAP.
  • SKS-6 is a crystalline layered silicate consisting of sodium silicate (Na2Si2O5).
  • Suitable polycarboxylates containing one carboxy group include lactic acid, glycolic acid and ether derivatives thereof as disclosed in Belgian Patent Nos. 831,368, 821,369 and 821,370.
  • Polycarboxylates containing two carboxy groups include the water-soluble salts of succinic acid, malonic acid, (ethylenedioxy) diacetic acid, maleic acid, diglycollic acid, tartaric acid, tartronic acid and fumaric acid, as well as the ether carboxylates described in German Offenle-enschrift 2,446,686, and 2,446,487, U.S. Pat. No. 3,935,257 and the sulfinyl carboxylates described in Belgian Patent No. 840,623.
  • Polycarboxylates containing three carboxy groups include, in particular, water-soluble citrates, aconitrates and citraconates as well as succinate derivatives such as the carboxymethyloxysuccinates described in British Patent No. 1,379,241, lactoxysuccinates described in Netherlands Application 7205873, and the oxypolycarboxylate materials such as 2-oxa-1,1,3-propane tricarboxylates described in British Patent No. 1,387,447.
  • Polycarboxylates containing four carboxy groups include oxydisuccinates disclosed in British Patent No. 1,261,829, 1,1,2,2,-ethane tetracarboxylates, 1,1,3,3-propane tetracarboxylates containing sulfo substituents include the sulfosuccinate derivatives disclosed in British Patent Nos. 1,398,421 and 1,398,422 and in U.S. Pat. No. 3,936,448, and the sulfonated pyrolysed citrates described in British Patent No. 1,082,179, while polycarboxylates containing phosphone substituents are disclosed in British Patent No. 1,439,000.
  • Alicyclic and heterocyclic polycarboxylates include cyclopentane-cis,cis-cis-tetracarboxylates, cyclopentadienide pentacarboxylates, 2,3,4,5-tetrahydro-furan—cis, cis, cis-tetracarboxylates, 2,5-tetrahydro-furan-tetrahydro-furan-cis, discarboxylates, 2,2,5,5,-tetrahydrofuran—tetracarboxylates, 1,2,3,4,5,6-hexane—hexacarboxylates and carboxymethyl derivatives of polyhydric alcohols such as sorbitol, mannitol and xylitol.
  • Aromatic polycarboxylates include mellitic acid, pyromellitic acid and the phthalic acid derivatives disclosed in British Patent No. 1,425,343.
  • the preferred polycarboxylates are hydroxy-carboxylates containing up to three carboxy groups per molecule, more particularly citrates.
  • Preferred builder systems for use in the present compositions include a mixture of a water-insoluble aluminosilicate builder such as zeolite A or of a layered silicate (SKS-6), and a water-soluble carboxylate chelating agent such as citric acid.
  • a water-insoluble aluminosilicate builder such as zeolite A or of a layered silicate (SKS-6)
  • a water-soluble carboxylate chelating agent such as citric acid.
  • a suitable chelant for inclusion in the detergent composi-ions in accordance with the invention is ethylenediamine-N,N′-disuccinic acid (EDDS) or the alkali metal, alkaline earth metal, ammonium, or substituted ammonium salts thereof, or mixtures thereof.
  • EDDS compounds are the free acid form and the sodium or magnesium salt thereof. Examples of such preferred sodium salts of EDDS include Na2EDDS and Na4EDDS. Examples of such preferred magnesium salts of EDDS include MgEDDS and Mg2EDDS. The magnesium salts are the most preferred for inclusion in compositions in accordance with the invention.
  • Preferred builder systems include a mixture of a water-insoluble aluminosilicate builder such as zeolite A, and a water soluble carboxylate chelating agent such as citric acid.
  • builder materials that can form part of the builder system for use in granular compositions include inorganic materials such as alkali metal carbonates, bicarbonates, silicates, and organic materials such as the organic phosphonates, amino polyalkylene phosphonates and amino polycarboxylates.
  • Suitable water-soluble organic salts are the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated form each other by not more than two carbon atoms.
  • Polymers of this type are disclosed in GB-A-1,596,756.
  • Examples of such salts are polyacrylates of MW 2000-5000 and their copolymers with maleic anhydride, such copolymers having a molecular weight of from 20,000 to 70,000, especially about 40,000.
  • Detergency builder salts are normally included in amounts of from 5% to 80% by weight of the composition. Preferred levels of builder for liquid detergents are from 5% to 30%.
  • Preferred detergent compositions in addition to the enzyme preparation of the invention, comprise other enzyme(s) which provides cleaning performance and/or fabric care benefits.
  • Such enzymes include proteases, lipases, cutinases, amylases, cellulases, peroxidases, oxidases (e.g. laccases).
  • protease suitable for use in alkaline solutions can be used. Suitable proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically or genetically modified mutants are included.
  • the protease may be a serine protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270.
  • Preferred commercially available protease enzymes include those sold under the trade names Alcalase, Savinase, Primase, Durazym, and Esperase by Novo Nordisk A/S (Denmark), those sold under the tradename Maxatase, Maxacal, Maxapem, Properase, Purafect and Purafect OXP by Genencor International, and those sold under the tradename Opticlean and Optimase by Solvay Enzymes.
  • Protease enzymes may be incorporated into the compositions in accordance with the invention at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at Ea level of from 0.01% to 0.2% of enzyme protein by weight of the composition.
  • Lipases Any lipase suitable for use in alkaline solutions can be used. Suitable lipases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included.
  • Examples of useful lipases include a Humicola lanuginosa lipase, e.g., as described in EP 258 068 and EP 305 216, a Rhizomucor miehei lipase, e.g., as described in EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C. antarctica lipase A or B described in EP: 214 761, a Pseudomonas lipase such as a P. alcaligenes and P. pseudoalcaligenes lipase, e.g., as described in EP 218 272, a P.
  • a Humicola lanuginosa lipase e.g., as described in EP 258 068 and EP 305 216
  • a Rhizomucor miehei lipase e.g., as described in EP 238 023
  • cepacia lipase e.g., as described in EP 331 376, a P. stutzeri lipase, e.g., as disclosed in GB 1,372,034, a P. fluorescens lipase, a Bacillus lipase, e.g., a B. subtilis lipase (Dartois et al., (1993), Biochemica et Biophysica acta 1131, 253-260), a B. stearothermophilus lipase (JP 64/744992) and a B. pumilus lipase (WO 91/16422).
  • cloned lipases may be useful, including the Penicillium camembertii lipase described by Yamaguchi et al., (1991), Gene 103, 61-67), the Geotricum candidum lipase (Schimada, Y. et al., (1989), J. Biochem., 106, 383-388), and various Rhizopus lipases such as a R. delemar lipase (Hass, M. J. et al., (1991), Gene 109, 117-113), a R. niveus lipase (Kugimiya et al., (1992), Biosci. Biotech. Biochem. 56, 716-719) and a R. oryzae lipase.
  • R. delemar lipase Hass, M. J. et al., (1991), Gene 109, 117-113
  • R. niveus lipase Kugimi
  • cutinases Other types of lipolytic enzymes such as cutinases may also be useful, e.g., a cutinase derived from Pseudomonas mendocina as described in WO 88/09367, or a cutinase derived from Fusarium solani pisi (e.g. described in WO 90/09446).
  • lipases such as M1 LipaseTM, Luma fastTM and LipomaxTM (Genencor), LipolaseTM and Lipolase UltraTM (Novo Nordisk A/S), and Lipase P “Amano” (Amano Pharmaceutical Co. Ltd.).
  • the lipases are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition.
  • Amylases Any amylase (a and/or b) suitable for use in alkaline solutions can be used. Suitable amylases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Amylases include, for example, a-amylases obtained from a special strain of B. licheniformis, described in more detail in GB 1,296,839. Commercially available amylases are DuramylTM, TermamylTM, FungamylTM and BANTM (available from Novo Nordisk A/S) and RapidaseTM and Maxamyl PTM (available from Genencor).
  • the amylases are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition.
  • Cellulases Any cellulase suitable for use in alkaline solutions can be used. Suitable cellulases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Suitable cellulases are disclosed in U.S. Pat. No. 4,435,307, which discloses fungal cellulases produced from Humicola insolens. Especially suitable cellulases are the 15 cellulases having color care benefits. Examples of such cellulases are cellulases described in European patent application No. 0 495 257 and the endoglucanase of the present invention.
  • CelluzymeTM produced by a strain of Humicola insolens , (Novo Nordisk A/S), and KAC-500(B)TM (Kao Corporation).
  • Cellulases are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition.
  • Peroxidases/Oxidases Peroxidase enzymes are used in combination with hydrogen peroxide or a source thereof (e.g. a percarbonate, perborate or persulfate). Oxidase enzymes are used in combination with oxygen. Both types of enzymes are used for “solution bleaching”, i.e. to prevent transfer of a textile dye from a dyed fabric to another fabric when said fabrics are washed together in a wash liquor, preferably together with an enhancing agent as described in e.g. WO 94/12621 and WO 95/01426. Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically or genetically modified mutants are included.
  • Peroxidase and/or oxidase enzymes are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition.
  • Mixtures of the above mentioned enzymes are encompassed herein, in particular a mixture of a protease, an amylase, a lipase and/or a cellulase.
  • the enzyme of the invention is normally incorporated in the detergent composition at a level from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level from 0.01% to 0.2% of enzyme protein by weight of the composition.
  • Additional optional detergent ingredients that can be included in the detergent compositions of the present invention include bleaching agents such as PB1, PB4 and percarbonate with a particle size of 400-800 microns.
  • bleaching agent components can include one or more oxygen bleaching agents and, depending upon the bleaching agent chosen, one or more bleach activators. When present oxygen bleaching compounds will typically be present at levels of from about 1% to about 25%. In general, bleaching compounds are optional added components in non-liquid formulations, e.g. granular detergents.
  • the bleaching agent component for use herein can be any of the bleaching agents useful for detergent compositions including oxygen bleaches as well as others known in the art.
  • the bleaching agent suitable for the present invention can be an activated or non-activated bleaching agent.
  • One category of oxygen bleaching agent that can be used encompasses percarboxylic acid bleaching agents and salts thereof. Suitable examples of this class of agents include magnesium monoperoxyphthalate hexahydrate, the magnesium salt of meta-chloro perbenzoic acid, 4-nonylamino-4-oxoperoxybutyric acid and diperoxydodecanedioic acid.
  • Such bleaching agents are disclosed in U.S. Pat. No. 4,483,781, U.S. Pat. No. 740,446, EP 0 133 354 and U.S. Pat. No. 4,412,934.
  • Highly preferred bleaching agents also include 6-nonylamino-6-oxoperoxycaproic acid as described in U.S. Pat. No. 4,634,551.
  • bleaching agents that can be used encompasses the halogen bleaching agents.
  • hypohalite bleaching agents include trichloro isocyanuric acid and the sodium and potassium dichloroisocyanurates and N-chloro and N-bromo alkane sulphonamides. Such materials are normally added at 0.5-10% by weight of the finished product, preferably 1-5% by weight.
  • the hydrogen peroxide releasing agents can be used in combination with bleach activators such as tetra-acetylethylenediamine (TAED), nonanoyloxybenzenesulfonate (NOBS, described in U.S. Pat. No. 4,412,934), 3,5-trimethyl-hexsanoloxybenzenesulfonate (ISONOBS, described in EP 120 591) or pentaacetylglucose (PAG), which are perhydrolyzed to form a peracid as the active bleaching species, leading to improved bleaching effect.
  • bleach activators such as tetra-acetylethylenediamine (TAED), nonanoyloxybenzenesulfonate (NOBS, described in U.S. Pat. No. 4,412,934), 3,5-trimethyl-hexsanoloxybenzenesulfonate (ISONOBS, described in EP 120 591) or pentaacetylglucose (PA
  • bleach activators C8(6-octanamido-caproyl) oxybenzene-sulfonate, C9(6-nonanamido caproyl) oxybenzenesulfonate and C10 (6-decanamido caproyl) oxybenzenesulfonate or mixtures thereof.
  • acylated citrate esters such as disclosed in European Patent Application No. 91870207.7.
  • bleaching agents including peroxyacids and bleaching systems comprising bleach activators and peroxygen bleaching compounds for use in cleaning compositions according to the invention are described in application U.S. Ser. No. 08/136,626.
  • the hydrogen peroxide may also be present by adding an enzymatic system (i.e. an enzyme and a substrate therefore) which is capable of generation of hydrogen peroxide at the beginning or during the washing and/or rinsing process.
  • an enzymatic system i.e. an enzyme and a substrate therefore
  • Such enzymatic systems are disclosed in European Patent Application EP 0 537 381.
  • Bleaching agents other than oxygen bleaching agents are also known in the art and can be utilized herein.
  • One type of non-oxygen bleaching agent of particular interest includes photoactivated bleaching agents such as the sulfonated zinc and/or aluminium phthalocyanines. These materials can be deposited upon the substrate during the washing process. Upon irradiation with light, in the presence of oxygen, such as by hanging clothes out to dry in the daylight, the sulfonated zinc phthalocyanine is activated and, consequently, the substrate is bleached.
  • Preferred zinc phthalocyanine and a photoactivated bleaching process are described in U.S. Pat. No. 4,033,718.
  • detergent composition will contain about 0.025% to about 1.25%, by weight, of sulfonated zinc phthalocyanine.
  • Bleaching agents may also comprise a manganese catalyst.
  • the manganese catalyst may, e.g., be one of the compounds described in “Efficient manganese catalysts for low-temperature bleaching”, Nature 369, 1994, pp. 637-639.
  • a suds suppressor exemplified by silicones, and silica-silicone mixtures.
  • Silicones can generally be represented by alkylated polysiloxane materials, while silica is normally used in finely divided forms exemplified by silica aerogels and xerogels and hydrophobic silicas of various types. Theses materials can be incorporated as particulates, in which the suds suppressor is advantageously releasably incorporated in a water-soluble or water-dispersible, substantially non surface-active detergent impermeable carrier. Alternatively the suds suppressor can be dissolved or dispersed in a liquid carrier and applied by spraying on to one or more of the other components.
  • a preferred silicone suds controlling agent is disclosed in U.S. Pat. No. 3,933,672.
  • Other particularly useful suds suppressors are the self-emulsifying silicone suds suppressors, described in German Patent Application DTOS 2,646,126.
  • An example of such a compound is DC-544, commercially available form Dow Corning, which is a siloxane-glycol copolymer.
  • Especially preferred suds controlling agent are the suds suppressor system comprising a mixture of silicone oils and 2-alkyl-alkanols. Suitable 2-alkyl-alkanols are 2-butyl-octanol which are commercially available under the trade name Isofol 12 R.
  • compositions can comprise a silicone/silica mixture in combination with fumed nonporous silica such as AerosilR.
  • the suds suppressors described above are normally employed at levels of from 0.001% to 2% by weight of the composition, preferably from 0.01% to 1% by weight.
  • compositions may be employed such as soil-suspending agents, soil-releasing agents, optical brighteners, abrasives, bactericides, tarnish inhibitors, coloring agents, and/or encapsulated or nonencapsulated perfumes.
  • encapsulating materials are water soluble capsules which consist of a matrix of polysaccharide and polyhydroxy compounds such as described in GB 1,464,616.
  • Suitable water soluble encapsulating materials comprise dextrins derived from ungelatinized starch acid esters of substituted dicarboxylic acids such as described in U.S. Pat. No. 3,455,838. These acid-ester dextrins are, preferably, prepared from such starches as waxy maize, waxy sorghum, sago, tapioca and potato. Suitable examples of said encapsulation materials include N-Lok manufactured by National Starch. The N-Lok encapsulating material consists of a modified maize starch and glucose. The starch is modified by adding monofunctional substituted groups such as octenyl succinic acid anhydride.
  • Antiredeposition and soil suspension agents suitable herein include cellulose derivatives such as methylcellulose, carboxymethylcellulose and hydroxyethylcellulose, and homo- or co-polymeric polycarboxylic acids or their salts.
  • Polymers of this type include the polyacrylates and maleic anhydride-acrylic acid copolymers previously mentioned as builders, as well as copolymers of maleic anhydride with ethylene, methylvinyl ether or methacrylic acid, the maleic anhydride constituting at least 20 mole percent of the copolymer. These materials are normally used at levels of from 0.5% to 10% by weight, more preferably form 0.75% to 8%, most preferably from 1% to 6% by weight of the composition.
  • Preferred optical brighteners are anionic in character, examples of which are disodium 4,4′-bis-(2-diethanolamino-4-anilino -s- triazin-6-ylamino)stilbene-2:2′-disulphonate, disodium 4, -4′-bis-(2-morpholino-4-anilino-s-triazin-6-ylamino-stilbene-2:2′-disulphonate, disodium 4,4′bis-(2,4-dianilino-s-triazin-6-ylamino)stilbene-2:2′-disulphonate, monosodium 4′,4′′bis-(2,4-dianilino-s-tri-azin-6 ylamino)stilbene-2-sulphonate, disodium 4,4′-bis-(2-anillino-4-(N-methyl-N-2-hydroxethylamino)-s-triazin-6-ylamino) stilbene-2,2′
  • polyethylene glycols particularly those of molecular weight 1000-10000, more particularly 2000 to 8000 and most preferably about 4000. These are used at levels of from 0.20% to 5% more preferably from 0.25% to 2.5% by weight. These polymers and the previously mentioned homo- or co-polymeric poly-carboxylate salts are valuable for improving whiteness maintenance, fabric ash deposition, and cleaning performance on clay, proteinaceous and oxidizable soils in the presence of transition metal impurities.
  • Soil release agents useful in compositions of the resent invention are conventionally copolymers or terpolymers f terephthalic acid with ethylene glycol and/or propylene lycol units in various arrangements. Examples of such polymers are disclosed in U.S. Pat. Nos. 4,116,885 and 4,711,730 and EP 0 272 033. A particular preferred polymer in accordance with EP 0 272 033 has the formula:
  • PEG is —(OC2H4)O—
  • PO is (OC3H6O)
  • T is (pOOC6H4CO).
  • polyesters as random copolymers of dimethyl terephthalate, dimethyl sulfoisophthalate, ethylene glycol and 1,2-propanediol, the end groups consisting primarily of sulphobenzoate and secondarily of mono esters of ethylene glycol and/or 1,2-propanediol.
  • the target is to obtain a polymer capped at both end by sulphobenzoate groups, “primarily”, in the present context most of said copolymers herein will be endcapped by sulphobenzoate groups.
  • some copolymers will be less than fully capped, and therefore their end groups may consist of monoester of ethylene glycol and/or 1,2-propanediol, thereof consist “secondarily” of such species.
  • the selected polyesters herein contain about 46% by weight of dimethyl terephthalic acid, about 16% by weight of 1,2-propanediol, about 10% by weight ethylene glycol, about 13% by weight of dimethyl sulfobenzoic acid and about 15% by weight of sulfoisophthalic acid, and have a molecular weight of about 3.000.
  • the polyesters and their method of preparation are described in detail in EP 311 342.
  • Fabric softening agents can also be incorporated into laundry detergent compositions in accordance with the present invention. These agents may be inorganic or organic in type. Inorganic softening agents are exemplified by the smectite clays disclosed in GB-A-1 400898 and in U.S. Pat. No. 5,019,292. Organic fabric softening agents include the water insoluble tertiary amines as disclosed in GB-A1 514 276 and EP 0 011 340 and their combination with mono C12-C14 quaternary ammonium salts are disclosed in E ⁇ -B-0 026 528 and di-long-chain amides as disclosed in EP 0 242 919. Other useful organic ingredients of fabric softening systems include high molecular weight polyethylene oxide materials as disclosed in EP 0 299 575 and 0 313 146.
  • Levels of smectite clay are normally in the range from 5% to 15%, more preferably from 8% to 12% by weight, with the material being added as a dry mixed component to the remainder of the formulation.
  • Organic fabric softening agents such as the water-insoluble tertiary amines or dilong chain amide materials are incorporated at levels of from 0.5% to 5% by weight, normally from 1% to 3% by weight whilst the high molecular weight polyethylene oxide materials and the water soluble cationic materials are added at levels of from 0.1% to 2%, normally from 0.15% to 1.5% by weight.
  • These materials are normally added to the spray dried portion of the composition, although in some instances it may be more convenient to add them as a dry mixed particulate, or spray them as molten liquid on to other solid components of the composition.
  • the detergent compositions according to the present invention may also comprise from 0.001% to 10%, preferably from 0.01% to 2%, more preferably form 0.05% to 1% by weight of polymeric dye- transfer inhibiting agents.
  • Said polymeric dye-transfer inhibiting agents are normally incorporated into detergent compositions in order to inhibit the transfer of dyes from colored fabrics onto fabrics washed therewith. These polymers have the ability of complexing or adsorbing the fugitive dyes washed out of dyed fabrics before the dyes have the opportunity to become attached to other articles in the wash.
  • Suitable polymeric dye-transfer inhibiting agents are polyamine N-oxide polymers, copolymers of N-vinyl-pyrrolidone and N-vinylimidazole, polyvinylpyrrolidone polymers, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
  • the detergent composition according to the invention can be in liquid, paste, gels, bars or granular forms.
  • Non-dusting granulates may be produced, e.g., as disclosed in U.S. Pat. Nos. 4,106,991 and 4,661,452 (both to Novo Industri A/S) and may optionally be coated by methods known in the art.
  • waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molecular weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
  • film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591.
  • Granular compositions according to the present invention can also be in “compact form”, i.e. they may have a relatively higher density than conventional granular detergents, i.e. form 550 to 950 g/l; in such case, the granular detergent compositions according to the present invention will contain a lower amount of “Inorganic filler salt”, compared to conventional granular detergents; typical filler salts are alkaline earth metal salts of sulphates and chlorides, typically sodium sulphate; “Compact” detergent typically comprise not more than 10% filler salt.
  • liquid compositions according to the present invention can also be in “concentrated form”, in such case, the liquid detergent compositions according to the present invention will contain a lower amount of water, compared to conventional liquid detergents.
  • the water content of the concentrated liquid detergent is less than 30%, more preferably less than 20%, most preferably less than 10% by weight of the detergent compositions.
  • compositions of the invention may for example, be formulated as hand and machine laundry detergent compositions including laundry additive compositions and compositions suitable for use in the pretreatment of stained fabrics, rinse added fabric softener compositions, and compositions for use in general household hard surface cleaning operations and dishwashing operations.
  • compositions for the present invention are not necessarily meant to limit or otherwise define the scope of the invention.
  • LAS Sodium linear C12 alkyl benzene sulphonate
  • TAS Sodium tallow alkyl sulphate
  • 25EY A C12-C15 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide
  • 45EY A C14-C15 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide
  • XYEZS C1X-C1Y sodium alkyl sulfate condensed with an average of Z moles of ethylene oxide per mole
  • Nonionic C13-C15 mixed ethoxylated/propoxylated fatty alcohol with an average degree of ethoxylation of 3.8 and an average degree of propoxylation of 4.5 sold under the tradename Plurafax LF404 by BASF Gmbh
  • CFAA C12-C14 alkyl N-methyl glucamide
  • TFAA C16-C18 alkyl N-methyl glucamide
  • NaSKS-6 Crystalline layered silicate of formula d-Na2Si2O5
  • MA/AA Copolymer of 1:4 maleic/acrylic acid, average molecular weight about 80,000
  • Polyacrylate Polyacrylate homopolymer with an average molecular weight of 8,000 sold under the tradename PA30 by BASF Gmbh
  • Zeolite A Hydrated Sodium Aluminosilicate of formula Na12(AlO2SiO2)12. 27H2O having a primary particle size in the range from 1 to 10 micrometers
  • Perborate Anhydrous sodium perborate monohydrate bleach, empirical formula NaBO2.H2O2
  • PB4 Anhydrous sodium perborate tetrahydrate
  • Percarbonate Anhydrous sodium percarbonate bleach of empirical formula 2Na2CO3.3H2O2
  • TAED Tetraacetyl ethylene diamine
  • CMC Sodium carboxymethyl cellulose
  • DETPMP Diethylene triamine penta (methylene phosphonic acid), marketed by Monsanto under the Tradename Dequest 2060
  • EDDS Ethylenediamine-N, N′-disuccinic acid, [S,S] isomer in the form of the sodium salt
  • Granular Suds suppressor 12% Silicone/silica, 18% stearyl alcohol, 70% starch in granular form
  • HMWPEO High molecular weight polyethylene oxide
  • TAE 25 Tallow alcohol ethoxylate (25)
  • a granular fabric cleaning composition in accordance with the invention may be prepared as follows: Sodium linear C12 alkyl 6.5 benzene sulfonate Sodium sulfate 15.0 Zeolite A 26.0 Sodium nitrilotriacetate 5.0 Enzyme of the invention 0.1 PVP 0.5 TAED 3.0 Boric acid 4.0 Perborate 18.0 Phenol sulphonate 0.1 Minors Up to 100
  • a compact granular fabric cleaning composition in accord with the invention may be prepared as follows: follows: 45AS 8.0 25E3S 2.0 25E5 3.0 25E3 3.0 TFAA 2.5 Zeolite A 17.0 NaSKS-6 12.0 Citric acid 3.0 Carbonate 7.0 MA/AA 5.0 CMC 0.4 Enzyme of the invention 0.1 TAED 6.0 Percarbonate 22.0 EDDS 0.3 Granular suds suppressor 3.5 water/minors Up to 100%
  • Granular fabric cleaning compositions in accordance with the invention which are especially useful in the laundering of coloured fabrics were prepared as follows: LAS 10.7 — TAS 2.4 — TFAA — 4.0 45AS 3.1 10.0 45E7 4.0 — 25E3S — 3.0 68E11 1.8 — 25E5 — 8.0 Citrate 15.0 7.0 Carbonate — 10 Citric acid 2.5 3.0 Zeolite A 32.1 25.0 Na-SKS-6 — 9.0 MA/AA 5.0 5.0 DETPMP 0.2 0.8 Enzyme of the invention 0.10 0.05 Silicate 2.5 — Sulphate 5.2 3.0 PVP 0.5 — Poly (4-vinylpyridine)-N- — 0.2 Oxide/copolymer of vinyl- imidazole and vinyl- pyrrolidone Perborate 1.0 — Phenol sulfonate 0.2 — Water/Minors Up to 100%
  • Granular fabric cleaning compositions in accordance with the invention which provide “Softening through the wash” capability may be prepared as follows: 45AS — 10.0 LAS 7.6 — 68AS 1.3 — 45E7 4.0 — 25E3 — 5.0 Coco-alkyl-dimethyl hydroxy- 1.4 1.0 ethyl ammonium chloride Citrate 5.0 3.0 Na-SKS-G — 11.0 Zeolite A 15.0 15.0 MA/AA 4.0 4.0 DETPMP 0.4 0.4 Perborate 15.0 — Percarbonate — 15.0 TAED 5.0 5.0 Smectite clay 10.0 10.0 HMWPEO — 0.1 Enzyme of the invention 0.10 0.05 Silicate 3.0 5.0 Carbonate 10.0 10.0 Granular suds suppressor 1.0 4.0 CMC 0.2 0.1 Water/Minors Up to 100%
  • Heavy duty liquid fabric cleaning compositions in accordance with the invention may be prepared as follows: I II LAS acid form — 25.0 Citric acid 5.0 2.0 25AS acid form 8.0 — 25AE2S acid form 3.0 — 25AE7 8.0 — CFAA 5 — DETPMP 1.0 1.0 Fatty acid 8 — Oleic acid — 1.0 Ethanol 4.0 5.0 Propanediol 2.0 6.0 Enzyme of the invention 0.10 0.05 Coco-alkyl dimethyl — 3.0 hydroxy ethyl ammonium chloride Smectite clay — 5.0 PVP 2.0 — Water/Minors Up to 100%
  • the present: invention relates to use of the endoglucanase of the invention in the bio-polishing process.
  • Bio-Polishing is a specific treatment of the yarn surface which improves fabric quality with respect to handle and appearance without loss of fabric wettability. The most important effects of Bio-Polishing can be characterized by less fuzz and pilling, increased gloss/luster, improved fabric handle, increased durable softness and altered water absorbency.
  • Bio-Polishing usually takes place in the wet processing of the manufacture of knitted and woven fabrics. Wet processing comprises such steps as e.g. desizing, scouring, bleaching, washing, dying/printing and finishing. During each of these steps, the fabric is more or less subjected to mechanical action.
  • Desizing is the act of removing size from textiles.
  • warp yarns Prior to weaving on mechanical looms, warp yarns are often coated with size starch or starch derivatives in order to increase their tensile strength. After weaving, the size coating must be removed before further processing the fabric in order to ensure Ea homogeneous and wash-proof result. It is known that in order to achieve the effects of Bio-Polishing, a combination of cellulytic and mechanical action is required. It is also known that “super-softness” is achievable when the treatment with a cellulase is combined with a conventional treatment with softening agents.
  • Bio-polishing may be obtained by applying the method described e.g. in WO 93/20278.
  • the endoglucanase of the present invention may be applied advantageously e.g. as follows:
  • pretreatment with the endoglucanase may degrade the cambium layer prior to debarking in mechanical drums resulting in advantageous energy savings.
  • fibre modification i.e. improvement of fibre properties where partial hydrolysis across the fibre wall is needed which requires deeper penetrating enzymes (e.g. in order to make coarse fibers more flexible). Deep treatment of fibers has so far not been possible for high yield pulps e.g. mechanical pulps or mixtures of recycled pulps. This has been ascribed to the nature of the fibre wall structure that prevents the passage of enzyme molecules due to physical restriction of the pore matrix of the fibre wall. It is contemplated that the present endoglucanase is capable of penetrating into the fibre wall.
  • the drainability of papermaking pulps may be improved by treatment of the pulp with hydrolysing enzymes, e.g. cellulases.
  • hydrolysing enzymes e.g. cellulases.
  • Use of the present endoglucanase may be more effective, e.g. result in a higher degree of loosening bundles of strongly hydrated micro-fibrils in the fines fraction (consisting of fibre debris) that limits the rate of drainage by blocking hollow spaces between fibers and in the wire mesh of the paper machine.
  • CSF Canadian standard freeness
  • increases and the Schopper-Riegler drainage index decreases when pulp in subjected to cellulase treatment see e.g. U.S. Pat. No. 4,923,565; TAPPI T227, SCAN C19:65.ence.
  • Partial hydrolysis of recycled paper during or upon pulping by use of hydrolysing enzymes such as cellulases are known to facilitate the removal and agglomeration of ink particles.
  • Use of the present endoglucanse may give a more effective loosening of ink from the surface structure due to a better penetration of the enzyme molecules into the fibrillar matrix of the fibre wall, thus softening the surface whereby ink particles are effectively loosened.
  • the agglomeration of loosened ink particles are also improved, due to a more efficient hydrolysis of cellulosic fragments found attached to ink particles originating from the fibres.
  • the treatment of lignocellulosic pulp may, e.g., be performed as described in WO 91/14819, WO 91/14822, WO 92/17573 and WO 92/18688.
  • the present invention relates to use of the endoglucanase and/or enzyme preparation according to the invention for degradation of plant material e.g. cell walls.
  • novel endoglucanase and/or enzyme preparation of the invention is useful in the preparation of wine, fruit or vegetable juice in order to increase yield.
  • Endoglucanases according to the invention may also be applied for enzymatic hydrolysis of various plant cell-wall derived materials or waste materials, e.g. agricultural residues such as wheat-straw, corn cobs, whole corn plants, nut shells, grass, vegetable hulls, bean hulls, spent grains, sugar beet pulp, and the like.
  • the plant material may be degraded in order to improve different kinds of processing, facilitate purification or extraction of other components like purification of beta-glucan or beta-glucan oligomers from cereals, improve the feed value, decrease the water binding capacity, improve the degradability in waste water plants, improve the conversion of e.g. grass and corn to ensilage, etc.
  • the cellulase variants of the invention show improved performance. Some of the variants may show improved performance with respect to increased catalytic activity.
  • cellulase activity can be expressed in S-CEVU.
  • Cellulolytic enzymes hydrolyse CMC, thereby increasing the viscosity of the incubation mixture.
  • the resulting reduction in viscosity may be determined by a vibration viscosimeter (e.g. MIVI 3000 from Sofraser, France).
  • Determination of the cellulolytic activity, measured in terms of S-CEVU may be determined according to the following analysis method (assay):
  • the S-CEVU assay quantifies the amount of catalytic activity present in the sample by measuring the ability of the sample to reduce the viscosity of a solution of carboxy-methylcellulose (CMC).
  • the assay is carried out at 40° C.; pH 7.5; 0.1M phosphate buffer; time 30 min; using a relative enzyme standard for reducing the viscosity of the CMC(carboxymethylcellulose Hercules 7 LFD) substrate; enzyme concentration approx. 0.15 S-CEVU/ml.
  • the arch standard is defined to 8200 S-CEVU/g.
  • position 119 was identified as a particular point of interest for making cellulase variants.
  • Position 119 (cellulase numbering) is located within 3 ⁇ from the substrate.
  • H histidine residue
  • Q glutamine residue
  • All Humicola insolens variants are, unless otherwise stated, constructed by application of the ChameleonTM Double-stranded, site-directed Mutagenesis kit, from Stratagene.
  • the following synthetic oligo-nucleotide were used as selection primer: S/M GAATGACTTGGTTGACGCGTCACCAGTCAC, or M/S GAATGACTTGGTTGAGTACTCACCAGTCAC.
  • S/M replaces the ScaI site in the beta-lactamase gene of the plasmid with a M1uI site and M/S does the reverse. The later is used to introduce secondary mutations in variants generated by the first selection primer.
  • Thielavia terrestis cellulase variants For construction of Thielavia terrestis cellulase variants, the Thielavia terrestis EG V cellulase cDNA obtainable from the plasmid deposited as DSM 10811 was used. DSM 10811 was deposited at the Deutsche Sammlung von Mikroorganismen und Zellkulturen on Jun. 30, 1995 according to the Budapest Treaty. The plasmid was digested with the restriction endonucleases BamHI and NotI The 4153 bp vector part and the 1211 bp BamHI-NotI fragment were isolated. Equal portions of the 1211 bp fragment were digested with respectively HgiAI and EcoRV and the 487 bp BamHI-HgiAI and 690 bp EcoRV-NotI fragments were isolated.
  • the ligation mixture was transformed into E. coli strain XL1, and from the resulting transformants Thielavia terrestris /Q119H was isolated and verified by DNA sequencing.
  • the cellulases with a cellulose binding domain CBD were purified by exploiting their binding to Avicel.
  • the cloned product was recovered after fermentation by separation of the extracellular fluid from the production organism.
  • the cellulase was then highly purified by affinity chromatography using 150 gram of Avicel in a slurry with 20 mM sodiumphosphate pH 7.5.
  • the Avicel slurry was mixed with the crude fermentation broth which in total contains about 1 gram of protein. After mixing at 4° C. for 20 min, the Avicel-bound enzyme is packed into a column with a dimension of 50 times 200 mm about 400 ml total.
  • Cellulases which natural lack CBD or the linker has been proteolytic cleaved or in which the CBD has been removed by introducing a stop codon after the catalytic domain can not be purified using Avicel.
  • the extracellular proteins are recovered free from the production organism.
  • the core cellulases were purified free of Aspergillus proteins by cation exchange chromatography.
  • the fermentation broth was adjusted to pH 3.5 and filtered to remove the precipitating proteins. Then the proteins were ultra filtrated (concentrated and washed with water) on a DOW GR81PP membrane with a cut off 6 KD until the conductivity of the eluate is below 1000 mS/cm.
  • the sample was finally applied to a S-Sepharose column equilibrated with a 20 mM citrate buffer pH 3.5 .
  • the enzyme will bind to the S-Sepharose at this low pH and it is eluted as a single peak using a NaCl gradient from 0 to 500 mM.
  • the eluted pure enzyme was concentrated on a Amicon cell with the DOW GR81PP membrane. All purified cellulases gave a single band in SDS-PAGE.
  • the Thielavia terrestris /Q119D was constructed as described in example 1 but using the following construction:
  • the CT1 encoding DNA was furnished with a C-terminal Xba1 site and subcloned into the pCaHj418 vector as described below.
  • PCT1 was used as template in a Pwo polymerase PCR, 94 C2′ ⁇ 3x(94 C,30′′-72 C,1′)-25x(94 C,30′′-55 C, 30′′-72, C 1′) ⁇ 72 C,5′ applying the two primers 8939: CGACTTCAATGTCCAGTCGG 25335: GCGCTCTAGAGGATTAAAGGCACTGC
  • the resulting 718 bp PCR product was digested with Sal1 and Xba1 and the 165 bp fragment was isolated. This fragment was ligated together with the 833 bp BamH1-Sal1 fragment from pCT1-2 into the 4.1 kb Xba1-BamH1 vector fragment of pCaHj418.
  • PCT2 was constructed by the ChameleonTM Double-stranded, site-directed Mutagenesis kit (from Stratagene) as described above with pCT1418 as template, the S/M primer as selection primer and the following mutagenic primer: 109330: CGACCTGGGATCGAACGACTTCGATATCGCCATGC
  • a successfully mutated plasmid pCT2 was isolated, verified by DNA sequencing and transformed into Aspergillus oryzae strain JaL228.
  • Thielavia terrestris cellulase and the Thielavia terrestris /Q119D variant was tested for activity towards PASC as described in example 9 at pH 7.0 and pH 10.0.
  • the plasmid pCT3 embodies DNA encoding the Thielavia terrestris endoglucanase core enzyme and followed by the linker CBD of Humicola grisea.
  • pCT3 was constructed by means of sequence overlap extension PCR, applying PWO polymerase.
  • pCT1418 (disclosed in example 2) a 876 bp PCR fragment was generated by the following primers: 101621: GGATGCCATGCTTGGAGGATAGCAACC 107823: GGGGGCGTGAAGACGGGAAGCTGGAGTCG
  • the isolated PCR fragments were applied as template in an assembly PCR reaction with primers 101621 and 107819: 94_C, 1′-3x(94_C, 30′′-70_C, 1′-72_C, 2′)-20x(94_C, 30′′-61_C, 30′′-72_C, 1,5′′)-72_C, 7′.
  • the resulting 1261 bp PCR product was isolated cut by restriction enzymes BamH1 and Xba1 and the resulting 1172 bp DNA fragment was isolated and ligated into the 4.1 kb vector fragment of BamH1-Xba1 digested pCaHj418.
  • the plasmid pPsF45 embodies DNA encoding the Pseudomonas cellolytica endoglucanase core enzyme headed by the H. insolens EGV endoglucanase signal peptide and followed by the linker CBD of same enzyme.
  • the selection primer was converting the unike Sca1 site in the lactamase gene of the plasmid to a Mlu1 site:
  • Disulfide bridges are known to stabilize protein structures. The removal of disulfide bridges in a cellulase will destabilizes the enzyme (thermostability) while retaining significant activity. This can be useful in applications where a fast inactivation of the enzyme is preferred, e.g. in denim or textile applications or for low temperature processes.
  • Humicola insolens EGV cellulase and five variants of Humicola insolens cellulase were constructed mutating either one or both residues involved in a disulfide bridge.
  • the specific activity was measured as disclosed under Materials and Methods.
  • the melting temperature of the enzymes were measured using Differential Scanning Calometry, DSC. DSC was done at neutral pH (7.0) using a MicroCalc Inc. MC calorimeter with a constant scan rate and raising the temperature from 20° C. to 90° C. at a rate of 90° C. per hour.
  • Variants of the present invention may show improved performance with respect to an altered sensitivity towards anionic tensides.
  • Anionic tensides are products frequently incorporated into detergent compositions. Unfolding of cellulases tested so far, is accompanied by a decay in the intrinsic fluorescence of the proteins. The intrinsic fluorescence derives from Trp side chains (and to a smaller extent Tyr side chains) and is sensitive to the hydrophobicity of the side chain environment. Unfolding leads to a more hydrophilic environment as the side-chains become more exposed to solvent, and this quenches fluorescence.
  • Fluorescence is followed on a Perkin/ElmerTM LS50 luminescence spectrometer.
  • the greatest change in fluorescence on unfolding is obtained by excitation at 280 nm and emission at 345 nm.
  • Slit widths (which regulate the magnitude of the signal) are usually 5 nm for both emission and excitation at a protein concentration of 5 ⁇ g/ml. Fluorescence is measured in 2-ml quartz cuvettes thermostatted with a circulating water bath and stirred with a small magnet. The magnet-stirrer is built into the spectrometer.
  • Unfolding can be followed in real time using the available software. Rapid unfolding (going to completion within less than 5-10 minutes) is monitored in the TimeDrive option, in which the fluorescence is measured every few (2-5) seconds. For slower unfolding, four cuvettes can be measured at a time in the cuvette-holder using the Wavelength Program option, in which the fluorescence of each cuvette is measured every 30 seconds. In all cases, unfolding is initiated by adding a small volume (typically 50 ⁇ l) of concentrated enzyme solution to the thermostatted cuvette solution where mixing is complete within a few seconds due to the rapid rotation of the magnet.
  • a small volume typically 50 ⁇ l
  • the protein concentration is 5-10 ⁇ g/ml (the protein concentration is not crucial, as LAS is in excess).
  • the unfolding of Humicola insolens cellulase can be compared with other enzymes (Table 1). This enables us to draw up the following ranking order for stability against anionic tenside:
  • t1 ⁇ 2 pH 10 s
  • t1 ⁇ 2 pH 7 s
  • Cellulase 1000 ppm LAS, 40° C.
  • Humicola insolens 48 28 Humicola insolens/ 63 9a H119Q
  • Positions already containing one of these residues are the primary target for mutagenesis
  • secondary targets are positions which has one of these residues on an equivalent position in another cellulase
  • third target are any surface exposed residue.
  • the reaction medium contained 5.0 g/l of a commercial regular powder detergent from the detergent manufacturer NOPA Denmark.
  • the detergent was formulated without surfactants for this experiment and pH adjusted to pH 7.0.
  • the reaction medium included 0.5 g/l PASC and was with or without 1 g/l LAS (linear alkylbenzenesulphonate), which is an anionic surfactant, and the reaction proceeded at the temperature 30° C. for 30 minutes.
  • Cellulase was dosed at 0.20 S-CEVU/l. After the 30 minutes of incubation the reaction was stopped with 2 N NaOH and the amount of reducing sugar ends determined through reduction of p-hydroxybenzoic acid hydrazide. The decrease in absorption of reduced p-hydroxybenzoic acid hydrazide relates to the cellulase activity.
  • the pH activity profile of a cellulase is governed by the pH dependent behavior of specific titratable groups, typically the acidic residues in the active site.
  • the pH profile can be altered by changing the electrostatic environment of these residues, either by substitution of residues involving charged or potentially charged groups such as Arg (R), Lys (K), Tyr (Y), His (H), Glu (E), Asp (D) or Cys (C) if not involved in a disulphide bridge or by changes in the surface accessibility of these specific titratable groups by mutations in the biding cleft within 5 ⁇ of the substrate.
  • Humicola insolens cellulase and variants of Humicola insolens cellulase involving substitution of charged or potentially charged residues have been tested for activity towards PASC at pH 7 and pH 10, respectively.
  • the method is enzymatic degradation of carboxy-methyl-cellulose, at different pH's. Buffers are prepared in the range 4.0 to 10.5 with intervals of 0.5 pH unit. The analyze is based on formation of new reducing ends in carboxy-methyl-cellulose, these are visualized by reaction with PHBAH in strong alkaline environment, were they forms a yellow compound with absorption maximum at 410 nm.
  • Buffer preparation 0.2 mol of each buffer substance is weighed out and dissolved in 1 liter of Milli Q water. 250 ml 0.2M buffer solution and 200 ml Milli Q water is mixed. The pH are measured using Radiometer PHM92 labmeter calibrated using standard buffer solutions from Radiometer. The pH of the buffers are adjusted to actual pH using 4M NaOH or 4M HCl and adjusted to total 500 ml with water. When adjusting Na-barbiturate to pH 8.0 there might be some precipitation, this can be re-dissolved by heating to 50° C.
  • MES (2[N-Morpholino]ethanesulfonic Acid) from SIGMA cat.no. M-8250, batchno. 68F-5625, pKa 6.09, MW 195.2;
  • MOPS (3-[N-Morpholino]propanesulfonic Acid) from SIGMA cat.no. M-1254, batchno. 115F-5629, pKa 7.15, MW 209.3;
  • PHBAH p-HYDROXY BENZOIC ACID HYDRAZIDE
  • K-Na-tartrate (Potassium sodium tartrate tetrahydrate) from MERCK cat.no. 8087, batch no. A653387 304;
  • CMC Carboxy Methyl Cellulose supplied by Hercules (FMC)7LF (December 1989).
  • this example demonstrates that the relative activity pH profile can be altered towards acidic or alkaline pH by creation of variants involving potentially charged residues and/or by altering residues in the binding cleft less that 5 ⁇ from the substrate.
  • the reaction medium contained phosphate buffer pH 7.0 and varying concentrations of LAS in the range 0.2-1.0 g/L. Two swatches were laundered at 40° C. for 30 minutes, rinsed and then dried. This laundering cycle was repeated four times. All enzymes was tested at each LAS concentration.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Paper (AREA)
  • Fats And Perfumes (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Described is a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of:
a. constructing a multiple alignment of at least two amino acid sequences known to have three-dimensional structures similar to endoglucanase V (EGV) from Humicola insolens known from Protein Data Bank entry 4ENG;
b. constructing a homology-built three-dimensional structure of the cellulolytic enzyme based on the structure of the EGV;
c. identifying amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å;
d. identifying surface-exposed amino acid residues of the enzyme;
e. identifying all charged or potentially charged amino acid residue positions of the enzyme;
f. choosing one or more positions wherein the amino acid residue is to be substituted, deleted or where an insertion is to be provided; and
g. carrying out the substitution, deletion or insertion by using conventional protein engineering techniques. Also described are cellulase variants obtained by this method.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This is a continuation application of PCT/DK97/00393 filed Sep. 17, 1997 and claims priority under 35 U.S.C. 119 of Danish application 1013/96 filed Sep. 17, 1996, the contents of which are fully incorporated herein by reference.[0001]
    • FIELD OF THE INVENTION
  • The present invention relates to cellulase variants, i.e. endo-β-1,4-glucanase variants, derived from a parental cellulase, i.e. endo-β-1,4-glucanase, by substitution, insertion and/or deletion, which variant has a catalytic core domain, in which the variant at position 5 holds an alanine residue (A), a serine residue (S), or a threonine residue (T); at position 8 holds a phenylalanine residue (F), or a tyrosine residue (Y); at position 9 holds a phenylalanine residue (F), a tryptophan residue (W), or a tyrosine residue (Y); at position 10 holds an aspartic acid residue (D); and at position 121 holds an aspartic acid residue (D). [0002]
    • BACKGROUND ART
  • Cellulases or cellulolytic enzymes are enzymes involved in hydrolyses of cellulose. In the hydrolysis of native cellulose, it is known that there are three major types of cellulase enzymes involved, namely cellobiohydrolase (1,4-β-D-glucan cellobiohydrolase, EC 3.2.1.91), endo-β-1,4-glucanase (endo-1,4-β-D-glucan 4-glucanohydrolase, EC 3.2.1.4) and β-glucosidase (EC 3.2.1.21). [0003]
  • Especially the endo-β-1,4-glucanases (EC No. 3.2.1.4) constitute an interesting group of hydrolases for the mentioned industrial uses. Endoglucanases catalyses endo hydrolysis of 1,4-β-D-glycosidic linkages in cellulose, cellulose derivatives (such as carboxy methyl cellulose and hydroxy ethyl cellulose), lichenin, β-1,4 bonds in mixed β-1,3 glucans such as cereal β-D-glucans or xyloglucans and other plant material containing cellulosic parts. The authorized name is endo-1,4-β-D-glucan 4-glucano hydrolase, but the abbreviated term endoglucanase is used in the present specification. Reference can be made to T.- M. Enveri, “Microbial Cellulases” in W. M. Fogarty, Microbial Enzymes and Biotechnology, Applied Sciences Publishers, p. 183-224 (1983); Methods in Enzymology, (1988) Vol. 160, p. 200-391 (edited by Wood, W. A. and Kellogg, S. T.); Béguin, P., “Molecular Biology of Cellulose Degradation”, Annu. Rev. Microbiol. (1990), Vol. 44, pp. 219-248; Béguin, P. and Aubert, J-P., “The biological degradation of cellulose”, FEMS, Microbiology Reviews 13 (1994) p. 25-58; Henrissat, B., “Cellulases and their interaction with cellulose”, Cellulose (1994), Vol. 1, pp. 169-196. [0004]
  • Cellulases are synthesized by a large number of microorganisms which include fungi, actinomycetes, myxobacteria and true bacteria but also by plants. Especially endoglucanases of a wide variety of specificities have been identified [0005]
  • A very important industrial use or cellulolytic enzymes is the use for treatment of cellulosic textile or fabric, e.g. as ingredients in detergent compositions or fabric softener compositions, for bio-polishing of new fabric (garment finishing), and for obtaining a “stone-washed” look of cellulose-containing fabric, especially denim, and several methods for such treatment have been suggested, e.g. in GB-A-1 368 599, EP-A-0 307 564 and EP-A-0 435 876, WO 91/17243, WO 91/10732, WO 91/17244, PCT/DK95/000108 and PCT/DK95/00132. Another important industrial use of cellulolytic enzymes is the use for treatment of paper pulp, e.g. for improving the drainage or for deinking of recycled paper. [0006]
  • It is also known that cellulases may or may not have a cellulose binding domain (a CBD). The CBD enhances the binding of the enzyme to a cellulose-containing fiber and increases the efficacy of the catalytic active part of the enzyme [0007]
  • Fungi and bacteria produces a spectrum of cellulolytic enzymes (cellulases) which, on the basis of sequence similarities (hydrophobic cluster analysis), can be classified into different families of glycosyl hydrolases [Henrissat B & Bairoch A; Biochem. J. 1993 293 781-788]. At present are known cellulases belonging to the families 5, 6, 7, 8, 9, 10, 12, 26, 44, 45, 48, 60, and 61 of glycosyl hydrolases. [0008]
  • Industrially well-performing endo-β-1,4-glucanases are described in e.g. WO 91/17243, WO 91/17244 and WO 91/10732, and specific cellulase variants are described in WO 94/07998. [0009]
  • It is an object of the present invention to provide novel variants of cellulolytic enzymes, which variants, when compared to the parental enzyme, show improved performance. [0010]
    • SUMMARY OF THE INVENTION
  • In a cellulolytic enzyme useful in industrial processes, i.e. an endo-β-1,4-glucanase, a number of amino acid residue positions important for the properties of the enzyme and thereby for the performance thereof in these processes has been identified. [0011]
  • Accordingly, in a first aspect the present invention provides a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of: [0012]
  • a. constructing a multiple alignment of at least two amino acid sequences known to have three-dimensional structures similar to endoglucanase V (EGV) from [0013] Humicola insolens known from Protein Data Bank entry 4ENG;
  • b. constructing a homology-built three-dimensional structure of the cellulolytic enzyme based on the structure of the EGV; [0014]
  • c. identifying amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å; [0015]
  • d. identifying surface-exposed amino acid residues of the enzyme; [0016]
  • e. identifying all charged or potentially charged amino acid residue positions of the enzyme; [0017]
  • f. choosing one or more positions wherein the amino acid residue is to be substituted, deleted or where an insertion is to be provided; [0018]
  • g. carrying out the substitution, deletion or insertion by using conventional protein engineering techniques. [0019]
  • By using the method of the invention, it is now possible effectively to transfer desirable properties from one cellulase to another by protein engineering methods which are known per se. [0020]
  • More particular the invention provides cellulase variants improved with respect to altered (increased or decreased) catalytic activity; and/or altered sensitivity to anionic tensides; and/or altered pH optimum and pH profile activity-wise as well as stability-wise. [0021]
  • Accordingly, in a further aspect, the invention provides a cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion, which variant has a catalytic core domain, in which the variant [0022]
  • at position 5 holds an alanine residue (A), a serine residue (S), or a threonine residue (T); [0023]
  • at position 8 holds a phenylalanine residue (F), or a tyrosine residue (Y); [0024]
  • at position 9 holds a phenylalanine residue (F), a tryptophan residue (W), or a tyrosine residue (Y); [0025]
  • at position 10 holds an aspartic acid residue (D); and [0026]
  • at position 121 holds an aspartic acid residue (D) (cellulase numbering).[0027]
    • DETAILED DISCLOSURE OF THE INVENTION
  • Cellulase Variants [0028]
  • The present invention provides new cellulase variants derived from a parental cellulase by substitution, insertion and/or deletion. A cellulase variant of this invention is a cellulase variant or mutated cellulase, having an amino acid sequence not found in nature. The cellulase variants of the invention show improved performance, in particular with respect to increased catalytic activity; and/or altered sensitivity to anionic tensides; and/or altered pH optimum; and/or altered thermostability. [0029]
  • Formally the cellulase variant or mutated cellulase of this invention may be regarded a functional derivative of a parental cellulase (i.e. the native or wild-type enzyme), and may be obtained by alteration of a DNA nucleotide sequence of the parental gene or its derivatives, encoding the parental enzyme. The cellulase variant or mutated cellulase may be expressed and produced when the DNA nucleotide sequence encoding the cellulase variant is inserted into a suitable vector in a suitable host organism. The host organism is not necessarily identical to the organism from which the parental gene originated. [0030]
  • In the literature, enzyme variants have also been referred to as mutants or muteins. [0031]
  • Amino Acids [0032]
  • In the context of this invention the following symbols and abbreviations for amino acids and amino acid residues are used: [0033]
    A = Ala = Alanine
    C = Cys = Cysteine
    D = Asp = Aspartic acid
    E = Glu = Glutamic acid
    F = Phe = Phenylalanine
    G = Gly = Glycine
    H = His = Histidine
    I = Ile = Isoleucine
    K = Lys = Lysine
    L = Leu = Leucine
    M = Met = Methionine
    N = Asn = Asparagine
    P = Pro = Proline
    Q = Gln = Glutamine
    R = Arg = Arginine
    S = Ser = Serine
    T = Thr = Threonine
    V = Val = Valine
    W = Trp = Tryptophan
    Y = Tyr = Tyrosine
    B = Asx = Asp or Asn
    Z = Glx = Glu or Gin
    X = Xaa = Any amino acid
    * = Deletion or absent amino acid
  • Cellulase Numbering [0034]
  • In the context of this invention a specific numbering of amino acid residue positions in cellulolytic enzymes is employed. By aligning the amino acid sequences of known cellulases, as in Table 1 below, it is possible to unambiguously allot an amino acid position number to any amino acid residue in any cellulolytic enzyme, if its amino acid sequence is known. [0035]
  • In Table 1, below, 11 selected amino acid sequences of cellulases of different microbial origin are aligned. These are (a) [0036] Humicola insolens; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis. The cellulases (a-i) are described in WO 96/29397, (j) is described in GeneBank under the accession number G45498, and (k) is described in GeneBank under the accession number S81598 and in Biol. Chem. Hoppe-Seyler 1995 376 (10) 617-625.
  • Using the numbering system originating from the amino acid sequence of the cellulase (endo-β-l,4-glucanase) obtained from the strain of [0037] Humicola insolens DSM 1L800, disclosed in e.g. WO 91/17243, which sequence is shown in the first column of Table 1, aligned with the amino acid sequence of a number of other cellulases, it is possible to indicate the position of an amino acid residue in a cellulolytic enzyme unambiguously.
  • In describing the various cellulase variants produced or contemplated according to the invention, the following nomenclatures are adapted for ease of reference: [0038]
  • [original amino acid; Position; Substituted amino acid][0039]
  • Accordingly, the substitution of glutamine with histidine in position 119 is designated as Q119H. [0040]
  • Amino acid residues which represent insertions in relation to the amino acid sequence of the cellulase from [0041] Humicola insolens, are numbered by the addition of letters in alphabetical order to the preceding cellulase number, such as e.g. position *21aV for the “inserted” valine (V), where no amino acid residue is present, between lysine at position 21 and alanine at position 22 of the amino acid sequence of the cellulase from Humicola insolens, cf. Table 1.
  • Deletion of a proline (P) at position 49 in the amino acid sequence of the cellulase from [0042] Humicola insolens is indicated as P49*.
  • Multiple mutations are separated by slash marks (″/″), e.g. Q119H/Q146R, representing mutations in positions 119 and 146 substituting glutamine (Q) with histidine (H), and glutamine (Q) with arginine (R), respectively. [0043]
  • If a substitution is made by mutation in e.g. a cellulose derived from a strain of [0044] Humicola insolens, the product is designed e.g. “Humicola insolens/*49P”.
  • All positions referred to in this application by cellulose numbering refer to the cellulase numbers described above, and are determined relative to the amino acid sequence of the cellulase derived from [0045] Humicola insolens, cf. Table 1, (a).
    TABLE 1
    Amino Acid Sequence Alignment;
    Cellulase Numbering of Selected Cellulases of Different
    Microbial Origin
    (a) Humicola insolens; (b) Acremonium sp.; (c) Volutella
    collectotorichoides; (d) Sordaria fimicola; (e) Thielavia
    terrestris; (f) Fusarium oxysporum; (g) Myceliphthora
    thermophila; (h) Crinipellis scabella; (i) Macrophomina
    phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis.
         a b c d e f g h i j k 
    1    A G G G G G G T T C *
    2    D S T S S S I A S N *
    3    G G G G G G G G G G G
    4    R H R K Q H Q V V Y M
    5    S T T S S S T T T A A
    6    T T T T T T T T T T T
    7    R R R R R R R R R R R
    8    Y Y Y Y Y Y Y Y Y Y Y
    9    W W W W W W W W W W W
    10   D D D D D D D D D D D
    11   C C C C C C C C C C C
    12   C C C C C C C C C C C
    13   K K K K K K K K K K L
    14   P P P P P P P P P P A
    15   S S S S S S S S S H S
    16   C C C C C C C C C C A
    17   G A G A A S A G A G S
    18   W W W W W W W W W W W
    19   A D D S P S P S T S E
    20   K E E G G G G G G A G
    21   K K K K K K K K K N K
    21a  * * * * * * * * * V *
    22   A A A A A A G A A P A
    23   P A S S A A P S S S P
    24   V V V V V V * V V L V
    25   N S S N S N S S S V Y
    26   Q R Q R Q A S A K S A
    27   P P P P P P P P P P P
    28   V V V V V A V V V L V
    29   F T K L Y L Q R G Q D
    30   S T T A A T A T T S A
    31   C C C C C C C C C C C
    32   N D D D D D D D D S K
    33   A R R A A K K R I A A
    34   N N N N N N N N N N D
    35   F N N N F D D G D N G
    36   Q S N N Q N N N N T V
    37   R P P P R P P T A R T
    38   I L L L L I F L Q L L
    39   T S A N S S N G T S I
    40   D P S D D N D P P D D
    41   F * * A F T G * S V S
    42   D G T N N N G * D S K
    42a  * * * * * * S D L * K
    43   A A A V V A T V L * K
    44   K V R K Q V R K K G P
    45   S S S S S N S S S S S
    46   G G G G G G G G S S G
    47   C C C C C C C C C C Q
    48   E D D D N E D D D D S
    49   P P S * * G A S * * G
    49a  * * * * * * * * * * C
    49b  * * * * * * * * * * N
    50   G N N G G G G G G G G
    51   G G G G G G G G G G G
    52   V V V S S S S T S G N
    53   A A A A A A A S A G K
    54   Y F Y Y Y Y Y F Y Y F
    55   S T T T S A M T Y M M
    56   C C C C C C C C C C C
    57   A N N A A T S A S W S
    58   D D D N D N S N N D C
    59   Q N N N Q Y Q N Q K M
    60   T Q Q W T S S G G I Q
    61   P P P P P P P P P P P
    62   W W W W W W W F W F F
    63   A A A A A A A A A A D
    64   V V V V V V V I V V D
    65   N N N N N N S D N S E
    66   D N D D D D D N D P T
    67   D N N N N E E N S T D
    68   F V L L L L L T L L P
    69   A A A A A A S A S A T
    70   L Y Y Y Y Y Y Y Y Y L
    71   G G G G G G G G G G A
    72   F F F F F F W F F Y F
    73   A A A A A A A A A A G
    74   A A A A A A A A A A F
    75   T T T T T T V A A T G
    76   S A A K S K K H K S A
    77   I F F L I I L L L S F
    78   A P S S A S A A S G T
    79   G G G G G G G G G D T
    80   S G G G G G S S K V G
    81   N N S T S S S S Q * Q
    82   E E E E E E E E E * E
    83   A A A S S A S A T * S
    84   G S S S S S Q A D * D
    85   W W W W W W W W W * T
    86   C C C C C C C C C C D
    87   C C C C C C C C C G C
    88   A A A A A A A Q G R A
    89   C C C C C C C C C C C
    90   Y Y Y Y Y Y Y Y Y Y F
    91   E A A A A A E E K Q Y
    92   L L L L L L L L L L A
    93   T Q Q T T T T T T Q E
    94   F F F F F F F F F F F
    95   T T T T T T T T T T E
    95a  * * * * * * * * * G *
    95b  * * * * * * * * * S *
    95c  * * * * * * * * * S *
    95d  * * * * * * * * * Y *
    95e  * * * * * * * * * N *
    95f  * * * * * * * * * A *
    95g  * * * * * * * * * P *
    95h  * * * * * * * * * G H
    95i  * * * * * * * * * D D
    95j  * * * * * * * * * P A
    95k  * * * * * * * * * G Q
    96   S S S S S S T S S S G
    97   G G G G G G G G T A K
    98   P P P P P P P P A A A
    99   V V V V V V V V V L M
    100  A A A S A K A V S A K
    101  G G G G G G G G G G R
    102  K K K K K K K K K K N
    103  K T T T T K K K Q T K
    104  M M M L M M M L M M L
    105  V V V V V I I T I I I
    106  V V V V V V V V V V F
    107  Q Q Q Q Q Q Q Q Q Q Q
    108  S S S S S S A V I A V
    109  T T T T T T T T T T T
    110  S N N S S N N N N N N
    111  T T T T T T T T T I V
    112  G G G G G G G G G G G
    113  G G G G G G G G G Y G
    114  D D D D D D D D D D D
    115  L L L L L L L L L V V
    116  G S S G G G G G G S Q
    117  S G G S S D D N N G S
    118  N T N N N N N N N G Q
    119  H H H H Q H H H H Q H
    120  F F F F F F F F F F F
    121  D D D D D D D D D D D
    122  L I I L I L L L I I F
    123  N Q L N A M A M A L O
    124  I M M M M M I I M V I
    125  P P P P P P P P P P P
    126  G G G G G G G G G G G
    127  G G G G G G G G G G G
    128  G G G G G G G G G G G
    129  V L L V V V V V V V L
    130  G G G G G G G G G G G
    131  I I I L I I I L I A A
    132  F F F F F F F F F F F
    132a * * * * * * * T * * P
    133  D D D D N D N Q N N K
    134  G G G G G G A G G A G
    135  C C C C C C C C C C C
    136  T T T K S T T P S S P
    137  P P P R S S D A K A A
    138  Q Q Q E Q E Q Q Q Q Q
    139  F F W F F F Y F W W W
    140  G G G G G G G G N G G
    140a * F V * * K A S G V V
    141  G T S G G A P W I S E
    142  L F F L L L P N * N A
    143  P P P P P G N G * A S
    143a * * * * * * G * N E L
    143b * * * * * * W * L L W
    144  G G G G G G G G G G G
    145  Q N N A A A D A N A D
    146  R R R Q Q Q R Q Q Q Q
    147  Y Y Y Y Y Y Y Y Y Y Y
    148  G G G G G G G G G G G
    149  G G G G G G G G G G G
    150  I T T I I I V F F F V
    150a * * * * * * * * * L *
    150b * * * * * * * * * A *
    150c * * * * * * * * * A *
    150d * * * * * * * * * C *
    150e * * * * * * * * * K *
    150f * * * * * * * * * Q *
    150g * * * * * * * * * Q *
    150h * * * * * * * * * L *
    150i * * * * * * * * * G *
    150j * * * * * * * * * Y *
    150k * * * * * * * * * N *
    151  S T T S S S H S T A K
    152  S S S S S S S S D S S
    153  R R R R R R K R R L A
    154  N S S S D S E D S S T
    155  E Q Q E Q E E Q Q Q E
    156  C C C C C C C C C Y C
    157  D A S D D D E S A K S
    158  R E Q S S S S Q S T K
    159  F L I F F Y F L L C L
    160  P P P P P P P P P V P
    160a * * * * * * * * * L *
    160b * * * * * * * * * N *
    160c * * * * * * * * * R *
    160d * * * * * * * * * C *
    160e * * * * * * * * * D *
    160f * * * * * * * * * S *
    160g * * * * * * * * * V *
    160h * * * * * * * * * F *
    160i * * * * * * * * * G *
    160j * * * * * * * * * S *
    160k * * * * * * * * * R *
    160l * * * * * * * * * G *
    160m * * * * * * * * * L *
    161  D S S A A E E A S T K
    162  A V A A P L A A K Q P
    163  L L L L L L L V W L L
    164  K R Q K K K K Q Q Q Q
    165  P D P P P D P A A Q E
    166  G G G G G G G G S G G
    167  C C C C C C C C C C C
    168  Y H N Q Q H N Q N T K
    169  W W W W W W W F W W W
    170  R R R R R R R R R F R
    171  F Y Y F F F F F P A F
    172  D D D D D D D D D E S
    173  W W W W W W W W W W E
    174  F F F F F F F M F F W
    175  K N N K Q E Q C E E G
    176  N D D N N N N G N A D
    177  A A A A A A A A A A N
    178  D D D D D D D D U D P
    179  N N N N N N N N N N V
    180  P P P P P P P P P P L
    181  S N D E T D S N T S K
    182  F V V F F F V V V L G
    183  S N S T T T T T D K S
    184  F W W F F F F F W Y P
    185  R R R K Q E Q R E K K
    186  Q R R Q Q Q E P P E R
    187  V V V V V V V V V V V
    188  Q R Q Q Q Q A T T P K
    189  C C C C C C C C C C C
    190  P P P P P P P P P P P
    191  A A A S A K S A Q A K
    192  E A A E E A S Q B E S
    193  L L L L I L L I L L L
    194  V T T T V L T T V T I
    195  A N D S A D S N A T D
    196  R R R R R I K I R R R
    197  T S T T S S S S T S S
    198  G C G G C G G C C G C
    199  C C C C C C C C C M C
    200  R V R K K K S V S N Q
  • The Enzyme (Endo-β-1,4-Glucanase) Variants of the Invention [0046]
  • The present invention relates to cellulase variants. More specifically the present invention provides cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion, which variant has a catalytic core domain, in which the variant [0047]
  • at position 5 holds an alanine residue (A), a serine residue (S), or a threonine residue (T); [0048]
  • at position 8 holds a phenylalanine residue (F), or a tyrosine residue (Y); [0049]
  • at position 9 holds a phenylalanine residue (F), a tryptophan residue (W), or a tyrosine residue (Y); [0050]
  • at position 10 holds an aspartic acid residue (D); and [0051]
  • at position 121 holds an aspartic acid residue (D) (cellulase numbering). [0052]
  • The endoglucanase of the invention may comprise a cellulose binding domain (CBD) existing as an integral part of the enzyme, or a CBD from another origin may be introduced into the endoglucanase thus creating an enzyme hybride. In this context, the term “cellulose-binding domain” is intended to be understood as defined by Peter Tomme et al. “Cellulose-Binding Domains: Classification and Properties” in “Enzymatic Degradation of Insoluble Carbohydrates”, John N. Saddler and Michael H. Penner (Eds.), ACS Symposium Series, No. 618, 1996. This definition classifies more than 120 cellulose-binding domains into 10 families (I-X), and demonstrates that CBDs are found in various enzymes such as cellulases, xylanases, mannanases, arabinofuranosidases, acetyl (esterases and chitinases. CBDs have also been found in algae, e.g. the red alga [0053] Porphyra purpurea as a non-hydrolytic polysaccharide-binding protein, see Tomme et al., op.cit. However, most of the CBDs are from cellulases and xylanases, CBDs are found at the N and C termini of proteins or are internal. Enzyme hybrids are known in the art, see e.g. WO 90/00609 and WO 95/16782, and may be prepared by transforming into a host cell a DNA construct comprising at least a fragment of DNA encoding the cellulose-binding domain ligated, with or without a linker, to a DNA sequence encoding the endoglucanase and growing the host cell to express the fused gene.
  • Enzyme hybrids may be described by the following formula: [0054]
  • CBD-MR-X or X-MR-CBD
  • wherein CBD is the N-terminal or the C-terminal region of an amino acid sequence corresponding to at least the cellulose-binding domain; MR is the middle region (the linker), and may be a bond, or a short linking group preferably of from about 2 to about 100 carbon atoms, more preferably of from 2 to 40 carbon atoms; or is preferably from about 2 to about 100 amino acids, more preferably of from 2 to 40 amino acids; and X is an N-terminal or C-terminal region of the enzyme according to the invention. [0055]
  • The Method of the Invention [0056]
  • In another aspect, the present invention relates to a method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of: [0057]
  • a. constructing a multiple alignment of at least two amino acid sequences known to have three-dimensional structures similar to endoglucanase V (EGV) from [0058] Humicola insolens known from Protein Data Bank entry 4ENG;
  • b. constructing a homology-built three-dimensional structure of the cellulolytic enzyme based on the structure of the EGV; [0059]
  • c. identifying amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å; [0060]
  • d. identifying surface-exposed amino acid residues of the enzyme; [0061]
  • e. identifying all charged or potentially charged amino acid residue positions of the enzyme; [0062]
  • f. choosing one or more positions wherein the amino acid residue is to be substituted, deleted or where an insertion is to be provided; [0063]
  • g. carrying out the substitution, deletion or insertion by using conventional protein engineering techniques. [0064]
  • Step f. of the method is preferably carried out by choosing positions which, as a result of the alignment of step a., carry the same amino acid residue in a majority of the aligned sequences; more preferably in at least 63% of the aligned sequences; even more preferably positions which, in the aligned sequences, carries different amino acid residues, cf. below. [0065]
  • In a preferred embodiment, the specific activity of the cellulase can be improved, preferably by carrying out a substition, deletion or insertion at amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å, more preferably not more than 3 Å, even more preferably not more than 2.5 Å. It is believed that residues present in a distance of not more than 2.5 Å are capable of being in direct contact with the substrate. [0066]
  • In another preferred embodiment, the pH activity profile, the pH activity optimum, the pH stability profile, or the pH stability optimum of the cellulase can be altered, preferably by carrying out a substitution, deletion or insertion at amino acid residue positions present either in a distance from the substrate binding cleft of not more than 5 Å, more preferably not more than 3 Å, even more preferably not more than 2.5 Å; or at surface-exposed amino acid residue positions of the enzyme, thereby altering the electrostatic environment either locally or globally. It is preferred to perform a substitution involving a charged or potentially charged residue, this residue either being the original residue or the replacement residue. In the present context, charged or potentially charged residues are meant to include: Arg, Lys, His, Cys (if not part of a disulfide bridge), Tyr, Glu, Asp. [0067]
  • In yet another preferred embodiment, the stability of the cellulase in the presence of an anionic tenside or anionic detergent component can be altered, preferably by carrying out a substitution, deletion or insertion at surface-exposed amino acid residue positions of the enzyme, thereby altering the electrostatic environment either locally or globally. It is preferred to perform a substitution involving a charged or potentially charged residue, this residue either being the original residue or the replacement residue. In the present context, charged or potentially charged residues are meant to include: Arg, Lys, His, Cys (if not part of a disulfide bridge), Tyr, Glu, Asp. Mutations towards a more negatively charged aa residue result in improved stability of the cellulase in the presence of an anionic tenside, whereas mutations towards a more positively charged aa residue decreases the stability of the cellulase towards anionic tensides. [0068]
  • Further, cellulase variants comprising any combination of two or more of the amino acid substitutions, deletions or insertions disclosed herein are also within the scope of the present invention, cf. the exemplified variants. [0069]
  • Multiple Sequence Alignment of Cellulases [0070]
  • The multiple sequence alignment is performed using the Pileup algorithm as implemented in the Wisconsin Sequence Analysis Package version 8.1-UNIX (GCG, Genetics Computer Group, Inc.). The method used is similar to the method described by Higgens and Sharp (CARBIOS 1989 5 151-153). A gap creation penalty of 3.0 and a gap extension penalty of 0.1 is used together with a scoring matrix as described in [0071] Nucl. Acids Res. 1986 14 (16) 6745-6763 (Dayhoff table (Schwartz, R. M. and Dayhoff, M. O.; Atlas of Protein Sequence and Structure (Dayhoff, M. O. Ed.); National Biomedical Research Foundation, Washington D.C. 1979 353-358) rescaled by dividing each value by the sum of its row and column, and normalizing to a mean of 0 and standard deviation of 1.0. The value for FY (Phe-Tyr)=1.425. Perfect matches are set to 1.5 and no matches on any row are better than perfect matches).
  • Pair-Wise Sequence Alignment of Cellulases [0072]
  • A pair-wise sequence alignment is performed using the algorithm described by Needleman & Wunsch ([0073] J. Mol. Biol. 1970 48 443-453), as implemented in the GAP routine in the Wisconsin Sequence Analysis Package (GCG). The parameters used for the GAP routine are the same as mentioned for the Pileup routine earlier.
  • Pair-Wise Sequence Alignment of Cellulases with Forced Pairing [0074]
  • A pair-wise sequence alignment with forced pairing of residues is performed using the algorithm described by Needleman & Wunsch ([0075] J. Mol. Biol. 1970 48 443-453), as implemented in the GAP routine in the Wisconsin Sequence Analysis Package (GCG). The parameters used for the GAP routine are the same as mentioned for the Pileup routine earlier, where the scoring matrix is modified to incorporate a residue named X which symbolize the residues to be paired. The diagonal value for X paired with X is set to 9.0 and all off diagonal values involving X is set to 0.
  • Complex between [0076] Humicola insolens Endoglucanase and Celloheptaose
  • Based on the X-ray structure of the core domain of the [0077] Humicola insolens EGV endoglucanase inactive variant (D10N) in complex with cellohexaose (Davies et. al.; Biochemistry 1995 34 16210-12220, PDB entry 4ENG) a model of the structure of the native Humicola insolens EGV endoglucanase core domain in complex with celloheptaose is build using the following steps:
  • 1. Using the Biopolymer module of the Insight II 95.0 (Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995) replace N10 with a aspartic acid. [0078]
  • 2. Make a copy of the sugar unit occupying subsite −3 by copying all the molecule and delete the extra atoms. Manually move the new sugar unit to best fit the unoccupied −1 binding site. Create the bonds to bind the new sugar unit to the two existing cellotriose units. [0079]
  • 3. Delete overlapping crystal water molecules. These are identified by using the Subset Interface By_Atom 2.5 command. [0080]
  • 4. Build hydrogens at a pH of 8.0 and applying charged terminals [0081]
  • 5. Protonate D121 using the Residue Replace <D121 residue name>ASP L command. [0082]
  • 6. Apply the CVFF forcefield template through the command Potentials Fix. [0083]
  • 7. Fix all atoms except the new sugar unit. [0084]
  • 8. Relax the atomic position of the new sugar unit using 300 cycles of simple energy minimization followed by 5000 steps of 1 fs simple molecular dynamics ending by 300 cycles of simple energy minimization all using the molecular mechanics program Discover 95.0/3.0.1 (Discover 95.0/3.0.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.). [0085]
  • Homology Building of Cellulases [0086]
  • The construction of a structural model of a cellulase with known amino acid sequence based on a known X-ray structure of the [0087] Humicola insolens EGV cellulase consists of the following steps:
  • 1. Define the approximate extend of the core region of the structure to be modeled and the alignment of the cysteine based on multiple sequence alignment between many known industrially useful cellulase sequences. [0088]
  • 2. Pair-wise sequence alignment between the new sequence and the sequence of the known X-ray structure. [0089]
  • 3. Define Structurally Conserved Regions (SCRs) based on the sequence alignment. [0090]
  • 4. Assign coordinates for the model structure within the SCRs. [0091]
  • 5. Find structures for the loops or Variable Regions (VRs) between the SCRs by a search in a loop structure database. [0092]
  • 6. Assign coordinates for the VRs in the model structure from the database search result. [0093]
  • 7. Create disulfide bonds and set protonation state. [0094]
  • 8. Refine the build structure using molecular mechanics. [0095]
  • The known X-ray structure of the [0096] Humicola insolens EGV cellulase will in the following be termed the reference structure. The structure to be modeled will be termed the model structure.
  • Ad 1: The approximate extent of the core part of the enzyme is determined by a multiple sequence alignment including many known cellulase sequences. Since the reference structure only contain atomic coordinates for the core part of the enzyme only the residues in the sequence to be modeled which align with the core part of the reference structure can be included in the model building. This alignment also determines the alignment of the cysteine. The multiple sequence alignment is performed using the Pileup algorithm as described earlier. [0097]
  • Ad 2: A pair-wise sequence alignment is performed as described earlier. If the cysteine in the conserved disulfide bridges and/or the active site residues (D10 and D121) does not align, a pair-wise sequence alignment using forced pairing of the cysteines in the conserved disulfide bridges and/or the active site residues is performed as described earlier. The main purpose of the sequence alignment is to define SCRs (see later) to be used for a model structure generation. [0098]
  • Ad 3: Based on the sequence alignment Structurally Conserved Regions (SCRs) are defined as continuous regions of overlapping sequence with no insertions or deletions. [0099]
  • Ad 4: Using the computer program Homology 95.0 (Homology User Guide, October 1995. San Diego: Biosym/MSI, 1995.) atomic coordinates in the model structure can be generated from the atomic coordinates of the reference structure using the command AssignCoords Sequences. [0100]
  • Ad 5: Using the computer program Homology 95.0 possible conformations for the remaining regions, named Variable Regions (VRs) are found by a search in the loop structure database included in Homology 95.0. This procedure is performed for each VR. [0101]
  • Ad 6: If the VR length is smaller than six residues the first loop structure in the database search result is selected for coordinate generation. In cases where longer loops are generated the first solution in the list which does not have severe atomic overlap are selected. The degree of atomic overlap can be analyzed using the Bump Monitor Add Intra command in the computer program Insight II 95.0 (Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.) a parameter of 0.25 for the Bump command will show the severe overlap. If more than ten bumps exists between the inserted loop region and the remaining part of the protein the next solution is tested. If no solution is found with these parameters, the solution with the fewest bumps is selected. The coordinates for the VR regions are generated using the command AssignCoords Loops in the program Homology 95.0. [0102]
  • Ad 7: The disulfide bonds are created using the Bond Create command in the Biopolymer module of Insight II 95.0 and the protonation state is set to match pH 8.0 with charged caps using the Hydrogens command. Finally the active proton donor (the residue equivalent to D121 in the reference structure) is protonated using the residue replace <D121 residue name> ASP L command. To finalize the data of the model the appropriate forcefield template is applied using the CVFF forcefield through the command Potentials Fix. [0103]
  • Ad 8: Finally the modeled structure is subjected to 500 cycles energy minimization using the molecular mechanics program Discover 95.0/3.0.1 (Discover 95.0/3.0.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.). The output from the above described procedure is atomic coordinates describing a structural model for the core domain of a new cellulase based on sequence homology to the [0104] Humicola insolens EGV cellulase.
  • Superpositioning of Cellulase Structures [0105]
  • To overlay two cellulase structures a superposition of the structures are performed using the Structure Alignment command of the Homology 95.0 (Homology User Guide, October 1995. San Diego: Biosym/MSI, 1995.). All parameters for the command are chosen as the default values. [0106]
  • Determination of Residues within 3 Å and 5 Å from the Substrate [0107]
  • In order to determine the amino acid residues within a specified distance from the substrate, a given cellulase structure is superimposed on the cellulase part of the model structure of the complex between [0108] Humicola insolens EGV endoglucanase and celloheptaose as described above. The residues within a specified distance of the substrate are then found using the Interface Subset command of the Insight II 95.0 (Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995). The specified distance are supplied as parameter to the program.
  • The results of this determination are presented in Tables 2 and 3 below. [0109]
  • Determination of Surface Accessibility [0110]
  • To determine the solvent accessibility the Access_Surf command in Homology 95.0 (Homology User Guide, October 1995; San Diego: Biosym/MSI, 1995) was used. The program uses the definition proposed by Lee and Richards (Lee, B. & Richards, F. M. “The interpretation of protein structures: Estimation of static accessibility”, J. Mol. Biol. 1971 55 379-400). A solvent probe radius of 1.4 Å was used and only heavy atoms (i.e. non-hydrogen atoms) were included in the calculation. Residues with zero accessibility is defined as being buried, all other residues are defined as being solvent exposed and on the surface of the enzyme structure. [0111]
  • Transferring Level of Specific Activity between Cellulases [0112]
  • In order to transfer the level of catalytic activity between two cellulases, the following protocol is applied using the methods described above. This method will pinpoint amino acid residues responsible for the difference in specific activity, and one or more of those amino acid residues must be replaced in one sequence in order to transfer the level of specific activity from the comparison cellulase: [0113]
  • 1) Perform multiple sequence alignment of all known industially useful cellulases (excluding the [0114] Trichoderma reesei cellulases). From this identify conserved disulfide bridges amongst the two involved sequences and the sequence of the Humicola insolens EGV cellulase are identified and the active site residues (D10 and D121) are located;
  • 2) Perform pair-wise sequence alignment of each sequence with the [0115] Humicola insolens EGV cellulase core domain (residues 1-201). If the cysteines in the conserved disulfide bridges does not align at the same positions and/or if the two active site residues (D10 and D121) does not align at the same positions then use the pair-wise sequence alignment of cellulases with forced pairing method. Include only residues in the sequences overlapping with the core domain (residues 1-201) of the Humicola insolens EGV cellulase;
  • 3) Create a homology build structure of each sequence; [0116]
  • 4) Determination of residues within 3 Å from the substrate in each of the homology build structures. Differences between the sequences in these positions will most probably be the residues responsible for the difference in specific activity. In the case where residues in inserts are found in any of the sequences within the above mentioned distance, the complete insert can be responsible for the difference in specific activity, and the complete insert must be transferred to the sequence without the insert or the complete insert must be deleted in the sequence with the insert; [0117]
  • 5) If not all specific activity was restored by substitution of residues within 3 Å of the substrate, determination of residues within 5 Å from the substrate in each of the homology build structures will reveal the most probable residues responsible for the remaining difference in specific activity. In the case where residues in inserts are found in any of the sequences within the above mentioned distance, the complete insert can be responsible for the difference in specific activity, and the complete insert must be transferred to the sequence without the insert or the complete insert must be deleted in the sequence with the insert. [0118]
  • Transferring the Level of Stability towards Anionic Tensides between Cellulases [0119]
  • In order to transfer level of stability towards anionic tensides between two cellulases, the following protocol is applied using the methods described above. This method will pinpoint amino acid residues responsible for the difference in level of stability towards anionic tensides, and one or more of those amino acid residues must be replaced in one sequence in order to transfer the level of specific activity from the comparison cellulase: [0120]
  • 1) Perform multiple sequence alignment of all known industrially useful cellulases (excluding [0121] Trichoderma reesei cellulases). From this identify conserved disulfide bridges amongst the two involved sequences and the sequence of the Humicola insolens EGV cellulase are identified and the active site residues (D10 and D121) are located;
  • 2) Perform pair-wise sequence alignment of each sequence with the [0122] Humicola insolens EGV cellulase core domain (residues 1-201). If the cysteines in the conserved disulfide bridges does not align at the same positions and/or if the two active site residues (D10 and D121) does not align at the same positions then use the pair-wise sequence alignment of cellulases with forced pairing method. Include only residues in the sequences overlapping with the core domain (residues 1-201) of the Humicola insolens EGV cellulase;
  • 3) Create a homology build structure of each sequence; [0123]
  • 4) Determination of residues located at the surface of the enzyme. This is done by calculation the surface accessibility. Residues with a surface accessibility greater than 0.0 Å[0124] 2 are exposed to the surface;
  • 5) Any residue exposed to the surface belonging to the following group of amino acids: D, E, H, K, R and C if not involved in disulfide bridge which differ between the two sequences will most probably be responsible for the difference in level of stability towards anionic tensides. In the case where residues in inserts are found in any of the sequences within the above mentioned group of amino acid types, the complete insert can be responsible for the difference in level of stability towards anionic tensides, and the complete insert must be transferred to the sequence without the insert or the complete insert must be deleted in the sequence with the insert. [0125]
  • Disulfide Bridges [0126]
  • Disulfide bridges (i.e. Cys-Cys bridges) stabilize the structure of the enzyme. It is believed that a certain number of stabilizing disulfide bridges are necessary to maintain the a proper stability of the enzyme. However, it is also contemplated that disulfide bridges can be removed from the protein structure resulting in an enzyme variant which is less stable, especially less thermostable, but which still has significant activity. [0127]
  • Therefore, in another aspect, the invention provides a cellulase variant which variant holds 4 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering). In a more specific embodiment the variant of the invention holds 5 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering). In its most specific embodiment, the variant of the invention holds 6 or more of the following disulfide bridges: C11-C135; C12-C47; C16-β-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering). [0128]
  • In another embodiment the invention provides a cellulase variant in which cysteine has been replaced by another natural amino acid at one or more of the positions 16, 86, 87, 89, 189, and/or 199 (cellulase numbering). [0129]
  • Binding Cleft Substitutions [0130]
  • In a further aspect, the invention provides a cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion at one or more amino acid residues located in the substrate binding cleft. Mutations introduced at positions close to the substrate affect the enzyme-substrate interactive bindings. [0131]
  • An appropriate way of determining the residues interacting with a potential substrate in a structure is to partitionate the structure in “shells”. The shells are defined as: 1st shell are residues directly interacting with the substrate, i.e. closest inter atomic distance between substrate and residue both including hydrogen atoms are smaller than 2.5 Å which will include all direct interaction via hydrogen bonds and other non bonded interactions. The subsequent (2nd, 3rd e.t.c.) shells are defined in the same way, as the residues with inter atomic distances smaller than 2.5 Å to the substrate or all previously determined shells. In this way the structure will be partitioned in shells. The routine “subset zone” in the program Insight II 95.0 (Insight II 95.0 User Guide, October 1995. San Diego: Biosym/MSI, 1995.) can be used to determine the shells. [0132]
  • In a preferred embodiment, the amino acid residue contemplated according to this invention is located in the substrate binding cleft at a distance of up to 5 Å from the substrate. [0133]
  • When subjecting the aligned cellulases to the computer modeling method disclosed above, the following positions within a distance of up to 5 Å from the substrate are revealed: 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 21a, 42, 44, 45, 47, 48, 49, 49a, 49b, 74, 82, 95j, 110, 111, 112, 113, 114, 115, 116, 119, 121, 123, 127, 128, 129, 130, 131, 132, 132a, 133, 145, 146, 147, 148, 149, 150b, 178, and/or 179 (cellulase numbering), cf. Table 2. [0134]
  • Accordingly, in a more specific embodiment, the invention provides a cellulase variant which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of these acid residues. In a particular 25 embodiment, the cellulase variant is derived from one of the cellulases identified in Table 2 ((a) [0135] Humicola insolens; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis), by substitution, insertion and/or deletion at one or more of the positions identified in Table 2 for these cellulases.
    TABLE 2
    Amino Acid Residues less than 5 Å from the Substrate
    Positions Identified by Cellulase Numbering
    (a) Humicola maclens; (b) Acremonium ap.; (c) Volutella
    collectotrichoides; (d) Sordaria fimicola; (e) Thielavia
    terrestris; (f) Fusarium oxysporum; (g) Myceliophthora
    thermophila; (h) Crinipellis scabella; (I) Macrophomina
    phaseolina; (j) Pseudomorias fluorescens; (k) Ustilago maydis.
         a b c d e f g h i j k 
    4                      Y
    5    S T T S S S T T T A A
    6    T T T T T T T T T T T
    7    R R R R R R R R R R R
    8    Y Y Y Y Y Y Y Y Y Y Y
    9    W W W W W W W W W W W
    10   D D D D D D D D D D D
    11               C
    12   C C C C C C C C C C C
    13   K K K K K K K K K K L
    14   P P P P P P P P P P A
    15   S S S S S S S S S H S
    16                     C
    18   W W W W W W W W W W W
    19   A D D S P S P S   T E
    20   K E E   G   G G   A
    21   K K K K K K K K K   K
    21a                    V
    42     G T           D
    44     V R K Q V R     G
    45   S S S S S N S S S S
    47   C C C C C C C C C C
    48   E D D D N E D D D D S
    49     P
    49a                      C
    49b                      N
    74   A A A A A A A A A A F
    82   E E E E E E   E E   E
    95j                    P
    110  S N N S S N N N N N N
    111  T T T T T T T T T I V
    112  G G G G G G G G G G G
    113  G G G G G G G G G Y G
    114  D D D D D D D D D D D
    115  L L L L L L L L L V V
    116          G
    119  H H H H Q H H H H Q N
    121  D D D D D D D D D D D
    123    Q
    127  G G G G G G G G G G G
    128  G G G G C G C C G C G
    129  V L L V V V V V V V L
    130  G C C G G G G G C C G
    131  I I I L I I I L I A A
    132  F F F F F F F F F F F
    132a               T     P
    133                  N N
    145                    A D
    146  R R R Q Q Q R Q Q Q Q
    147  Y Y Y Y Y Y Y Y Y Y Y
    148  G G G G G G G G G G G
    149  G     G G G     G
    150b                   A
    178  D D D D D D D D D D P
    179  N N N N N N N N N N V
  • In another preferred embodiment, the amino acid residue contemplated according to this invention is located in the substrate binding cleft at a distance of up to 3 Å from the substrate. [0136]
  • When subjecting the aligned cellulases to the computer modeling method disclosed above, the following positions within a distance of up to 3 A from the substrate are revealed: 6, 7, 8, 10, 12, 13, 14, 15, 18, 20, 21, 45, 48, 74, 110, 111, 112, 113, 114, 115, 119, 121, 127, 128, 129, 130, 131, 132, 132a, 147, 148, 150b, 178, and/or 179 (cellulase numbering). cf. Table 3. [0137]
  • Accordingly, in a more specific embodiment, the invention provides a cellulase variant which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of these acid residues. In a particular embodiment, the cellulase variant is derived from one of the cellulases identified in Table 3 ((a) [0138] Humicola insolens; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis), by substitution, insertion and/or deletion at one or more of the positions identified in Table 3 for these cellulases.
    TABLE 3
    Amino Acid Residues less than 3 Å from the Substrate
    Positions Identif led by Cellulase Numbering
    (a) Humi cola maclens; (b) Acremonium sp.; (c) Volutella
    collectotrichoides; (d) Sordaria fimicola; (e) Thielavia
    terrestris; (f) Fusarium oxysporum; (g) Myceliophthora
    thermophila; (h) Crinipellis scabella; (I) Macrophomina
    phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis.
         a b c d e f g h i j k 
    6    T T T T T T T T T T T
    7    R R R R R R R R R R R
    8    Y Y Y Y Y Y Y Y Y Y Y
    10   D D D D D D D D   D D
    12   C C C C C C C C C C C
    13   K K K K   K     K   L
    14     P     P P P P P   A
    15   S S S S S S S S S H S
    18   W W W W W W W W W W W
    20     E E
    21   K     K
    45   S S S S S N S S S S S
    48     D     N E D     D
    74   A     A A A A A A   F
    110    N N   S N N N N N N
    111  T T T T T T T T T
    112  G G G G G G G G G G G
    113  G G G G       G G Y G
    114  D D D D D D D D D D D
    115  L L L L L L L L L V V
    119  H H H   Q H   H   Q
    121  D D D D D D D D D D D
    127  G     G G G G   G
    128  G     G G G G G G   G
    129  V L L V V V V V V V L
    130  G G G G G G G G G G G
    131  I I I L I I I L I A A
    132  F F F F F F F F F F F
    132a               T     P
    146          Q     Q   Q Q
    147  Y Y Y Y Y Y Y Y Y Y Y
    148  G G G G G G G G G G G
    150b                   A
    178  D D D D       D   D P
    179  N N N N N N N N N N
  • Partly Conserved Amino Acid Residues [0139]
  • As defined herein a “partly conserved amino acid residue” is an amino acid residue identified according to Table 1, at a position at which position between 7 to 10 amino acid residues of the 11 residues (i.e. more than 63%) indicated in Table 1 for that position, are identical. [0140]
  • Accordingly, the invention further provides a cellulase variant, in which variant an amino acid residue has been changed into a conserved amino acid residue at one or more positions according to Table 1, at which position(s) between 7 and 10 amino acid residues of the 11 residues identified in Table 1, are identical. [0141]
  • In a preferred embodiment the invention provides a cellulase variant, which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 13, 14, 15, 20, 21, 22, 24, 28, 32, 34, 45, 48, 50, 53, 54, 62, 63, 64, 65, 6E6, 68, 69, 70, 71, 72, 73, 74, 75, 79, 85, 88, 90, 92, 93, 95, 96, 97, 98, 99, 104, 106, 110, 111, 113, 115, 116, 118, 119, 131, 134, 138, 140, 146, 152, 153, 163, 166, 169, 170, 171, 172, 173, 174, 174, 177, 178, 179, 180, 193, 196, and/or 197 (cellulase numbering). [0142]
  • In a more specific embodiment the invention provides a cellulase variant that has been subjected to substitutions, insertions and/or deletions, so as to comprise one or more of the amino acid residues at the positions identified in Table 4, below. The positions in Table 4 reflects the “partly conserved amino acid residue positions” as well as the non-conserved positions present within 5 Å of the substrate in binding cleft all of which indeed are present in the aligned sequences in Table 1. [0143]
    TABLE 4
    Selected Substitutions, Insertions and/or Dele-
    tions
    Positions Identified by Cellulase Numbering
    Position Amino Acid Residue
      4 R, H, K, Q, V, Y, M
      5 S, T, A
     13 K, L
     14 P, A
     15 H, S
     16 C, A
     19 A, D, S, P, T, E
     20 A, E, G, K
     21 K, N
     21a V, *
     22 A, G, P
     24 *, L, V
     28 A, L, V
     32 D, K, N, S
     34 D, N
     38 F, I, L, Q
     42 D, G, T, N, S, K, *
     44 K, V, R, Q, G, P
     45 N, S
     46 G, S
     47 C, Q
     48 D, E, N, S
     49 P, S, A, G, *
     49a C, *
     49b N, *
     50 G, N
     53 A, G, K, S
     54 F, Y
     62 F, W
     63 A, D
     64 D, I V
     65 D, E, N, S
     66 D, N, P, T
     68 F, L, P, T, V
     69 A, S, T
     70 L, Y
     71 A, G
     72 F, W, Y
     73 A, G
     74 A, F
     75 A, G, T, V
     79 G, T
     82 E, *
     88 A, G, Q, R
     90 F, Y
     92 A, L
     93 E, Q, T
     95 E, T
     95j P, *
     96 S, T
     97 A, G, T
     98 A, P
     99 L, V
    104 L, M
    106 F, V
    110 N, S
    111 I, T, V
    113 G, Y
    115 L, V
    116 G, Q, S
    118 G, N, Q, T
    119 H, N, Q
    129 L, V
    131 A, I, L
    132 A, P, T, *
    133 D, K, N, Q
    134 A, G
    138 E, Q
    145 A, D, N, Q
    146 Q, R
    150b A, *
    152 D, S
    153 A, K, L, R
    163 L, V, W
    166 G, S
    169 F, W
    170 F, R
    171 A, F, Y
    172 D, E, S
    173 E, W
    174 F, M, W
    177 A, N
    178 D, P
    179 N, V
    180 L, P
    193 T, L
    196 T, K, R
    197 S, T
  • In a yet more preferred embodiment, the invention provides a cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion at one or more amino acid residues as indicated in Tables 5-6, below. The cellulase variant may be derived from any parental cellulase holding the amino acid residue stated at the position indicated. In particular the parental cellulase may be a [0144] Humicola insolens cellulase; an Acremonium sp. Cellulase; a Volutella collectotrichoides cellulase; a Sordaria fimicola cellulase; a Thielavia terrestris cellulase; a Fusariuim oxysporum cellulase; a Myceliophthora thermophila cellulase; a Crinipellis scabella cellulase; a Macrophomina phaseolina cellulase; a Pseudomonas fluorescens cellulase; or a Ustilago maydis cellulase.
  • Moreover, the cellulase variant may be characterized by having improved performance, in particular with respect to [0145]
  • 1. improved performance defined as increased catalytic activity; [0146]
  • 2. altered sensitivity to anionic tenside; and/or [0147]
  • 3. altered pH optimum; [0148]
  • as also indicated in Tables 5-6. The positions listed in Table 5 reflect transfer of properties between the different cellulases aligned in Table 1. The positions listed in Table 6 reflect transfer of properties from [0149] Humicola insolens EGV to the other cellulases aligned in Table 1.
    TABLE 5
    Preferred Cellulase Variants
    Positions Identified by Cellulase Numbering
    K13L, L13K (1, 2, 3);
    P14A, A14P (1);
    S15H, H15S (1, 3);
    K20E, K20G, K20A, E20K, G20K, A20K, E20G, E20A, G20E, A20E,
    G20A, A20G (1, 2, 3);
    K21N, N21K (1, 2, 3);
    A22G, A22P, G22A, P22A, G22P, P22G (1);
    V24*, V24L, *24V, L24V, *24L, L24* (1);
    V28A, V28L, A28V, L28V, A28L, L28A (1);
    N32D, N32S, N32K, D32N, S32N, K32N, D32S, D32K, S32D, K32D,
    S32K, K32S (2, 3);
    N34D, D34N (2);
    I38L, I38F, I38Q, L38I, F38I, Q38I, L38F, L38Q, F38L, Q38L,
    F38Q, Q38F (1)
    S45N, N45S (1);
    G46S, S46G (1);
    E48D, E48N, D48E, N48E, D48N, N48D (1, 2, 3);
    G50N, N50G (1);
    A53S, A53G, A53K, S53A, G53A, K53A, S53G, S53K, G53S, K53S,
    G53K, K53G (1);
    Y54F, F54Y (1, 3);
    W62F, F62W (1, 2);
    A63D, D63A (2, 3);
    V64I, V64D, I64V, D64V, I64D, D64I (2);
    N65S, N65D, N65E, S65N, D65N, E65N, S65D, S65E, D65S, E65S,
    D65E, E65D (2);
    D66N, D66P, D66T, N66D, P66D, T66D, N66P, N66T, P66N, T66N,
    P66T, T66P (2, 3);
    F68V, F68L, F68T, F68P, V68F, L68F, T68F, P68F, V68L, V68T,
    V68P, L68V, T68V, P68V, L68T, L68P, T68L, P68L, T68P, P68T
    (1, 2);
    A69S, A69T, S69A, T69A, S69T, T69S (1);
    L70Y, Y70L (1);
    G71A, A71G (1);
    F72W, F72Y, W72F, Y72F, W72Y, Y72W (1);
    A73G, G73A (1);
    A74F, F74A (1);
    T75V, T75A, T75G, V75T, A75T, G75T, V75A, V75G, A75V, G75V,
    A75G, G75A (1);
    G79T, T79G (1);
    W85T, T85W (1);
    A88Q, A88G, A88R, Q88A, G88A, R88A, Q88G, Q88R, G88Q, R88Q,
    G88R, R88G (1, 2, 3);
    Y90F, F90Y (1);
    L92A, A92L (1);
    T93Q, T93E, Q93T, E93T, Q93E, E93Q (2);
    T95E, E95T (2);
    S96T, T96S (1);
    G97T, G97A, T97G, A97G, T97A, A97T (1);
    P98A, A98P (1);
    V99L, L99V (1);
    M104L, L104M (1);
    V106F, F106V (1, 3);
    S110N, N110S (1);
    T111I, T111V, I111T, V111T, I111V, V111I (1);
    G113Y, Y113G (1, 3);
    L115V, V115L (1);
    G116S, G116Q, S116G, Q116G, S116Q, Q116S (1);
    N118T, N118G, N118Q, T118N, G118N, Q118N, T118G, T118Q,
    G118T, Q118T, G118Q, Q118G (1);
    H119Q, H119N, Q119H, N119H (1, 2);
    V129L, L129V (1);
    I131L, I131A, L131I, A131I, L131A, A131L (1);
    G134A, A134G (1);
    Q138E, E138Q (1, 2, 3);
    G140N, N140G (1);
    R146Q, Q146R (1, 2, 3);
    S152D, D152S (2);
    R153K, R153L, R153A, K153R, L153R, A153R, K153L, K153A,
    L153K, A153K, L153A, A153L (2);
    L163V, L163W, V163L, W163L, V163W, W163V (1);
    G166S, S166G (1);
    W169F, F169W (1);
    R170F, F170R (1, 2, 3);
    F171Y, F171A, Y171F, A171F, Y171A, A171Y (1);
    D172E, D172S, E172D, S172D, E172S, S172E (2);
    W173E, E173W (1, 2, 3);
    F174M, F174W, M174F, W174F, M174W, W174M (1);
    A177N, N177A (1);
    D178P, P178D (1, 2, 3);
    N179V, V179N (1);
    P180L, L180P (1);
    L193I, I193L (1);
    R196I, R196K, I196R, K196R, I196K, K196I (2, 3);
    T197S, S197T (1)
  • [0150]
    TABLE 6
    Preferred Cellulase Variants
    Positions Identified by Cellulase Numbering
    L13K (1, 2, 3);
    A14P (1);
    H15S (1, 3);
    E20K, G20K, A20K (1, 2, 3);
    N21K (1, 2, 3);
    G22A, P22A (1);
    *24V, L24V (1);
    A28V, L28V (1);
    D32N, S32N, K32N (2, 3);
    D34N (2);
    L38I, F38I, Q38I (1);
    N45S (1);
    S46G (1);
    D48E, N48E (1, 2, 3);
    N50G (1);
    S53A, G53A, K53A (1);
    F54Y (1, 3);
    F62W (1, 2);
    D63A (2, 3);
    I64V, DG4V (2);
    S65N, D65N, E65N (2)
    N66D, R66D, T66D (2, 3);
    V68F, L68F, T68F, P68F (1, 2);
    S69A, T69A (1)
    Y70L (1)
    A71G (1)
    W72F, Y72F (1)
    G73A (1)
    F74A (1)
    V75T, A75T, G75T (1)
    T79G (1);
    T85W (1);
    Q88A, G88A, R88A (1, 2, 3)
    F90Y (1)
    A92L (1)
    Q93T, E93T (2);
    E95T (2);
    T96S (1);
    T97G, A97G (1);
    A98P (1);
    L99V (1);
    L104M (1);
    F106V (1, 3);
    N110S (1);
    I111T, V111T (1);
    Y113G (1, 3);
    V115L (1);
    S116G, Q116G (1);
    T118N, G118N, Q118N (1);
    Q119H, N119H (1, 2);
    L129V (1);
    L131I, A131I (1);
    A134G (1);
    E138Q (1, 2, 3);
    N140G (1);
    Q146R (1, 2, 3);
    D152S (2);
    K153R, L153R, A153R (2);
    V163L, W163L (1);
    S166G (1);
    F169W (1);
    P170R (1, 2, 3);
    Y171F, A171F (1);
    E172D, S172D (2);
    E173W (1, 2, 3);
    M174F, W174F (1);
    N177A (1);
    P178D (1, 2, 3);
    V179N (1);
    L180P (1);
    I193L (1);
    I196R, K196R (2,3);
    S197T (1)
  • Altered Sensibility Towards Anionic Tensides [0151]
  • As mentioned above, anionic tensides are products frequently incorporated into detergent compositions. Sometimes cellulolytic enzymes having an increased stability towards anionic tensides is a desire, and sometimes cellulolytic enzymes having an increased sensitivity are preferred. In a further aspect the invention provides cellulase variants of an altered anionic tenside sensitivity. [0152]
  • Accordingly, a cellulase variant of the invention of altered anionic tenside sensitivity is a cellulase variant which has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 2, 4, 7, 8, 10, 13, 15, 19, 20, 21, 25, 26, 29, 32, 33, 34, 35, 37, 40, 42, 42a, 43, 44, 48, 53, 54, 55, 58, 59, 63, 64, 65, 66, 67, 70, 72, 76, 79, 80, 82, 84, 86, 88, 90, 91, 93, 95, 95d, 95h, 95j, 97, 100, 101, 102, 103, 113, 114, 117, 119, 121, 133, 136, 137, 138, 139, 140a, 141, 143a, 145, 146, 147, 150e, 150j, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160c, 160e, 160k, 161, 162, 164, 165, 168, 170, 171, 172, 173, 175, 176, 178, 181, 183, 184, 185, 186, 188, 191, 192, 195, 196, 200, and/or 201 (cellulase numbering). These positions contain, in at least one of the cellulase sequences aligned in Table 1, a charged or potentially charged aa residue. [0153]
  • In a particular embodiment, the cellulase variant is derived from one of the cellulases identified in Table 7, below, ((a) [0154] Humicola insolens; (b) Acremonium sp.; (c) Volutella collectotrichoides; (d) Sordaria fimicola; (e) Thielavia terrestris; (f) Fusarium oxysporum; (g) Myceliophthora thermophila; (h) Crinipellis scabella; (i) Macrophomina phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis), by substitution, insertion and/or deletion at one or more of the positions identified in Table 7 for these cellulases.
    TABLE 7
    Altered Sensitivity towards Anionic Tensides
    Positions identified by Cellulase Numbering
    (a) Humicola irisolens; (b) Acremonium sp.; (c) Volutella
    collectotrichoides; (d) Sordaria fimicola; (e) Thielavia
    terrestris; (f) Fusarium oxysporum; (g) Myceliophthora
    thermophila; (h) Cririipellis scabella; (i) Macrophomina
    phaseolina; (j) Pseudomonas fluorescens; (k) Ustilago maydis.
         a b c d e f g h i j k 
    2    D
    4    R H R K   H       Y  
    7    R R R R R R R R R R R
    8    Y Y Y Y Y Y Y Y Y Y Y
    10   D D D D D D D D D D D
    13   K K K K K K K K K K K
    15                     H
    19     D D               E
    20   K E E
    21   K K K K K K K K K   K
    25                       Y
    26     R   R         K
    29       K   Y     R     D
    32     D D D D D D D D   K
    33     R R     K K R
    34                       D
    35             D D   D
    37   R       R         R
    40   D     D D   D     D D
    42  D               D   K
    42a                 D     K
    43                       D
    44   K   R K     R K K
    48   E D D D   E D D D D
    53                       K
    54   Y   Y Y Y Y Y   Y Y
    55                   Y
    58   D D D   D         D
    59             Y       K
    63                       D
    64                       D
    65                 D     E
    66   D   D D D D D   D
    67   D         E E       D
    70     Y Y Y Y Y Y Y Y Y
    72                     Y
    76         K   K K H K
    79                     D
    80                   K
    82   E E E E E E E E E   E
    84                   D   D
    86                       D
    88                     R
    90   Y Y Y Y Y Y Y Y Y Y
    91   E           E E K   Y
    93                       E
    95                       E
    95d                    Y
    95h                      H
    95i                    D D
    97                       K
    100            K         K
    101                      R
    102  K K K K K K K K K K
    103  K         K K K     K
    113                    Y
    114  D D D D D D D D D D D
    117            D D
    119  H H H H   H H H H
    121  D D D D D D D D D D D
    133  D D D D D   D       K
    136        K
    137        R     D   K
    138        E   E
    139                Y
    140a           K
    141                      E
    143a                   E L
    145             D        D
    146  R R R       R
    147  Y Y Y Y Y Y Y Y Y Y Y
    150e                   K
    150j                   Y
    151              H       K
    152                  D
    153  R R R R R K R R
    154          D   E D
    155  E     E   E E       E
    156                    Y
    157  D     D D D E     K
    158  R E                 K
    159            Y
    160c                   R
    160e                   D
    160k                   R
    161  D         E E       K
    162                  K
    164  K R   K K K K
    165    D       D         E
    168  Y H       H         K
    170  R R R R R R R R R   R
    171    Y Y
    172  D D D D D D D D D E
    173                      E
    175  K     K   E     E E
    176    D D               D
    178  D D D D D D D D D D
    181      D E   D         K
    183                  D K
    184                    Y
    185  R R R K   E   R E K K
    186    R R       E     E R
    188    R                 K
    191            K         K
    192  E     E E   E   E E
    195      D     D         D
    196  R R R R R   K   R R R
    200  R   R K K K
    201  R R R R R R R R R R R
  • In a still further aspect, the present invention relates to an enzyme composition comprising an enzyme exhibiting cellulolytic activity as described above. [0155]
  • The enzyme composition of the invention may, in addition to the cellulase of the invention, comprise one or more other enzyme types, for instance hemi-cellulase such as xylanase and mannanase, other cellulase components, chitinase, lipase, esterase, pectinase, cutinase, phytase, oxidoreductase, peroxidase, laccase, oxidase, pactinmethylesterase, polygalacturonase, protease, or amylase. [0156]
  • The enzyme composition may be prepared in accordance with methods known in the art and may be in the form of a liquid or a dry composition. For instance, the enzyme composition may be in the form of a granulate or a microgranulate. The enzyme to be included in the composition may be stabilized in accordance with methods known in the art. [0157]
  • Examples are given below of preferred uses of the enzyme composition of the invention. The dosage of the enzyme composition of the invention and other conditions under which the composition is used may be determined on the basis of methods known in the art. [0158]
  • The enzyme composition according to the invention may be useful for at least one of the following purposes. [0159]
  • Uses [0160]
  • During washing and wearing, dyestuff from dyed fabrics or garment will conventionally bleed from the fabric which then looks faded and worn. Removal of surface fibers from the fabric will partly restore the original colors and looks of the fabric. By the term “color clarification”, as used herein, is meant the partly restoration of the initial colors of fabric or garment throughout multiple washing cycles. [0161]
  • The term “de-pilling” denotes removing of pills from the fabric surface. [0162]
  • The term “soaking liquor” denotes an aqueous liquor in which laundry may be immersed prior to being subjected to a conventional washing process. The soaking liquor may contain one or more ingredients conventionally used in a washing or laundering process. [0163]
  • The term “washing liquor” denotes an aqueous liquor in which laundry is subjected to a washing process, i.e. usually a combined chemical and mechanical action either manually or in a washing machine. Conventionally, the washing liquor is an aqueous solution of a powder or liquid detergent composition. [0164]
  • The term “rinsing liquor” denotes an aqueous liquor in which laundry is immersed and treated, conventionally immediately after being subjected to a washing process, in order to rinse the laundry, i.e. essentially remove the detergent solution from the laundry. The rinsing liquor may contain a fabric conditioning or softening composition. [0165]
  • The laundry subjected to the method of the present invention may be conventional washable laundry. Preferably, the major part of the laundry is sewn or un-sewn fabrics, including knits, wovens, denims, yarns, and toweling, made from cotton, cotton blends or natural or manmade cellulosics (e.g. originating from xylan-containing cellulose fibers such as from wood pulp) or blends thereof. Examples of blends are blends of cotton or rayon/viscose with one or more companion material such as wool, synthetic fibers (e.g. polyamide fibers, acrylic fibers, polyester fibers, polyvinyl alcohol fibers, polyvinyl chloride fibers, polyvinylidene chloride fibers, polyurethane fibers, polyurea fibers, aramid fibers), and cellulose-containing fibers (e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fibers, lyocell). [0166]
    • DETERGENT DISCLOSURE AND EXAMPLES
  • Surfactant System [0167]
  • The detergent compositions according to the present invention comprise a surfactant system, wherein the surfactant can be selected from nonionic and/or anionic and/or cationic and/or ampholytic and/or zwitterionic and/or semi-polar surfactants. [0168]
  • The surfactant is typically present at a level from 0.1% to 60% by weight. [0169]
  • The surfactant is preferably formulated to be compatible with enzyme components present in the composition. In liquid or gel compositions the surfactant is most preferably formulated in such a way that it promotes, or at least does not degrade, the stability of any enzyme in these compositions. [0170]
  • Preferred systems to be used according to the present invention comprise as a surfactant one or more of the nonionic and/or anionic surfactants described herein. [0171]
  • Polyethylene, polypropylene, and polybutylene oxide condensates of alkyl phenols are suitable for use as the nonionic surfactant of the surfactant systems of the present invention, with the polyethylene oxide condensates being preferred. These compounds include the condensation products of alkyl phenols having an alkyl group containing from about 6 to about 14 carbon atoms, preferably from about 8 to about 14 carbon atoms, in either a straight chain or branched-chain configuration with the alkylene oxide. In a preferred embodiment, the ethylene oxide is present in an amount: equal to from about 2 to about 25 moles, more preferably from about 3 to about 15 moles, of ethylene oxide per mole of alkyl phenol. Commercially available nonionic surfactants of this type include IgepalTM CO-630, marketed by the GAF Corporation; and TritonTM X-45, X-114, X-100 and X-102, all marketed by the Rohm & Haas Company. These surfactants are commonly referred to as alkylphenol alkoxylates (e.g., alkyl phenol ethoxylat(es). [0172]
  • The condensation products of primary and secondary aliphatic alcohols with about 1 to about 25 moles of ethylene oxide are suitable for use as the nonionic surfactant of the nonionic surfactant systems of the present invention. The alkyl chain of the aliphatic alcohol can either be straight or branched, primary or secondary, and generally contains from about 8 to about 22 carbon atoms. Preferred are the condensation products of alcohols having an alkyl group containing from about 8 to about 20 carbon atoms, more preferably from about 10 to about 18 carbon atoms, with from about 2 to about 10 moles of ethylene oxide per mole of alcohol. About 2 to about 7 moles of ethylene oxide and most preferably from 2 to 5 moles of ethylene oxide per mole of alcohol are present in said condensation products. Examples of commercially available nonionic surfactants of this type include TergitolTM 15-S-9 (The condensation product of C11-C15 linear alcohol with 9 moles ethylene oxide), TergitolTM 24-L-6 NMW (the condensation product of C12-C14 primary alcohol with 6 moles ethylene oxide with a narrow molecular weight distribution), both marketed by Union Carbide Corporation; NeodolTM 45-9 (the condensation product of C14-C15 linear alcohol with 9 moles of ethylene oxide), NeodolTM 23-3 (the condensation product of C12-C13 linear alcohol with 3.0 moles of ethylene oxide), NeodolTM 45-7 (the condensation product of C14-C15 linear alcohol with 7 moles of ethylene oxide), NeodolTM 45-5 (the condensation product of C14-C15 linear alcohol with 5 moles of ethylene oxide) marketed by Shell Chemical Company, KyroTM EOB (the condensation product of C13-C15 alcohol with 9 moles ethylene oxide), marketed by The Procter & Gamble Company, and Genapol LA 050 (the condensation product of C12-C14 alcohol with 5 moles of ethylene oxide) marketed by Hoechst. Preferred range of HILB in these products is from 8-11 and most preferred from 8-10. [0173]
  • Also useful as the nonionic surfactant of the surfactant systems of the present invention are alkylpolysaccharides disclosed in U.S. Pat. No. 4,565,647, having a hydrophobic group containing from about 6 to about 30 carbon atoms, preferably from about 10 to about 16 carbon atoms and a polysaccharide, e.g. a polyglycoside, hydrophilic group containing from about 1.3 to about 10, preferably from about 1.3 to about 3, most preferably from about 1.3 to about 2.7 saccharide units. Any reducing saccharide containing 5 or 6 carbon atoms can be used, e.g., glucose, galactose and galactosyl moieties can be substituted for the glucosyl moieties (optionally the hydrophobic group is attached at the 2-, 3-, 4-, etc. positions thus giving a glucose or galactose as opposed to a glucoside or galactoside). The intersaccharide bonds can be, e.g., between the one position of the additional saccharide units and the 2-, 3-, 4-, and/or 6- positions on the preceding saccharide units. [0174]
  • The preferred alkylpolyglycosides have the formula [0175]
  • R2O (CnH2nO)t(glycosyl)x
  • wherein R2 is selected from the group consisting of alkyl, alkylphenyl, hydroxyalkyl, hydroxyalkylphenyl, and mixtures thereof in which the alkyl groups contain from about 10 to about 18, preferably from about 12 to about 14, carbon atoms; n is 2 or 3, preferably 2; t is from 0 to about 10, preferably 0; and x is from about 1.3 to about 10, preferably from about 1.3 to about 3, most preferably from about 1.3 to about 2.7. The glycosyl is preferably derived from glucose. To prepare these compounds, the alcohol or alkylpolyethoxy alcohol is formed first and then reacted with glucose, or a source of glucose, to form the glucoside (attachment at the 1-position). The additional glycosyl units can then be attached between their 1-position and the preceding glycosyl units 2-, 3-, 4-, and/or 6-position, preferably predominantly the 2-position. [0176]
  • The condensation products of ethylene oxide with a hydrophobic base formed by the condensation of propylene oxide with propylene glycol are also suitable for use as the additional nonionic surfactant systems of the present invention. The hydrophobic portion of these compounds will preferably have a molecular weight from about 1500 to about 1800 and will exhibit water insolubility. The addition of polyoxyethylene moieties to this hydrophobic portion tends to increase the water solubility of the molecule as a whole, and the liquid character of the product is retained up to the point where the polyoxyethylene content is about 50% of the total weight of the condensation product, which corresponds to condensation with up to about 40 moles of ethylene oxide. Examples of compounds of this type include certain of the commercially available PluronicTM surfactants, marketed by BASF. [0177]
  • Also suitable for use as the nonionic surfactant of the nonionic surfactant system of the present invention, are the condensation products of ethylene oxide with the product resulting from the reaction of propylene oxide and ethylenediamine. The hydrophobic moiety of these products consists of the reaction product of ethylenediamine and excess propylene oxide, and generally has a molecular weight of from about 2500 to about 3000. This hydrophobic moiety is condensed with ethylene oxide to the extent that the condensation product contains from about 40% to about 80% by weight of polyoxyethylene and has a molecular weight of from about 5,000 to about 11,000. Examples of this type of nonionic surfactant include certain of the commercially available TetronicTM compounds, marketed by BASF. [0178]
  • Preferred for use as the nonionic surfactant of the surfactant systems of the present invention are polyethylene oxide condensates of alkyl phenols, condensation products of primary and secondary aliphatic alcohols with from about 1 to about 25 moles of ethyleneoxide, alkylpolysaccharides, and mixtures hereof. Most preferred are C8-C14 alkyl phenol ethoxylates having from 3 to 15 ethoxy groups and C8-C18 alcohol ethoxylates (preferably C10 avg.) having from 2 to 10 ethoxy groups, and mixtures thereof. [0179]
  • Highly preferred nonionic surfactants are polyhydroxy fatty acid amide surfactants of the formula [0180]
    Figure US20030092097A1-20030515-C00001
  • wherein R1 is H, or R1 is C1-4 hydrocarbyl, 2-hydroxyethyl, 2-hydroxypropyl or a mixture thereof, R2 is C5-31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative thereof. Preferably, R1 is methyl, R2 is straight C11-15 alkyl or C16-18 alkyl or alkenyl chain such as coconut alkyl or mixtures thereof, and Z is derived from a reducing sugar such as glucose, fructose, maltose or lactose, in a reductive amination reaction. [0181]
  • Highly preferred anionic surfactants include alkyl alkoxylated sulfate surfactants. Examples hereof are water soluble salts or acids of the formula RO(A)mSO3M wherein R is an unsubstituted C10-C-24 alkyl or hydroxyalkyl group having a C10-C24 alkyl component, preferably a C12-C20 alkyl or hydroxyalkyl, more preferably C12-C18 alkyl or hydroxyalkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically between about 0.5 and about 6, more preferably between about 0.5 and about 3, and M is H or a cation which can be, for example, a metal cation (e.g., sodium, potassium, lithium, calcium, magnesium, etc.), ammonium or substituted-ammonium cation. Alkyl ethoxylated sulfates as well as alkyl propoxylated sulfates are contemplated herein. Specific examples of substituted ammonium cations include methyl-, dimethyl, trimethyl-ammonium cations and quaternary ammonium cations such as tetramethyl-ammonium and dimethyl piperdinium cations and those derived from alkylamines; such as ethylamine, diethylamine, triethylamine, mixtures thereof, and the like. Exemplary surfactants are C12-C18 alkyl polyethoxylate (1.0) sulfate (C12-C18E(1.0)M), C12-C18 alkyl polyethoxylate (2.25) sulfate (C12-C18(2.25)M, and C12-C18 alkyl polyethoxylate (3.0) sulfate (C12-C18E(3.0)M), and C12-C18 alkyl polyethoxylate (4.0) sulfate (C12-C18E(4.0)M), wherein M is conveniently selected from sodium and potassium. [0182]
  • Suitable anionic surfactants to be used are alkyl ester sulfonate surfactants including linear esters of C8-C20 carboxylic acids (i.e., fatty acids) which are sulfonated with gaseous SO3 according to “The Journal of the American Oil Chemists Society”, 52 (1975), pp. 323-329. Suitable starting materials would include natural fatty substances as derived from tallow, palm oil, etc. [0183]
  • The preferred alkyl ester sulfonate surfactant, especially for laundry applications, comprise alkyl ester sulfonate surfactants of the structural formula: [0184]
    Figure US20030092097A1-20030515-C00002
  • wherein R3 is a C8-C20 hydrocarbyl, preferably an alkyl, or combination thereof, R4 is a C1-C6 hydrocarbyl, preferably an alkyl, or combination thereof, and M is a cation which forms a water soluble salt with the alkyl ester sulfonate. Suitable salt-forming cations include metals such as sodium, potassium, and lithium, and substituted or unsubstituted ammonium cations, such as monoethanolamine, diethonolamine, and triethanolamine. Preferably, R3 is C10-C16 alkyl, and R4 is methyl, ethyl or isopropyl. Especially preferred are the methyl ester sulfonates wherein R3 is C10-C16 alkyl. [0185]
  • Other suitable anionic surfactants include the alkyl sulfate surfactants which are water soluble salts or acids of the formula ROSO3M wherein R preferably is a C10-C24 hydrocarbyl, preferably an alkyl or hydroxyalkyl having a C10-C20 alkyl component, more preferably a C12-C18 alkyl or hydroxyalkyl, and M is H or a cation, e.g., an alkali metal cation (e.g. sodium, potassium, lithium), or ammonium or substituted ammonium (e.g. methyl-, dimethyl-, and trimethyl ammonium cations and quaternary ammonium cations such as tetramethyl-ammonium and dimethyl piperdinium cations and quaternary ammonium cations derived from alkylamines such as ethylamine, diethylamine, triethylamine, and mixtures thereof, and the like). Typically, alkyl chains of C12-C16 are preferred for lower wash temperatures (e.g. below about 50° C.) and C16-C18 alkyl chains are preferred for higher wash temperatures (e.g. above about 50° C.). [0186]
  • Other anionic surfactants useful for detersive purposes can also be included in the laundry detergent compositions of the present invention. Theses can include salts (including, for example, sodium, potassium, ammonium, and substituted ammonium salts such as mono- di- and triethanolamine salts) of soap, C8-C22 primary or secondary alkanesulfonates, C8-C24 olefinsulfonates, sulfonated polycarboxylic acids prepared by sulfonation of the pyrolyzed product of alkaline earth metal citrates, e.g., as described in British patent specification No. 1,082,179, C8-C24 alkylpolyglycolethersulfates (containing up to 10 moles of ethylene oxide); alkyl glycerol sulfonates, fatty acyl glycerol sulfonates, fatty oleyl glycerol sulfates, alkyl phenol ethylene oxide ether sulfates, paraffin sulfonates, alkyl phosphates, isethionates such as the acyl isethionates, N-acyl taurates, alkyl succinamates and sulfosuccinates, monoesters of sulfosuccinates (especially saturated and unsaturated C12-C18 monoesters) and diesters of sulfosuccinates (especially saturated and unsaturated C6-C12 diesters), acyl sarcosinates, sulfates of alkylpolysaccharides such as the sulfates of alkylpolyglucoside (the nonionic nonsulfated compounds being described below), branched primary alkyl sulfates, and alkyl polyethoxy carboxylates such as those of the formula RO(CH2CH2O)k—CH2C00-M+ wherein R is a C8-C22 alkyl, k is an integer from 1 to 10, and M is a soluble salt forming cation. Resin acids and hydrogenated resin acids are also suitable, such as rosin, hydrogenated, rosin, and resin acids and hydrogenated resin acids present in or derived from tall oil. [0187]
  • Alkylbenzene sulfonates are highly preferred. Especially preferred are linear (straight-chain) alkyl benzene sulfonates (LAS) wherein the alkyl group preferably contains from 10 to 18 carbon atoms. [0188]
  • Further examples are described in “Surface Active Agents and Detergents” (Vol. I and II by Schwartz, Perrry and Berch). A variety of such surfactants are also generally disclosed in U.S. Pat. No. 3,929,678, (Column 23, line 58 through Column 29, line 23, herein incorporated by reference). [0189]
  • When included therein, the laundry detergent compositions of the present invention typically comprise from about 1% to about 40%, preferably from about 3% to about 20% by weight of such anionic surfactants. [0190]
  • The laundry detergent compositions of the present invention may also contain cationic, ampholytic, zwitterionic, and semi-polar surfactants, as well as the nonionic and/or anionic surfactants other than those already described herein. [0191]
  • Cationic detersive surfactants suitable for use in the laundry detergent compositions of the present invention are those having one long-chain hydrocarbyl group. Examples of such cationic surfactants include the ammonium surfactants such as alkyltrimethylammonium halogenides, and those surfactants having the formula: [0192]
  • [R2(OR3)y][R4(OR3)y]2R5N+X—
  • wherein R2 is an alkyl or alkyl benzyl group having from about 8 to about 18 carbon atoms in the alkyl chain, each R3 is selected form the group consisting of —CH2CH2—, —CH2CH(CH3)—, —CH2CH(CH20H)—, —CH2CH2CH2—, and mixtures thereof; each R4 is selected from the group consisting of C1-C4 alkyl, C1-C4 hydroxyalkyl, benzyl ring structures formed by joining the two R4 groups, —CH2CHOHCHOHCOR6CHOHCH2OH, wherein R6 is any hexose or hexose polymer having a molecular weight less than about 1000, and hydrogen when y is not 0; R5 is the same as R4 or is an alkyl chain, wherein the total number of carbon atoms or R2 plus R5 is not more than about 18; each y is from 0 to about 10, and the sum of the y values is from 0 to about 15; and X is any compatible anion. [0193]
  • Highly preferred cationic surfactants are the water soluble quaternary ammonium compounds useful in the present composition having the formula: [0194]
  • R1R2R3R4N+X—  (i)
  • wherein R1 is C8-C16 alkyl, each of R2, R3 and R4 is independently C1-C4 alkyl, C1-C4 hydroxy alkyl, benzyl, and —(C2H40)xH where x has a value from 2 to 5, and X is an anion. Not more than one of R2, R3 or R4 should be benzyl. [0195]
  • The preferred alkyl chain length for R1 is C12-C15, particularly where the alkyl group is a mixture of chain lengths derived from coconut or palm kernel fat or is derived synthetically by olefin build up or OXO alcohols synthesis. [0196]
  • Preferred groups for R2R3 and R4 are methyl and hydroxyethyl groups and the anion X may be selected from halide, methosulphate, acetate and phosphate ions. [0197]
  • Examples of suitable quaternary ammonium compounds of formulae (i) for use herein are: [0198]
  • coconut trimethyl ammonium chloride or bromide; [0199]
  • coconut methyl dihydroxyethyl ammonium chloride or bromide; [0200]
  • decyl triethyl ammonium chloride; [0201]
  • decyl dimethyl hydroxyethyl ammonium chloride or bromide; [0202]
  • C12-15 dimethyl hydroxyethyl ammonium chloride or bromide; [0203]
  • coconut dimethyl hydroxyethyl ammonium chloride or bromide; [0204]
  • myristyl trimethyl ammonium methyl sulphate; [0205]
  • lauryl dimethyl benzyl ammonium chloride or bromide; [0206]
  • lauryl dimethyl (ethenoxy)4 ammonium chloride or bromide; [0207]
  • choline esters (compounds of formula (i) wherein R1 is CH2—CH2—O—C—C12-14 alkyl and R2R3R4 are methyl). [0208]
    Figure US20030092097A1-20030515-C00003
  • di-alkyl imidazolines [compounds of formula (i)]. [0209]
  • Other cationic surfactants useful herein are also described in U.S. Pat. No. 4,228,044 and in EP 000 224. [0210]
  • When included therein, the laundry detergent compositions of the present invention typically comprise from 0.2% to about 25%, preferably from about 1% to about 8% by weight of such cationic surfactants. [0211]
  • Ampholytic surfactants are also suitable for use in the laundry detergent compositions of the present invention. These surfactants can be broadly described as aliphatic derivatives of secondary or tertiary amines, or aliphatic derivatives of heterocyclic secondary and tertiary amines in which the aliphatic radical can be straight- or branched-chain. One of the aliphatic substituents contains at least about 8 carbon atoms, typically from about 8 to about 18 carbon atoms, and at least one contains an anionic water-solubilizing group, e.g. carboxy, sulfonate, sulfate. See U.S. Pat. No. 3,929,678 (column 19, lines 18-35) for examples of ampholytic surfactants. [0212]
  • When included therein, the laundry detergent compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such ampholytic surfactants. [0213]
  • Zwitterionic surfactants are also suitable for use in laundry detergent compositions. These surfactants can be broadly described as derivatives of secondary and tertiary amines, derivatives of heterocyclic secondary and tertiary amines, or derivatives of quaternary ammonium, quaternary phosphonium or tertiary sulfonium compounds. See U.S. Pat. No. 3,929,678 (column 19, line 38 through column 22, line 48) for examples of zwitterionic surfactants. [0214]
  • When included therein, the laundry detergent compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such zwitterionic surfactants. [0215]
  • Semi-polar nonionic surfactants are a special category of nonionic surfactants which include water-soluble amine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms and 2 moieties selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; water soluble phosphine oxides containing one alkyl moiety of from about 10 to about 18 carbon atoms and 2 moieties selected from the group consisting of is alkyl groups and hydroxyalkyl groups containing from about 1 to about 3 carbon atoms; and water-soluble sulfoxides containing one alkyl moiety from about 10 to about 18 carbon atoms and a moiety selected from the group consisting of alkyl and hydroxyalkyl moieties of from about 1 to about 3 carbon atoms. [0216]
  • Semi-polar nonionic detergent surfactants include the amine oxide surfactants having the formula: [0217]
    Figure US20030092097A1-20030515-C00004
  • wherein R3 is an alkyl, hydroxyalkyl, or alkyl phenyl group or mixtures thereof containing from about 8 to about 22 carbon atoms; R4 is an alkylene or hydroxyalkylene group containing from about 2 to about 3 carbon atoms or mixtures thereof; x is from 0 to about 3: and each R5 is an alkyl or hydroxyalkyl group containing from about 1 to about 3 carbon atoms or a polyethylene oxide group containing from about 1 to about 3 ethylene oxide groups. The R5 groups can be attached to each other, e.g., through an oxygen or nitrogen atom, to form a ring structure. [0218]
  • These amine oxide surfactants in particular include C10-C18 alkyl dimethyl amine oxides and C8-C12 alkoxy ethyl dihydroxy ethyl amine oxides. [0219]
  • When included therein, the laundry detergent compositions of the present invention typically comprise from 0.2% to about 15%, preferably from about 1% to about 10% by weight of such semi-polar nonionic surfactants. [0220]
  • Builder System [0221]
  • The compositions according to the present invention may further comprise a builder system. Any conventional builder system is suitable for use herein including aluminosilicate materials, silicates, polycarboxylates and fatty acids, materials such as ethylenediamine tetraacetate, metal ion sequestrants such as aminopolyphosphonates, particularly ethylenediamine tetramethylene phosphonic acid and diethylene triamine pentamethylenephosphonic acid. Though less preferred for obvious environmental reasons, phosphate builders can also be used herein. [0222]
  • Suitable builders can be an inorganic ion exchange material, commonly an inorganic hydrated aluminosilicate material, more particularly a hydrated synthetic zeolite such as hydrated zeolite A, X, B, HS or MAP. [0223]
  • Another suitable inorganic builder material is layered silicate, e.g. SKS-6 (Hoechst). SKS-6 is a crystalline layered silicate consisting of sodium silicate (Na2Si2O5). [0224]
  • Suitable polycarboxylates containing one carboxy group include lactic acid, glycolic acid and ether derivatives thereof as disclosed in Belgian Patent Nos. 831,368, 821,369 and 821,370. Polycarboxylates containing two carboxy groups include the water-soluble salts of succinic acid, malonic acid, (ethylenedioxy) diacetic acid, maleic acid, diglycollic acid, tartaric acid, tartronic acid and fumaric acid, as well as the ether carboxylates described in German Offenle-enschrift 2,446,686, and 2,446,487, U.S. Pat. No. 3,935,257 and the sulfinyl carboxylates described in Belgian Patent No. 840,623. Polycarboxylates containing three carboxy groups include, in particular, water-soluble citrates, aconitrates and citraconates as well as succinate derivatives such as the carboxymethyloxysuccinates described in British Patent No. 1,379,241, lactoxysuccinates described in Netherlands Application 7205873, and the oxypolycarboxylate materials such as 2-oxa-1,1,3-propane tricarboxylates described in British Patent No. 1,387,447. [0225]
  • Polycarboxylates containing four carboxy groups include oxydisuccinates disclosed in British Patent No. 1,261,829, 1,1,2,2,-ethane tetracarboxylates, 1,1,3,3-propane tetracarboxylates containing sulfo substituents include the sulfosuccinate derivatives disclosed in British Patent Nos. 1,398,421 and 1,398,422 and in U.S. Pat. No. 3,936,448, and the sulfonated pyrolysed citrates described in British Patent No. 1,082,179, while polycarboxylates containing phosphone substituents are disclosed in British Patent No. 1,439,000. [0226]
  • Alicyclic and heterocyclic polycarboxylates include cyclopentane-cis,cis-cis-tetracarboxylates, cyclopentadienide pentacarboxylates, 2,3,4,5-tetrahydro-furan—cis, cis, cis-tetracarboxylates, 2,5-tetrahydro-furan-tetrahydro-furan-cis, discarboxylates, 2,2,5,5,-tetrahydrofuran—tetracarboxylates, 1,2,3,4,5,6-hexane—hexacarboxylates and carboxymethyl derivatives of polyhydric alcohols such as sorbitol, mannitol and xylitol. Aromatic polycarboxylates include mellitic acid, pyromellitic acid and the phthalic acid derivatives disclosed in British Patent No. 1,425,343. [0227]
  • Of the above, the preferred polycarboxylates are hydroxy-carboxylates containing up to three carboxy groups per molecule, more particularly citrates. [0228]
  • Preferred builder systems for use in the present compositions include a mixture of a water-insoluble aluminosilicate builder such as zeolite A or of a layered silicate (SKS-6), and a water-soluble carboxylate chelating agent such as citric acid. [0229]
  • A suitable chelant for inclusion in the detergent composi-ions in accordance with the invention is ethylenediamine-N,N′-disuccinic acid (EDDS) or the alkali metal, alkaline earth metal, ammonium, or substituted ammonium salts thereof, or mixtures thereof. Preferred EDDS compounds are the free acid form and the sodium or magnesium salt thereof. Examples of such preferred sodium salts of EDDS include Na2EDDS and Na4EDDS. Examples of such preferred magnesium salts of EDDS include MgEDDS and Mg2EDDS. The magnesium salts are the most preferred for inclusion in compositions in accordance with the invention. [0230]
  • Preferred builder systems include a mixture of a water-insoluble aluminosilicate builder such as zeolite A, and a water soluble carboxylate chelating agent such as citric acid. [0231]
  • Other builder materials that can form part of the builder system for use in granular compositions include inorganic materials such as alkali metal carbonates, bicarbonates, silicates, and organic materials such as the organic phosphonates, amino polyalkylene phosphonates and amino polycarboxylates. [0232]
  • Other suitable water-soluble organic salts are the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated form each other by not more than two carbon atoms. [0233]
  • Polymers of this type are disclosed in GB-A-1,596,756. Examples of such salts are polyacrylates of MW 2000-5000 and their copolymers with maleic anhydride, such copolymers having a molecular weight of from 20,000 to 70,000, especially about 40,000. [0234]
  • Detergency builder salts are normally included in amounts of from 5% to 80% by weight of the composition. Preferred levels of builder for liquid detergents are from 5% to 30%. [0235]
  • Enzymes [0236]
  • Preferred detergent compositions, in addition to the enzyme preparation of the invention, comprise other enzyme(s) which provides cleaning performance and/or fabric care benefits. [0237]
  • Such enzymes include proteases, lipases, cutinases, amylases, cellulases, peroxidases, oxidases (e.g. laccases). [0238]
  • Proteases: Any protease suitable for use in alkaline solutions can be used. Suitable proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically or genetically modified mutants are included. The protease may be a serine protease, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279). Examples of trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270. [0239]
  • Preferred commercially available protease enzymes include those sold under the trade names Alcalase, Savinase, Primase, Durazym, and Esperase by Novo Nordisk A/S (Denmark), those sold under the tradename Maxatase, Maxacal, Maxapem, Properase, Purafect and Purafect OXP by Genencor International, and those sold under the tradename Opticlean and Optimase by Solvay Enzymes. Protease enzymes may be incorporated into the compositions in accordance with the invention at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at Ea level of from 0.01% to 0.2% of enzyme protein by weight of the composition. [0240]
  • Lipases: Any lipase suitable for use in alkaline solutions can be used. Suitable lipases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. [0241]
  • Examples of useful lipases include a [0242] Humicola lanuginosa lipase, e.g., as described in EP 258 068 and EP 305 216, a Rhizomucor miehei lipase, e.g., as described in EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C. antarctica lipase A or B described in EP: 214 761, a Pseudomonas lipase such as a P. alcaligenes and P. pseudoalcaligenes lipase, e.g., as described in EP 218 272, a P. cepacia lipase, e.g., as described in EP 331 376, a P. stutzeri lipase, e.g., as disclosed in GB 1,372,034, a P. fluorescens lipase, a Bacillus lipase, e.g., a B. subtilis lipase (Dartois et al., (1993), Biochemica et Biophysica acta 1131, 253-260), a B. stearothermophilus lipase (JP 64/744992) and a B. pumilus lipase (WO 91/16422).
  • Furthermore, a number of cloned lipases may be useful, including the [0243] Penicillium camembertii lipase described by Yamaguchi et al., (1991), Gene 103, 61-67), the Geotricum candidum lipase (Schimada, Y. et al., (1989), J. Biochem., 106, 383-388), and various Rhizopus lipases such as a R. delemar lipase (Hass, M. J. et al., (1991), Gene 109, 117-113), a R. niveus lipase (Kugimiya et al., (1992), Biosci. Biotech. Biochem. 56, 716-719) and a R. oryzae lipase.
  • Other types of lipolytic enzymes such as cutinases may also be useful, e.g., a cutinase derived from [0244] Pseudomonas mendocina as described in WO 88/09367, or a cutinase derived from Fusarium solani pisi (e.g. described in WO 90/09446).
  • Especially suitable lipases are lipases such as M1 LipaseTM, Luma fastTM and LipomaxTM (Genencor), LipolaseTM and Lipolase UltraTM (Novo Nordisk A/S), and Lipase P “Amano” (Amano Pharmaceutical Co. Ltd.). [0245]
  • The lipases are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition. [0246]
  • Amylases: Any amylase (a and/or b) suitable for use in alkaline solutions can be used. Suitable amylases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Amylases include, for example, a-amylases obtained from a special strain of [0247] B. licheniformis, described in more detail in GB 1,296,839. Commercially available amylases are DuramylTM, TermamylTM, FungamylTM and BANTM (available from Novo Nordisk A/S) and RapidaseTM and Maxamyl PTM (available from Genencor).
  • The amylases are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition. [0248]
  • Cellulases: Any cellulase suitable for use in alkaline solutions can be used. Suitable cellulases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Suitable cellulases are disclosed in U.S. Pat. No. 4,435,307, which discloses fungal cellulases produced from [0249] Humicola insolens. Especially suitable cellulases are the 15 cellulases having color care benefits. Examples of such cellulases are cellulases described in European patent application No. 0 495 257 and the endoglucanase of the present invention.
  • Commercially available cellulases include CelluzymeTM produced by a strain of [0250] Humicola insolens, (Novo Nordisk A/S), and KAC-500(B)TM (Kao Corporation).
  • Cellulases are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition. [0251]
  • Peroxidases/Oxidases: Peroxidase enzymes are used in combination with hydrogen peroxide or a source thereof (e.g. a percarbonate, perborate or persulfate). Oxidase enzymes are used in combination with oxygen. Both types of enzymes are used for “solution bleaching”, i.e. to prevent transfer of a textile dye from a dyed fabric to another fabric when said fabrics are washed together in a wash liquor, preferably together with an enhancing agent as described in e.g. WO 94/12621 and WO 95/01426. Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically or genetically modified mutants are included. [0252]
  • Peroxidase and/or oxidase enzymes are normally incorporated in the detergent composition at a level of from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level of from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level of from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level of from 0.01% to 0.2% of enzyme protein by weight of the composition. [0253]
  • Mixtures of the above mentioned enzymes are encompassed herein, in particular a mixture of a protease, an amylase, a lipase and/or a cellulase. [0254]
  • The enzyme of the invention, or any other enzyme incorporated in the detergent composition, is normally incorporated in the detergent composition at a level from 0.00001% to 2% of enzyme protein by weight of the composition, preferably at a level from 0.0001% to 1% of enzyme protein by weight of the composition, more preferably at a level from 0.001% to 0.5% of enzyme protein by weight of the composition, even more preferably at a level from 0.01% to 0.2% of enzyme protein by weight of the composition. [0255]
  • Bleaching Agents [0256]
  • Additional optional detergent ingredients that can be included in the detergent compositions of the present invention include bleaching agents such as PB1, PB4 and percarbonate with a particle size of 400-800 microns. These bleaching agent components can include one or more oxygen bleaching agents and, depending upon the bleaching agent chosen, one or more bleach activators. When present oxygen bleaching compounds will typically be present at levels of from about 1% to about 25%. In general, bleaching compounds are optional added components in non-liquid formulations, e.g. granular detergents. [0257]
  • The bleaching agent component for use herein can be any of the bleaching agents useful for detergent compositions including oxygen bleaches as well as others known in the art. [0258]
  • The bleaching agent suitable for the present invention can be an activated or non-activated bleaching agent. [0259]
  • One category of oxygen bleaching agent that can be used encompasses percarboxylic acid bleaching agents and salts thereof. Suitable examples of this class of agents include magnesium monoperoxyphthalate hexahydrate, the magnesium salt of meta-chloro perbenzoic acid, 4-nonylamino-4-oxoperoxybutyric acid and diperoxydodecanedioic acid. Such bleaching agents are disclosed in U.S. Pat. No. 4,483,781, U.S. Pat. No. 740,446, EP 0 133 354 and U.S. Pat. No. 4,412,934. Highly preferred bleaching agents also include 6-nonylamino-6-oxoperoxycaproic acid as described in U.S. Pat. No. 4,634,551. [0260]
  • Another category of bleaching agents that can be used encompasses the halogen bleaching agents. Examples of hypohalite bleaching agents, for example, include trichloro isocyanuric acid and the sodium and potassium dichloroisocyanurates and N-chloro and N-bromo alkane sulphonamides. Such materials are normally added at 0.5-10% by weight of the finished product, preferably 1-5% by weight. [0261]
  • The hydrogen peroxide releasing agents can be used in combination with bleach activators such as tetra-acetylethylenediamine (TAED), nonanoyloxybenzenesulfonate (NOBS, described in U.S. Pat. No. 4,412,934), 3,5-trimethyl-hexsanoloxybenzenesulfonate (ISONOBS, described in EP 120 591) or pentaacetylglucose (PAG), which are perhydrolyzed to form a peracid as the active bleaching species, leading to improved bleaching effect. In addition, very suitable are the bleach activators C8(6-octanamido-caproyl) oxybenzene-sulfonate, C9(6-nonanamido caproyl) oxybenzenesulfonate and C10 (6-decanamido caproyl) oxybenzenesulfonate or mixtures thereof. Also suitable activators are acylated citrate esters such as disclosed in European Patent Application No. 91870207.7. [0262]
  • Useful bleaching agents, including peroxyacids and bleaching systems comprising bleach activators and peroxygen bleaching compounds for use in cleaning compositions according to the invention are described in application U.S. Ser. No. 08/136,626. [0263]
  • The hydrogen peroxide may also be present by adding an enzymatic system (i.e. an enzyme and a substrate therefore) which is capable of generation of hydrogen peroxide at the beginning or during the washing and/or rinsing process. Such enzymatic systems are disclosed in European Patent Application EP 0 537 381. [0264]
  • Bleaching agents other than oxygen bleaching agents are also known in the art and can be utilized herein. One type of non-oxygen bleaching agent of particular interest includes photoactivated bleaching agents such as the sulfonated zinc and/or aluminium phthalocyanines. These materials can be deposited upon the substrate during the washing process. Upon irradiation with light, in the presence of oxygen, such as by hanging clothes out to dry in the daylight, the sulfonated zinc phthalocyanine is activated and, consequently, the substrate is bleached. Preferred zinc phthalocyanine and a photoactivated bleaching process are described in U.S. Pat. No. 4,033,718. Typically, detergent composition will contain about 0.025% to about 1.25%, by weight, of sulfonated zinc phthalocyanine. [0265]
  • Bleaching agents may also comprise a manganese catalyst. The manganese catalyst may, e.g., be one of the compounds described in “Efficient manganese catalysts for low-temperature bleaching”, Nature 369, 1994, pp. 637-639. [0266]
  • Suds Suppressors [0267]
  • Another optional ingredient is a suds suppressor, exemplified by silicones, and silica-silicone mixtures. Silicones can generally be represented by alkylated polysiloxane materials, while silica is normally used in finely divided forms exemplified by silica aerogels and xerogels and hydrophobic silicas of various types. Theses materials can be incorporated as particulates, in which the suds suppressor is advantageously releasably incorporated in a water-soluble or water-dispersible, substantially non surface-active detergent impermeable carrier. Alternatively the suds suppressor can be dissolved or dispersed in a liquid carrier and applied by spraying on to one or more of the other components. [0268]
  • A preferred silicone suds controlling agent is disclosed in U.S. Pat. No. 3,933,672. Other particularly useful suds suppressors are the self-emulsifying silicone suds suppressors, described in German Patent Application DTOS 2,646,126. An example of such a compound is DC-544, commercially available form Dow Corning, which is a siloxane-glycol copolymer. Especially preferred suds controlling agent are the suds suppressor system comprising a mixture of silicone oils and 2-alkyl-alkanols. Suitable 2-alkyl-alkanols are 2-butyl-octanol which are commercially available under the trade name Isofol 12 R. [0269]
  • Such suds suppressor system are described in European Patent Application EP 0 593 841. [0270]
  • Especially preferred silicone suds: controlling agents are described in European Patent Application No. 92201649.8. Said compositions can comprise a silicone/silica mixture in combination with fumed nonporous silica such as AerosilR. [0271]
  • The suds suppressors described above are normally employed at levels of from 0.001% to 2% by weight of the composition, preferably from 0.01% to 1% by weight. [0272]
  • Other Components [0273]
  • Other components used in detergent compositions may be employed such as soil-suspending agents, soil-releasing agents, optical brighteners, abrasives, bactericides, tarnish inhibitors, coloring agents, and/or encapsulated or nonencapsulated perfumes. [0274]
  • Especially suitable encapsulating materials are water soluble capsules which consist of a matrix of polysaccharide and polyhydroxy compounds such as described in GB 1,464,616. [0275]
  • Other suitable water soluble encapsulating materials comprise dextrins derived from ungelatinized starch acid esters of substituted dicarboxylic acids such as described in U.S. Pat. No. 3,455,838. These acid-ester dextrins are, preferably, prepared from such starches as waxy maize, waxy sorghum, sago, tapioca and potato. Suitable examples of said encapsulation materials include N-Lok manufactured by National Starch. The N-Lok encapsulating material consists of a modified maize starch and glucose. The starch is modified by adding monofunctional substituted groups such as octenyl succinic acid anhydride. [0276]
  • Antiredeposition and soil suspension agents suitable herein include cellulose derivatives such as methylcellulose, carboxymethylcellulose and hydroxyethylcellulose, and homo- or co-polymeric polycarboxylic acids or their salts. Polymers of this type include the polyacrylates and maleic anhydride-acrylic acid copolymers previously mentioned as builders, as well as copolymers of maleic anhydride with ethylene, methylvinyl ether or methacrylic acid, the maleic anhydride constituting at least 20 mole percent of the copolymer. These materials are normally used at levels of from 0.5% to 10% by weight, more preferably form 0.75% to 8%, most preferably from 1% to 6% by weight of the composition. [0277]
  • Preferred optical brighteners are anionic in character, examples of which are disodium 4,4′-bis-(2-diethanolamino-4-anilino -s- triazin-6-ylamino)stilbene-2:2′-disulphonate, disodium 4, -4′-bis-(2-morpholino-4-anilino-s-triazin-6-ylamino-stilbene-2:2′-disulphonate, disodium 4,4′bis-(2,4-dianilino-s-triazin-6-ylamino)stilbene-2:2′-disulphonate, monosodium 4′,4″bis-(2,4-dianilino-s-tri-azin-6 ylamino)stilbene-2-sulphonate, disodium 4,4′-bis-(2-anillino-4-(N-methyl-N-2-hydroxethylamino)-s-triazin-6-ylamino) stilbene-2,2′-disulphate, di-sodium 4,4′-bis-(4-phenyl-2,1,3-triazol-2-yl)-stilbene-2,2′ disulphonate, di-so-dium 4,4′bis (2-anilino-4-(1-methyl-2-hydroxyethylamino)-s-triazin-6-ylamino) stilbene-2,2′disulphonate, sodium 2(stilbyl-4″-(naphtho-1′,2′:4,5)-1,2,3,-triazole-2″-sulphonate and 4,4′-bis (2-sulphostyryl)biphenyl. [0278]
  • Other useful polymeric materials are the polyethylene glycols, particularly those of molecular weight 1000-10000, more particularly 2000 to 8000 and most preferably about 4000. These are used at levels of from 0.20% to 5% more preferably from 0.25% to 2.5% by weight. These polymers and the previously mentioned homo- or co-polymeric poly-carboxylate salts are valuable for improving whiteness maintenance, fabric ash deposition, and cleaning performance on clay, proteinaceous and oxidizable soils in the presence of transition metal impurities. [0279]
  • Soil release agents useful in compositions of the resent invention are conventionally copolymers or terpolymers f terephthalic acid with ethylene glycol and/or propylene lycol units in various arrangements. Examples of such polymers are disclosed in U.S. Pat. Nos. 4,116,885 and 4,711,730 and EP 0 272 033. A particular preferred polymer in accordance with EP 0 272 033 has the formula: [0280]
  • (CH3)(PEG)43)0.75(POH)0.25[T-PO)(T-PEG)0.4]T(POH)0.25((PEG)43CH3)0.75
  • where PEG is —(OC2H4)O—, PO is (OC3H6O) and T is (pOOC6H4CO). [0281]
  • Also very useful are modified polyesters as random copolymers of dimethyl terephthalate, dimethyl sulfoisophthalate, ethylene glycol and 1,2-propanediol, the end groups consisting primarily of sulphobenzoate and secondarily of mono esters of ethylene glycol and/or 1,2-propanediol. The target is to obtain a polymer capped at both end by sulphobenzoate groups, “primarily”, in the present context most of said copolymers herein will be endcapped by sulphobenzoate groups. However, some copolymers will be less than fully capped, and therefore their end groups may consist of monoester of ethylene glycol and/or 1,2-propanediol, thereof consist “secondarily” of such species. [0282]
  • The selected polyesters herein contain about 46% by weight of dimethyl terephthalic acid, about 16% by weight of 1,2-propanediol, about 10% by weight ethylene glycol, about 13% by weight of dimethyl sulfobenzoic acid and about 15% by weight of sulfoisophthalic acid, and have a molecular weight of about 3.000. The polyesters and their method of preparation are described in detail in EP 311 342. [0283]
  • Softening Agents [0284]
  • Fabric softening agents can also be incorporated into laundry detergent compositions in accordance with the present invention. These agents may be inorganic or organic in type. Inorganic softening agents are exemplified by the smectite clays disclosed in GB-A-1 400898 and in U.S. Pat. No. 5,019,292. Organic fabric softening agents include the water insoluble tertiary amines as disclosed in GB-A1 514 276 and EP 0 011 340 and their combination with mono C12-C14 quaternary ammonium salts are disclosed in Eβ-B-0 026 528 and di-long-chain amides as disclosed in EP 0 242 919. Other useful organic ingredients of fabric softening systems include high molecular weight polyethylene oxide materials as disclosed in EP 0 299 575 and 0 313 146. [0285]
  • Levels of smectite clay are normally in the range from 5% to 15%, more preferably from 8% to 12% by weight, with the material being added as a dry mixed component to the remainder of the formulation. Organic fabric softening agents such as the water-insoluble tertiary amines or dilong chain amide materials are incorporated at levels of from 0.5% to 5% by weight, normally from 1% to 3% by weight whilst the high molecular weight polyethylene oxide materials and the water soluble cationic materials are added at levels of from 0.1% to 2%, normally from 0.15% to 1.5% by weight. These materials are normally added to the spray dried portion of the composition, although in some instances it may be more convenient to add them as a dry mixed particulate, or spray them as molten liquid on to other solid components of the composition. [0286]
  • Polymeric Dye-transfer Inhibiting Agents [0287]
  • The detergent compositions according to the present invention may also comprise from 0.001% to 10%, preferably from 0.01% to 2%, more preferably form 0.05% to 1% by weight of polymeric dye- transfer inhibiting agents. Said polymeric dye-transfer inhibiting agents are normally incorporated into detergent compositions in order to inhibit the transfer of dyes from colored fabrics onto fabrics washed therewith. These polymers have the ability of complexing or adsorbing the fugitive dyes washed out of dyed fabrics before the dyes have the opportunity to become attached to other articles in the wash. [0288]
  • Especially suitable polymeric dye-transfer inhibiting agents are polyamine N-oxide polymers, copolymers of N-vinyl-pyrrolidone and N-vinylimidazole, polyvinylpyrrolidone polymers, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. [0289]
  • Addition of such polymers also enhances the performance of the enzymes according the invention. [0290]
  • The detergent composition according to the invention can be in liquid, paste, gels, bars or granular forms. [0291]
  • Non-dusting granulates may be produced, e.g., as disclosed in U.S. Pat. Nos. 4,106,991 and 4,661,452 (both to Novo Industri A/S) and may optionally be coated by methods known in the art. Examples of waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molecular weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids. Examples of film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591. [0292]
  • Granular compositions according to the present invention can also be in “compact form”, i.e. they may have a relatively higher density than conventional granular detergents, i.e. form 550 to 950 g/l; in such case, the granular detergent compositions according to the present invention will contain a lower amount of “Inorganic filler salt”, compared to conventional granular detergents; typical filler salts are alkaline earth metal salts of sulphates and chlorides, typically sodium sulphate; “Compact” detergent typically comprise not more than 10% filler salt. The liquid compositions according to the present invention can also be in “concentrated form”, in such case, the liquid detergent compositions according to the present invention will contain a lower amount of water, compared to conventional liquid detergents. Typically, the water content of the concentrated liquid detergent is less than 30%, more preferably less than 20%, most preferably less than 10% by weight of the detergent compositions. [0293]
  • The compositions of the invention may for example, be formulated as hand and machine laundry detergent compositions including laundry additive compositions and compositions suitable for use in the pretreatment of stained fabrics, rinse added fabric softener compositions, and compositions for use in general household hard surface cleaning operations and dishwashing operations. [0294]
  • The following examples are meant to exemplify compositions for the present invention, but are not necessarily meant to limit or otherwise define the scope of the invention. [0295]
  • In the detergent compositions, the abbreviated component identifications have the following meanings: [0296]
  • LAS: Sodium linear C12 alkyl benzene sulphonate [0297]
  • TAS: Sodium tallow alkyl sulphate [0298]
  • XYAS: Sodium C1X-C1Y alkyl sulfate [0299]
  • SS: Secondary soap surfactant of formula 2-butyl octanoic acid [0300]
  • 25EY: A C12-C15 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide [0301]
  • 45EY: A C14-C15 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide [0302]
  • XYEZS: C1X-C1Y sodium alkyl sulfate condensed with an average of Z moles of ethylene oxide per mole [0303]
  • Nonionic: C13-C15 mixed ethoxylated/propoxylated fatty alcohol with an average degree of ethoxylation of 3.8 and an average degree of propoxylation of 4.5 sold under the tradename Plurafax LF404 by BASF Gmbh [0304]
  • CFAA: C12-C14 alkyl N-methyl glucamide [0305]
  • TFAA: C16-C18 alkyl N-methyl glucamide [0306]
  • Silicate: Amorphous Sodium Silicate (SiC)2:Na2O ratio=2.0) [0307]
  • NaSKS-6: Crystalline layered silicate of formula d-Na2Si2O5 [0308]
  • Carbonate: Anhydrous sodium carbonate [0309]
  • Phosphate: Sodium tripolyphosphate [0310]
  • MA/AA: Copolymer of 1:4 maleic/acrylic acid, average molecular weight about 80,000 [0311]
  • Polyacrylate: Polyacrylate homopolymer with an average molecular weight of 8,000 sold under the tradename PA30 by BASF Gmbh [0312]
  • Zeolite A: Hydrated Sodium Aluminosilicate of formula Na12(AlO2SiO2)12. 27H2O having a primary particle size in the range from 1 to 10 micrometers [0313]
  • Citrate: Tri-sodium citrate dihydrate [0314]
  • Citric: Citric Acid [0315]
  • Perborate: Anhydrous sodium perborate monohydrate bleach, empirical formula NaBO2.H2O2 [0316]
  • PB4: Anhydrous sodium perborate tetrahydrate [0317]
  • Percarbonate: Anhydrous sodium percarbonate bleach of empirical formula 2Na2CO3.3H2O2 [0318]
  • TAED: Tetraacetyl ethylene diamine [0319]
  • CMC: Sodium carboxymethyl cellulose [0320]
  • DETPMP: Diethylene triamine penta (methylene phosphonic acid), marketed by Monsanto under the Tradename Dequest 2060 [0321]
  • PVP: Polyvinylpyrrolidone polymer [0322]
  • EDDS: Ethylenediamine-N, N′-disuccinic acid, [S,S] isomer in the form of the sodium salt [0323]
  • Suds Suppressor: 25% paraffin wax Mpt 50° C., 17% hydrophobic silica, 58% paraffin oil [0324]
  • Granular Suds suppressor: 12% Silicone/silica, 18% stearyl alcohol, 70% starch in granular form [0325]
  • Sulphate: Anhydrous sodium sulphate [0326]
  • HMWPEO: High molecular weight polyethylene oxide [0327]
  • TAE 25: Tallow alcohol ethoxylate (25) [0328]
    • DETERGENT EXAMPLE I
  • A granular fabric cleaning composition in accordance with the invention may be prepared as follows: [0329]
    Sodium linear C12 alkyl 6.5
    benzene sulfonate
    Sodium sulfate 15.0
    Zeolite A 26.0
    Sodium nitrilotriacetate 5.0
    Enzyme of the invention 0.1
    PVP 0.5
    TAED 3.0
    Boric acid 4.0
    Perborate 18.0
    Phenol sulphonate 0.1
    Minors Up to 100
    • DETERGENT EXAMPLE II
  • A compact granular fabric cleaning composition (density 800 g/l) in accord with the invention may be prepared as follows: [0330]
    follows:
    45AS 8.0
    25E3S 2.0
    25E5 3.0
    25E3 3.0
    TFAA 2.5
    Zeolite A 17.0
    NaSKS-6 12.0
    Citric acid 3.0
    Carbonate 7.0
    MA/AA 5.0
    CMC 0.4
    Enzyme of the invention 0.1
    TAED 6.0
    Percarbonate 22.0
    EDDS 0.3
    Granular suds suppressor 3.5
    water/minors Up to 100%
    • DETERGENT EXAMPLE III
  • Granular fabric cleaning compositions in accordance with the invention which are especially useful in the laundering of coloured fabrics were prepared as follows: [0331]
    LAS 10.7 —
    TAS 2.4 —
    TFAA — 4.0
    45AS 3.1 10.0
    45E7 4.0 —
    25E3S — 3.0
    68E11 1.8 —
    25E5 — 8.0
    Citrate 15.0 7.0
    Carbonate — 10
    Citric acid 2.5 3.0
    Zeolite A 32.1 25.0
    Na-SKS-6 — 9.0
    MA/AA 5.0 5.0
    DETPMP 0.2 0.8
    Enzyme of the invention 0.10 0.05
    Silicate 2.5 —
    Sulphate 5.2 3.0
    PVP 0.5 —
    Poly (4-vinylpyridine)-N- — 0.2
    Oxide/copolymer of vinyl-
    imidazole and vinyl-
    pyrrolidone
    Perborate 1.0 —
    Phenol sulfonate 0.2 —
    Water/Minors Up to 100%
    • DETERGENT EXAMPLE IV
  • Granular fabric cleaning compositions in accordance with the invention which provide “Softening through the wash” capability may be prepared as follows: [0332]
    45AS — 10.0
    LAS 7.6 —
    68AS 1.3 —
    45E7 4.0 —
    25E3 — 5.0
    Coco-alkyl-dimethyl hydroxy- 1.4 1.0
    ethyl ammonium chloride
    Citrate 5.0 3.0
    Na-SKS-G — 11.0
    Zeolite A 15.0 15.0
    MA/AA 4.0 4.0
    DETPMP 0.4 0.4
    Perborate 15.0 —
    Percarbonate — 15.0
    TAED 5.0 5.0
    Smectite clay 10.0 10.0
    HMWPEO — 0.1
    Enzyme of the invention 0.10 0.05
    Silicate 3.0 5.0
    Carbonate 10.0 10.0
    Granular suds suppressor 1.0 4.0
    CMC 0.2 0.1
    Water/Minors Up to 100%
    • DETERGENT EXAMPLE V
  • Heavy duty liquid fabric cleaning compositions in accordance with the invention may be prepared as follows: [0333]
    I II
    LAS acid form — 25.0
    Citric acid 5.0 2.0
    25AS acid form 8.0 —
    25AE2S acid form 3.0 —
    25AE7 8.0 —
    CFAA 5 —
    DETPMP 1.0 1.0
    Fatty acid 8 —
    Oleic acid — 1.0
    Ethanol 4.0 5.0
    Propanediol 2.0 6.0
    Enzyme of the invention 0.10 0.05
    Coco-alkyl dimethyl — 3.0
    hydroxy ethyl ammonium
    chloride
    Smectite clay — 5.0
    PVP 2.0 —
    Water/Minors Up to 100%
  • Textile Applications [0334]
  • In another embodiment, the present: invention relates to use of the endoglucanase of the invention in the bio-polishing process. Bio-Polishing is a specific treatment of the yarn surface which improves fabric quality with respect to handle and appearance without loss of fabric wettability. The most important effects of Bio-Polishing can be characterized by less fuzz and pilling, increased gloss/luster, improved fabric handle, increased durable softness and altered water absorbency. Bio-Polishing usually takes place in the wet processing of the manufacture of knitted and woven fabrics. Wet processing comprises such steps as e.g. desizing, scouring, bleaching, washing, dying/printing and finishing. During each of these steps, the fabric is more or less subjected to mechanical action. In general, after the textiles have been knitted or woven, the fabric proceeds to a desizing stage, followed by a scouring stage, etc. Desizing is the act of removing size from textiles. Prior to weaving on mechanical looms, warp yarns are often coated with size starch or starch derivatives in order to increase their tensile strength. After weaving, the size coating must be removed before further processing the fabric in order to ensure Ea homogeneous and wash-proof result. It is known that in order to achieve the effects of Bio-Polishing, a combination of cellulytic and mechanical action is required. It is also known that “super-softness” is achievable when the treatment with a cellulase is combined with a conventional treatment with softening agents. It is contemplated that use of the endoglucanase of the invention for bio-polishing of cellulosic fabrics is advantageous, e.g. a more thorough polishing can be achieved. Bio-polishing may be obtained by applying the method described e.g. in WO 93/20278. [0335]
  • Stone-Washing [0336]
  • It is known to provide a “stone-washed” look (localized abrasion of the color) in dyed fabric, especially in denim fabric or jeans, either by washing the denim or jeans made from such fabric in the presence of pumice stones to provide the desired localized lightening of the color of the fabric or by treating the fabric enzymatically, in particular with cellulytic enzymes. The treatment with an endoglucanase of the present invention may be carried out either alone such as disclosed in U.S. Pat. No. 4,832,864, together with a smaller amount of pumice than required in the traditional process, or together with perlite such as disclosed in WO 95/09225. [0337]
  • Pulp and Paper Applications [0338]
  • In the papermaking pulp industry, the endoglucanase of the present invention may be applied advantageously e.g. as follows: [0339]
  • For debarking: pretreatment with the endoglucanase may degrade the cambium layer prior to debarking in mechanical drums resulting in advantageous energy savings. [0340]
  • For defibration: treatment of a material containing cellulosic fibers with the endoglucanase prior to refining or beating may result in reduction of the energy consumption due to the hydrolysing effect of the cellulase on the interfibre surfaces. Use of the endoglucanase may result in improved energy savings as compared to the use of known enzymes, since it is believed that the enzyme composition of the invention may possess a higher ability to penetrate fibre walls. [0341]
  • For fibre modification, i.e. improvement of fibre properties where partial hydrolysis across the fibre wall is needed which requires deeper penetrating enzymes (e.g. in order to make coarse fibers more flexible). Deep treatment of fibers has so far not been possible for high yield pulps e.g. mechanical pulps or mixtures of recycled pulps. This has been ascribed to the nature of the fibre wall structure that prevents the passage of enzyme molecules due to physical restriction of the pore matrix of the fibre wall. It is contemplated that the present endoglucanase is capable of penetrating into the fibre wall. [0342]
  • For drainage improvement. The drainability of papermaking pulps may be improved by treatment of the pulp with hydrolysing enzymes, e.g. cellulases. Use of the present endoglucanase may be more effective, e.g. result in a higher degree of loosening bundles of strongly hydrated micro-fibrils in the fines fraction (consisting of fibre debris) that limits the rate of drainage by blocking hollow spaces between fibers and in the wire mesh of the paper machine. The Canadian standard freeness (CSF) increases and the Schopper-Riegler drainage index decreases when pulp in subjected to cellulase treatment, see e.g. U.S. Pat. No. 4,923,565; TAPPI T227, SCAN C19:65.ence. [0343]
  • For inter fibre bonding. Hydrolytic enzymes are applied in the manufacture of papermaking pulps for improving the inter fibre bonding. The enzymes rinse the fibre surfaces for impurities e.g. cellulosic debris, thus enhancing the area of exposed cellulose with attachment to the fibre wall, thus improving the fibre-to-fibre hydrogen binding capacity. This process is also referred to as dehornification. Paper and board produced with a cellulase containing enzyme preparation may have an improved strength or a reduced grammage, a smoother surface and an improved printability. [0344]
  • For enzymatic deinking. Partial hydrolysis of recycled paper during or upon pulping by use of hydrolysing enzymes such as cellulases are known to facilitate the removal and agglomeration of ink particles. Use of the present endoglucanse may give a more effective loosening of ink from the surface structure due to a better penetration of the enzyme molecules into the fibrillar matrix of the fibre wall, thus softening the surface whereby ink particles are effectively loosened. The agglomeration of loosened ink particles are also improved, due to a more efficient hydrolysis of cellulosic fragments found attached to ink particles originating from the fibres. [0345]
  • The treatment of lignocellulosic pulp may, e.g., be performed as described in WO 91/14819, WO 91/14822, WO 92/17573 and WO 92/18688. [0346]
  • Degradation of Plant Material [0347]
  • In yet another embodiment, the present invention relates to use of the endoglucanase and/or enzyme preparation according to the invention for degradation of plant material e.g. cell walls. [0348]
  • It is contemplated that the novel endoglucanase and/or enzyme preparation of the invention is useful in the preparation of wine, fruit or vegetable juice in order to increase yield. Endoglucanases according to the invention may also be applied for enzymatic hydrolysis of various plant cell-wall derived materials or waste materials, e.g. agricultural residues such as wheat-straw, corn cobs, whole corn plants, nut shells, grass, vegetable hulls, bean hulls, spent grains, sugar beet pulp, and the like. The plant material may be degraded in order to improve different kinds of processing, facilitate purification or extraction of other components like purification of beta-glucan or beta-glucan oligomers from cereals, improve the feed value, decrease the water binding capacity, improve the degradability in waste water plants, improve the conversion of e.g. grass and corn to ensilage, etc. [0349]
    • EXAMPLES
  • The invention is further illustrated in the following examples which are not intended to be in any way limiting to the scope of the invention as claimed. [0350]
  • Materials and Methods [0351]
  • Cellulolytic Activity [0352]
  • The cellulase variants of the invention show improved performance. Some of the variants may show improved performance with respect to increased catalytic activity. [0353]
  • In the context of this invention, cellulase activity can be expressed in S-CEVU. Cellulolytic enzymes hydrolyse CMC, thereby increasing the viscosity of the incubation mixture. The resulting reduction in viscosity may be determined by a vibration viscosimeter (e.g. MIVI 3000 from Sofraser, France). [0354]
  • Determination of the cellulolytic activity, measured in terms of S-CEVU, may be determined according to the following analysis method (assay): The S-CEVU assay quantifies the amount of catalytic activity present in the sample by measuring the ability of the sample to reduce the viscosity of a solution of carboxy-methylcellulose (CMC). The assay is carried out at 40° C.; pH 7.5; 0.1M phosphate buffer; time 30 min; using a relative enzyme standard for reducing the viscosity of the CMC(carboxymethylcellulose Hercules 7 LFD) substrate; enzyme concentration approx. 0.15 S-CEVU/ml. The arch standard is defined to 8200 S-CEVU/g. [0355]
    • Example 1
  • Preparation of Cellulase Variants [0356]
  • Based on the disclosed sequence alignment (Table 1) and computer modeling method, position 119 was identified as a particular point of interest for making cellulase variants. Position 119 (cellulase numbering) is located within 3 Å from the substrate. In position 119 the wild-type [0357] Humicola insolens cellulase holds a histidine residue (H), whereas the wild-type Thielavia terrestris cellulase holds a glutamine residue (Q).
  • In this experiment, histidine was substituted for glutamine in the [0358] Thielavia terrestris cellulase (thereby obtaining the cellulase variant Thielavia terrestris/Q119H). The variant obtained was tested for specific activity.
  • All [0359] Humicola insolens variants are, unless otherwise stated, constructed by application of the Chameleon™ Double-stranded, site-directed Mutagenesis kit, from Stratagene. The following synthetic oligo-nucleotide were used as selection primer:
    S/M GAATGACTTGGTTGACGCGTCACCAGTCAC, or
    M/S GAATGACTTGGTTGAGTACTCACCAGTCAC.
  • S/M replaces the ScaI site in the beta-lactamase gene of the plasmid with a M1uI site and M/S does the reverse. The later is used to introduce secondary mutations in variants generated by the first selection primer. [0360]
  • For construction of [0361] Thielavia terrestis cellulase variants, the Thielavia terrestis EG V cellulase cDNA obtainable from the plasmid deposited as DSM 10811 was used. DSM 10811 was deposited at the Deutsche Sammlung von Mikroorganismen und Zellkulturen on Jun. 30, 1995 according to the Budapest Treaty. The plasmid was digested with the restriction endonucleases BamHI and NotI The 4153 bp vector part and the 1211 bp BamHI-NotI fragment were isolated. Equal portions of the 1211 bp fragment were digested with respectively HgiAI and EcoRV and the 487 bp BamHI-HgiAI and 690 bp EcoRV-NotI fragments were isolated.
  • These fragments and the vector part were ligated in the presence of 5 fold molar excess of a synthetic DNA fragment, resulting from the annealing of two single stranded DNA oligomers: [0362]
    18802: CACTGGCGGCGACCTGGGATCTAACCACTTCGAT
    18803: ATCGAAGTGGTTAGATCCCAGGTCGCCGCCTGTGCTC
  • The ligation mixture was transformed into [0363] E. coli strain XL1, and from the resulting transformants Thielavia terrestris/Q119H was isolated and verified by DNA sequencing.
  • All the cellulase variants ware produced by cloning the gene and transforming the gene into [0364] Aspergillus oryzae using a plasmid with the gene inserted between the fungal amylase promoter and the AMG terminator from A. niger. [Christensen, T. Wöldike, H. Boel, E., Mortensen, S. B., Hjortsoj, K., Thim, L. and Hansen, M. T. (1988) Biotechnology 6: 1419-1422].
  • The cellulases with a cellulose binding domain CBD were purified by exploiting their binding to Avicel. The cloned product was recovered after fermentation by separation of the extracellular fluid from the production organism. The cellulase was then highly purified by affinity chromatography using 150 gram of Avicel in a slurry with 20 mM sodiumphosphate pH 7.5. The Avicel slurry was mixed with the crude fermentation broth which in total contains about 1 gram of protein. After mixing at 4° C. for 20 min, the Avicel-bound enzyme is packed into a column with a dimension of 50 times 200 mm about 400 ml total. [0365]
  • The column is washed with the 200 ml buffer, then washed with 0.5 M NaCl in the same buffer until no more protein elutes, and washed with 500 ml buffer (20 mM Tris pH 8.5). Finally the pure full length enzyme is eluted with 1% Triethylamine pH 11.8. The eluted enzyme solution is adjusted to pH 8 and concentrated using a Amicon cell unit with a membrane DOW GR61PP (polypropylene with a cut off of 20 KD) to 5 mg protein per ml. The enzymes have all been purified yielding a single band on SDS-PAGE. [0366]
  • Cellulases which natural lack CBD or the linker has been proteolytic cleaved or in which the CBD has been removed by introducing a stop codon after the catalytic domain, can not be purified using Avicel. The extracellular proteins are recovered free from the production organism. The core cellulases were purified free of Aspergillus proteins by cation exchange chromatography. The fermentation broth was adjusted to pH 3.5 and filtered to remove the precipitating proteins. Then the proteins were ultra filtrated (concentrated and washed with water) on a DOW GR81PP membrane with a cut off 6 KD until the conductivity of the eluate is below 1000 mS/cm. The sample was finally applied to a S-Sepharose column equilibrated with a 20 mM citrate buffer pH 3.5 . [0367]
  • The enzyme will bind to the S-Sepharose at this low pH and it is eluted as a single peak using a NaCl gradient from 0 to 500 mM. The eluted pure enzyme was concentrated on a Amicon cell with the DOW GR81PP membrane. All purified cellulases gave a single band in SDS-PAGE. [0368]
  • The specific activity data are summarized in the following table: [0369]
    Specific activity
    Enzyme/variant [%]
    Humicola insolens 100 
    Thielavia terrestris 35
    Thielavia terrestris/Q119H 92
  • From this experiment it is seen that by introducing the mutation Q119H into the [0370] Thielavia terrestris cellulase, the specific activity if the resulting cellulase variants was increased to the level of that of the homologous Humicola insolens cellulase.
    • Example 2
  • [0371] Thielavia terrestris Variant with Improved Alkaline Performance Profile
  • In this experiment the [0372] Thielavia terrestris/Q119D was constructed as described in example 1 but using the following construction: For easy cassette swap and standard primer utilization, the CT1 encoding DNA was furnished with a C-terminal Xba1 site and subcloned into the pCaHj418 vector as described below. PCT1 was used as template in a Pwo polymerase PCR, 94 C2′ −3x(94 C,30″-72 C,1′)-25x(94 C,30″-55 C, 30″-72, C 1′) −72 C,5′ applying the two primers
    8939: CGACTTCAATGTCCAGTCGG
    25335: GCGCTCTAGAGGATTAAAGGCACTGC
  • The resulting 718 bp PCR product was digested with Sal1 and Xba1 and the 165 bp fragment was isolated. This fragment was ligated together with the 833 bp BamH1-Sal1 fragment from pCT1-2 into the 4.1 kb Xba1-BamH1 vector fragment of pCaHj418. [0373]
  • From this ligation pCT1418 was isoltated from [0374] E. coli transformants.
  • PCT2 was constructed by the Chameleon™ Double-stranded, site-directed Mutagenesis kit (from Stratagene) as described above with pCT1418 as template, the S/M primer as selection primer and the following mutagenic primer: 109330: CGACCTGGGATCGAACGACTTCGATATCGCCATGC [0375]
  • A successfully mutated plasmid pCT2 was isolated, verified by DNA sequencing and transformed into [0376] Aspergillus oryzae strain JaL228.
  • The [0377] Thielavia terrestris cellulase and the Thielavia terrestris/Q119D variant was tested for activity towards PASC as described in example 9 at pH 7.0 and pH 10.0.
  • The results are presented in the table below which shows the activity at pH10 compared to the activity at pH 7. This demonstrates that the [0378] Thielavia terrestris/Q119D variant has relatively more alkaline activity as compared to the parent Thielavia terrestris.
    Relative activity
    pH 10/pH 7
    [%]
    Thielavia terrestris 27
    Thielavia terrestris/Q119D 62
    • Example 3
  • Construction of a Cellulase Hybrid Variant [0379]
  • The plasmid pCT3 embodies DNA encoding the [0380] Thielavia terrestris endoglucanase core enzyme and followed by the linker CBD of Humicola grisea.
  • pCT3 was constructed by means of sequence overlap extension PCR, applying PWO polymerase. [0381]
  • From a cDNA clone of [0382] Humicola grisea a 415 bp fragment was generated by the following primers:
    109452: CGACTCCAGCTTCCCCGTCTTCACGCCCCC
    107819: CGAGCTTCTAGATCTCGACTAGAGGCACTGGGAG
  • From pCT1418 (disclosed in example 2) a 876 bp PCR fragment was generated by the following primers: [0383]
    101621: GGATGCCATGCTTGGAGGATAGCAACC
    107823: GGGGGCGTGAAGACGGGAAGCTGGAGTCG
  • For both reactions the following set up was used: 96_C, 1[0384] 40 -3x(94_C, 30″-50_C, 1′-72_C, 1′)-25x(94_C, 30″-61_C, 30″-72_C, 1′)-72_C, 7′.
  • The isolated PCR fragments were applied as template in an assembly PCR reaction with primers 101621 and 107819: 94_C, 1′-3x(94_C, 30″-70_C, 1′-72_C, 2′)-20x(94_C, 30″-61_C, 30″-72_C, 1,5″)-72_C, 7′. The resulting 1261 bp PCR product was isolated cut by restriction enzymes BamH1 and Xba1 and the resulting 1172 bp DNA fragment was isolated and ligated into the 4.1 kb vector fragment of BamH1-Xba1 digested pCaHj418. [0385]
  • Correct clones were isolated and verified by DNA sequencing of plasmids isolated from [0386] E. coli XL1 transformants resulting above ligation reaction.
    cDNA sequence of Huraicola grisea:
    CAAGAACCTCACACTCATTTTATTCACGCTCATTTATTCTAAAACTTCAA
    TATGCGCTCTGCTCCTATTTTCCGCACGGCCCTGGCGGCTGCGCTCCCCC
    TTGCCGCACTCGCCGCCGATGGCAAGTCGACCAGATACTGGGACTGCTGC
    AAGCCATCGTGCTCTTGGCCCGGAAAGGCACTCGTGAACCAGCCTGTCTT
    CACTTGCGACGCCAAATTCCAGCGCATCACCGACCCCAATACCAAGTCGG
    GCTGCGATGGCGGCTCGGCCTTTTCGTGTGCTGACCAGACCCCCTGGGCT
    CTGAACGACGATGTCGCCTATGGCTTCGCTGCCACGGCTATTTCGGGTGG
    ATCGGAAGCCTCGTGGTGCTGCGCATGCTACGCTCTTACTTTCACCTCGG
    GCCCTGTGGCCGGCAAGACCATGGTCGTCCAGTCGACCAACACCGGCGGC
    GATCTCGGCAGCAACCATTTCGACCTCCAGATTCCAGGCGGCGGTGTCGG
    CATCTTTGATGGGTGCACCCCCCAGTTCGGAGGTCTCGCTGGCGAACGCT
    ACGGTGGCATCTCAGACCGCAGCTCCTGCGACTCGTTCCCTGCGGCGCTC
    AAGCCCGGCTGCCTCTGGCGCTTCGATTGGTTCAAGAACGCCGACAACCC
    GACCTTTACCTTCAAGCAGGTGCAGTGCCCCGCCGAGCTTGTTGCCAGGA
    CCGGCTGCAAGCGCGAGGATGACGGCAACTTCCCCGTCTTCACGCCCCCC
    GCGGGTAGCAACACCGGCGGTAGCCAGTCGAGCTCCACTATCGCTTCCAG
    CTCGACCTCCAAGGCTCAGACTTCGGCCGCCAGCTCCACCTCCAAGGCTG
    TCGTGACTCCCGTCTCCAGCTCCACCTCGAAGGCCGCTGAGGTCCCCAAA
    TCCAGCTCGACCTCCAAGGCTGCCGAGGTCGCCAAGCCCAGCTCAACTTC
    GACCTCGACCTCGACCTCGACCAAGGTCAGCTGCTCTGCGACCGGTGGCT
    CCTGCGTCGCTCAGAAGTGGGCGCAGTGCGGCGGCAATGGCTTCACCGGC
    TGCACGTCGTGCGTCAGCGGCACCACCTGCCAGAAGCAAAATGACTGGTA
    CTCCCAGTGCCTCTAAGTCGTTTGTAGTAGCAGTTTGAAGGATGTCAGGG
    ATGAGGGAGGGAGGAGTGGGGGAAAAGTACGCCGCAGTTTTTTGGTAGAC
    TTACTGTATTGTTGAGTAATTACCCATTCGCTTCTTGTACGAAAAAAAAA
    AAAAAAAAAA
    • Example 4
  • Construction of Variants of a Hybrid Cellulase [0387]
  • The plasmid pPsF45 embodies DNA encoding the [0388] Pseudomonas cellolytica endoglucanase core enzyme headed by the H. insolens EGV endoglucanase signal peptide and followed by the linker CBD of same enzyme.
  • Two variants of this hybrid enzyme were constructed by means of the above-mentioned Stratagene Chameleon® kit: PsF45/H15S, and PsF45/Q119H (cellulase numbering) by application of the following mutagenic primers [0389]
    PsF45/H15S:
    GCTGCAAGCCGTCCTGTGGCTGGAGCGCTAACGTGCCCGCG
    PsF45/Q119H:
    CGATGTTTCCGGAGGCCACTTTGACATTCTGGTTCC
  • Deviations from template sequence are indicated in bold type. [0390]
  • The selection primer was converting the unike Sca1 site in the lactamase gene of the plasmid to a Mlu1 site: [0391]
  • GAATGACTTGGTTGACGCGTCACCAGTCAC [0392]
  • The two variants were verified by DNA sequencing and one correct version of each variant was identified. [0393]
  • The two plasmids emharboring the variant sequences pPsF45H15S and pPsF45Q119H were used to transform [0394] A. oryzae strain JaL142 together with the AMDS selection plasmid pToC202. From the resulting transformants LaC2829 and LaC 2830 were isolated after 3 reisolation steps via spores.
    • Example 5
  • Removal of Disulfide Bridges [0395]
  • Disulfide bridges are known to stabilize protein structures. The removal of disulfide bridges in a cellulase will destabilizes the enzyme (thermostability) while retaining significant activity. This can be useful in applications where a fast inactivation of the enzyme is preferred, e.g. in denim or textile applications or for low temperature processes. [0396]
  • In this example [0397] Humicola insolens EGV cellulase and five variants of Humicola insolens cellulase were constructed mutating either one or both residues involved in a disulfide bridge. The specific activity was measured as disclosed under Materials and Methods. The melting temperature of the enzymes were measured using Differential Scanning Calometry, DSC. DSC was done at neutral pH (7.0) using a MicroCalc Inc. MC calorimeter with a constant scan rate and raising the temperature from 20° C. to 90° C. at a rate of 90° C. per hour.
  • The results are presented in the table below which shows that removal of a disulfide bridge leads to a variant with a significantly lower melting temperature but retaining significant activity. [0398]
    Specific
    activity Melting temp.
    [%] [° C.]
    Humicola insolens 100  81
    Humicola insolens/C12G, C47M 15 63.7
    Humicola insolens/C12M, C47G 53 64.3
    Humicola insolens/C47G 48 57.3
    Humicola insolens/C87M, C199G 75 63.4
    Humicola insolens/C16M, C86G 103  59.2
    • Example 6
  • Mutation of Conserved Residues in the Binding Cleft <5 Å from Substrate [0399]
  • When comparing the positions within a distance of 5 Å from the substrate to the sequence alignment in Table 1 the type of amino acid residue at these positions are conserved in the aligned cellulases for the following positions: 6, 7, 8, 9, 10, 11, 12, 18, 45, 112, 114, 121, 127, 128, 130, 132, 147, 148, 149. Conserved residues are normally thought to be extremely important for the activity, but the inventors have found that a certain variability is allowed while maintaining significant activity. Only the two residues D10 and D121 (cellulase numbering) are necessary to maintain reasonable activity. [0400]
  • Variants of the [0401] Humicola insolens EGV cellulase were prepared and the specific activity was measured as disclosed in Materials and Methods.
  • The type of mutations and the variants specific activity are summarized in the following table: [0402]
    Specific activity
    Variant [%]
    Humicola insolens 100 
    Humicola insolens/T6S 34
    Humicola insolens/R7I 33
    Humicola insolens/R7W 29
    Humicola insolens/Y8F 67
    Humicola insolens/W9F 83
    Humicola insolens/C12M, C47G 53
    Humicola insolens/W18Y 49
    Humicola insolens/W18F 53
    Humicola insolens/S45T 85
    Humicola insolens/S45N 85
    Humicola insolens/D114N 6
    Humicola insolens/F132D 11
    Humicola insolens/Y147D 34
    Humicola insolens/Y147C 30
    Humicola insolens/Y147W 74
    Humicola insolens/Y147V 33
    Humicola insolens/Y147R 45
    Humicola insolens/Y147G 34
    Humicola insolens/Y147Q 41
    Humicola insolens/Y147N 53
    Humicola insolens/Y147K 45
    Humicola insolens/Y147H 75
    Humicola insolens/Y147P 57
    Humicola insolens/Y147S 55
  • From this experiment it is seen that mutating conserved residues in the binding cleft can be performed while retaining significant activity of the cellulase variant. [0403]
    • Example 7
  • Mutation of Non-Conserved Residues in the Binding Cleft <5 Å from the Substrate [0404]
  • Based on the sequence alignment in Table 1 and the disclosed computer modeling method the following residues located within a distance of 5Å from the substrate and not being conserved amongst the aligned sequences in were identified as points of interest for making cellulase variants. [0405]
  • In this experiment non-conserved residues located no more than 5 Å from the substrate were modified in the [0406] Humicola insolens EGV cellulase and the specific activity was measured as described under Materials and Methods.
  • The type of mutations and the variants specific activity are summarized in the following table: [0407]
    Specific activity
    [%]
    Humicola insolens 100
    Humicola insolens/R4H 73
    Humicola insolens/R4Q 70
    Humicola insolens/K13L 37
    Humicola insolens/K13R 100
    Humicola insolens/K13Q 38
    Humicola insolens/P14A 99
    Humicola insolens/P14T 71
    Humicola insolens/S15T 18
    Humicola insolens/S15H 10
    Humicola insolens/C16M, C86G 103
    Humicola insolens/A19P 51
    Humicola insolens/A19T 84
    Humicola insolens/A19G 78
    Humicola insolens/A19S 89
    Humicola insolens/K20G 91
    Humicola insolens/D42Y 102
    Humicola insolens/D42W 103
    Humicola insolens/C47G 48
    Humicola insolens/E48D 93
    Humicola insolens/E48Q 71
    Humicola insolens/E48D, P49* 88
    Humicola insolens/E48N, P49* 79
    Humicola insolens/S110N 94
    Humicola insolens/L115I 18
    Humicola insolens/G116D 71
    Humicola insolens/H119R 15
    Humicola insolens/H119Q 39
    Humicola insolens/H119F 11
    Humicola insolens/N123A 61
    Humicola insolens/N123M 80
    Humicola insolens/N123Q 76
    Humicola insolens/N123Y 8
    Humicola insolens/N123D 86
    Humicola insolens/V129L 72
    Humicola insolens/D133N 102
    Humicola insolens/D178N 81
  • From this experiment it is seen that most of the non-conserved residues in the binding cleft can be mutated while retaining all or most of the activity of the cellulase. [0408]
    • Example 8
  • Resistance to Anionic Surfactants in Detergent [0409]
  • A. Variants of the present invention may show improved performance with respect to an altered sensitivity towards anionic tensides. Anionic tensides are products frequently incorporated into detergent compositions. Unfolding of cellulases tested so far, is accompanied by a decay in the intrinsic fluorescence of the proteins. The intrinsic fluorescence derives from Trp side chains (and to a smaller extent Tyr side chains) and is sensitive to the hydrophobicity of the side chain environment. Unfolding leads to a more hydrophilic environment as the side-chains become more exposed to solvent, and this quenches fluorescence. [0410]
  • Fluorescence is followed on a Perkin/Elmer™ LS50 luminescence spectrometer. In practice, the greatest change in fluorescence on unfolding is obtained by excitation at 280 nm and emission at 345 nm. Slit widths (which regulate the magnitude of the signal) are usually 5 nm for both emission and excitation at a protein concentration of 5 μg/ml. Fluorescence is measured in 2-ml quartz cuvettes thermostatted with a circulating water bath and stirred with a small magnet. The magnet-stirrer is built into the spectrometer. [0411]
  • Unfolding can be followed in real time using the available software. Rapid unfolding (going to completion within less than 5-10 minutes) is monitored in the TimeDrive option, in which the fluorescence is measured every few (2-5) seconds. For slower unfolding, four cuvettes can be measured at a time in the cuvette-holder using the Wavelength Program option, in which the fluorescence of each cuvette is measured every 30 seconds. In all cases, unfolding is initiated by adding a small volume (typically 50 μl) of concentrated enzyme solution to the thermostatted cuvette solution where mixing is complete within a few seconds due to the rapid rotation of the magnet. [0412]
  • Data are measured in the software program GraphPad Prism. Unfolding fits in all cases to a single-exponential function from which a single half-time of unfolding (or unfolding rate constant) can be obtained. [0413]
  • Typical unfolding conditions are: [0414]
  • a. 10 mM CAPS pH 10, 1000 ppm LAS, 40° C. [0415]
  • b. 10 mM HEPES pH 10, 200 ppm LAS, 25° C. [0416]
  • In both cases, the protein concentration is 5-10 μg/ml (the protein concentration is not crucial, as LAS is in excess). Under these conditions, the unfolding of [0417] Humicola insolens cellulase can be compared with other enzymes (Table 1). This enables us to draw up the following ranking order for stability against anionic tenside:
  • [0418] Thielavia terrestris/Q119H≅Thielavia terrestris>>Humicola insolens≅Humicola insolens/H119Q.
    t½ pH 10 (s) t½ pH 7 (s)
    Cellulase (1000 ppm LAS, 40° C.) (200 ppm LAS, 25° C.)
    Humicola insolens 48  28
    Humicola insolens/ 63  9a
    H119Q
    Thielavia terrestris 970  690
    Thielavia terrestris/ 1100  550
    Q1191H
  • a Unfolding is double-exponential. The t½ of the slower phase is approx. 120 sec. [0419]
  • B. The alteration of the surface electrostatics of an enzyme will influence the sensibility towards anionic tensides such as LAS (linear alkylbenzenesulfonate). Especially variants where positive charged residues have been removed and/or negatively charged residues have been introduced will increase the resistance towards LAS, whereas the opposite, i.e. the introduction of positively charged residues and/or the removal of negatively charged residues will lower the resistance towards LAS. The residues Arg (R), Lys (K) and His (H) are viewed as positively or potentially positively charged residue and the residues Asp (D), Glu (E) and Cys (C) if not included in a disulphide bridge are viewed as negatively or potentially negatively charged residues. Positions already containing one of these residues are the primary target for mutagenesis, secondary targets are positions which has one of these residues on an equivalent position in another cellulase, and third target are any surface exposed residue. In this experiment wild type [0420] Humicola insolens cellulase are being compared to Humicola insolens cellulase variants belonging to all three of the above groups, comparing the stability towards LAS in detergent.
  • Cellulase resistance to anionic surfactants was measured as activity on PASC (phosphoric acid swollen cellulose) in the presence of anionic surfactant vs. activity on PASC in the absence of anionic surfactant. [0421]
  • The reaction medium contained 5.0 g/l of a commercial regular powder detergent from the detergent manufacturer NOPA Denmark. The detergent was formulated without surfactants for this experiment and pH adjusted to pH 7.0. Further the reaction medium included 0.5 g/l PASC and was with or without 1 g/l LAS (linear alkylbenzenesulphonate), which is an anionic surfactant, and the reaction proceeded at the temperature 30° C. for 30 minutes. Cellulase was dosed at 0.20 S-CEVU/l. After the 30 minutes of incubation the reaction was stopped with 2 N NaOH and the amount of reducing sugar ends determined through reduction of p-hydroxybenzoic acid hydrazide. The decrease in absorption of reduced p-hydroxybenzoic acid hydrazide relates to the cellulase activity. [0422]
  • The type of mutation and the resistance towards LAS for variants with increased LAS resistance is summarized in the following table: [0423]
    Relative LAS
    resistance
    Variant [%]
    Humicola insolens 100
    Humicola insolens/R158E 341
    Humicola insolens/Y8F, W62E, A162P, 179
    Humicola insolens/R158E, A162P 347
    Humicola insolens/R158G 322
    Humicola insolens/S152D 161
    Humicola insolens/R158E/R196E 319
    Humicola insolens/R158E, D161P, A162P 351
    Humicola insolens/R4H, R158E, D161P, A162P 344
    Humicola insolens/H119Q 148
    Humicola insolens/Y8F, W62E, R252L, Y280F 131
    Humicola insolens/R252L, Y280F 133
    Humicola insolens/W62E, A162P 130
    Humicola insolens/W62E, A162P 129
    Humicola insolens/S117D 143
    Humicola insolens/A57C, A162C 134
    Humicola insolens/N154D 149
    Humicola insolens/R4H, D161P, A162P, R196E 134
  • From this table it is seen that mutations of residues resulting in the removal of positively charged residue and/or the introduction of a negatively charged residue increase the resistance towards LAS. [0424]
  • As described above the type of mutation and the resistance towards LAS for variants with decreased LAS resistance is summarized in the following table: [0425]
    Relative LAS
    resistance
    Variant [%]
    Humicola insolens 100
    Humicola insolens/Y147H 71
    Humicola insolens/E192P 52
    Humicola insolens/D161P, A162P 64
    Humicola insolens/D67T 44
    Humicola insolens/Q36T, D67T 67
    Humicola insolens/D66N 47
    Humicola insolens/D67N 71
    Humicola insolens/V64R 58
    Humicola insolens/N65R 48
    Humicola insolens/T93R 60
    Humicola insolens/Q36T, D67T, A83T 64
    Humicola insolens/E91Q 71
    Humicola insolens/A191K 63
    Humicola insolens/D42W 67
    Humicola insolens/S117K 62
    Humicola insolens/R4H, A63R, N65R, D67R 54
    Humicola insolens/D133N 0
    Humicola insolens/D58A 15
    Humicola insolens/D67R 39
    Humicola insolens/A63R 38
    Humicola insolens/R37N, D58A 6
    Humicola insolens/K175R 32
    Humicola insolens/D2N 43
    Humicola insolens/N65R, D67R 40
    Humicola insolens/T136D, G141R 5
    Humicola insolens/Y147K 17
    Humicola insolens/Y147R 1
    Humicola insolens/D161P 35
    Humicola insolens/D66P 40
    Humicola insolens/D66A, D67T 39
    Humicola insolens/DG7T, *143NGT 7
    Humicola insolens/Q36T, D67T, *143NGT 0
    Humicola insolens/N65R, D67R, S76K 22
    Humicola insolens/W62R 25
    Humicola insolens/S117R, F120S 31
    Humicola insolens/K13R 16
    Humicola insolens/D10E 0
  • From this table it is seen that mutations of residues resulting in the introduction of positively charged residue and/or the removal of a negatively charged residue decrease the resistance towards LAS. [0426]
    • Example 9
  • Alteration of pH Activity Profile [0427]
  • The pH activity profile of a cellulase is governed by the pH dependent behavior of specific titratable groups, typically the acidic residues in the active site. The pH profile can be altered by changing the electrostatic environment of these residues, either by substitution of residues involving charged or potentially charged groups such as Arg (R), Lys (K), Tyr (Y), His (H), Glu (E), Asp (D) or Cys (C) if not involved in a disulphide bridge or by changes in the surface accessibility of these specific titratable groups by mutations in the biding cleft within 5 Å of the substrate. [0428]
  • In this example [0429] Humicola insolens cellulase and variants of Humicola insolens cellulase involving substitution of charged or potentially charged residues have been tested for activity towards PASC at pH 7 and pH 10, respectively.
  • In order to determine the pH optimum for cellulases we have selected organic buffers because it is common known that e.g. borate forms covalent complexes with mono- and oligo-saccharides and phosphate can precipitate with Ca-ions. In DATA FOR BIOCHEMICAL RESEARCH Third Edition OXFORD SCIENCE PUBLICATIONS page 223 to 241, suitable organic buffers has been found. In respect of their pKa values we decided to use Na-acetate in the range 4-5.5, MES at 6.0, MOPS in the range 6.5-7.5, Na-barbiturate 8.0-8.5 and glycine in the range 9.0-10.5. [0430]
  • Method: [0431]
  • The method is enzymatic degradation of carboxy-methyl-cellulose, at different pH's. Buffers are prepared in the range 4.0 to 10.5 with intervals of 0.5 pH unit. The analyze is based on formation of new reducing ends in carboxy-methyl-cellulose, these are visualized by reaction with PHBAH in strong alkaline environment, were they forms a yellow compound with absorption maximum at 410 nm. [0432]
  • Experimental Protocol: [0433]
  • Buffer preparation: 0.2 mol of each buffer substance is weighed out and dissolved in 1 liter of Milli Q water. 250 ml 0.2M buffer solution and 200 ml Milli Q water is mixed. The pH are measured using Radiometer PHM92 labmeter calibrated using standard buffer solutions from Radiometer. The pH of the buffers are adjusted to actual pH using 4M NaOH or 4M HCl and adjusted to total 500 ml with water. When adjusting Na-barbiturate to pH 8.0 there might be some precipitation, this can be re-dissolved by heating to 50° C. [0434]
  • Acetic acid 100% 0.2 mol=12.01 g. [0435]
  • MES 0.2 mol=39.04 g. [0436]
  • MOPS 0.2 mol=41.86 g. [0437]
  • Na-barbiturate 0.2 mol=41.24 g. [0438]
  • Glycine 0.2mol=15.01 g. [0439]
  • Buffers: [0440]
  • pH: 4.0, 4.5, 5.0 & 5.5 Na-acetate 0.1M [0441]
  • pH: 6.0 Na-MES 0.1M [0442]
  • pH: 6.5, 7.0 & 7.5 Na-MOPS 0.1M [0443]
  • pH: 8.0 & 8.5 Na-barbiturate 0.1M [0444]
  • pH: 9.0, 9.5, 10.0 & 10.5 Na.glycine 0.1M [0445]
  • The actual pH is measured in a series treated as the main values, but without stop reagent, pH is measured after 20 min. incubation at 40° C. [0446]
  • Substrate Preparation: [0447]
  • 2.0 g CMC, in 250 ml conic glass flask with a magnet rod, is moistened with 2.5 ml. 96% ethanol, 100 ml. Milli Q water is added and then boiled to transparency on a heating magnetic stirrer. Approximately 2 min. boiling. Cooled to room temperature on magnetic stirrer. [0448]
  • Stop Reagent: [0449]
  • 1.5 g PHBAH and 5 g K-Na-tartrate dissolved in 2% NaOH. [0450]
  • Procedure: [0451]
  • There are made 3 main values and 2 blank value using 5 ml glass test tubes. (1 main value for pH determination) [0452]
    Main values Blank value
    Buffer 1.0 ml. 1.0 ml.
    Substrate CMC 0.75 ml. 0.75 ml.
    Mix 5 sec. 5 sec.
    Preheat 10 min./40° C. —
    Enzyme 0.25 ml. —
    Mix 5 sec. —
    Incubation 20 min./40° C. room temp.
    PHBAH-reagent 1 ml. 1 ml.
    Mix 5 sec. —
    Enzyme — 0.25 ml.
    Mix — 5 sec.
  • Mixing on a Heidolph REAX 2000 mixer with permanent mix and maximum speed (9). No stirring during incubation on water bath with temperature control. Immediately after adding PHBAH-reagent and mixing the samples are boiled 10 min. Cooled in cold tap water for 5 min. Absorbance read at 410 nm. [0453]
  • Determination of Activity [0454]
  • The absorbance at 410 nm from the 2 Main values are added and divided by 2 and the 2 Blank values are added and divided by 2, the 2 mean values are subtracted. The percentages are calculated by using the highest value as 100%. [0455]
  • The measured pH is plotted against the relative activity. [0456]
  • Buffer Reagents: [0457]
  • Acetic acid 100% from MERCK cat.no.1.00063, batcno.K20928263 422, pKa 4.76, MW 60.05; [0458]
  • MES (2[N-Morpholino]ethanesulfonic Acid) from SIGMA cat.no. M-8250, batchno. 68F-5625, pKa 6.09, MW 195.2; [0459]
  • MOPS (3-[N-Morpholino]propanesulfonic Acid) from SIGMA cat.no. M-1254, batchno. 115F-5629, pKa 7.15, MW 209.3; [0460]
  • Na-barbiturate (5,5-Diethylbarbituric acid sodium salt) from MERCK cat.no. 6318, batch no. K20238018 404, pKa 7.98, MW 206.2; [0461]
  • Glycine from MERCK cat.no.4201, batch no. K205535601 405, pKa 9.78, MW 75.07; [0462]
  • PHBAH (p-HYDROXY BENZOIC ACID HYDRAZIDE): From SIGMA cat.no.H-9882, batch no. 53H7704; [0463]
  • K-Na-tartrate (Potassium sodium tartrate tetrahydrate) from MERCK cat.no. 8087, batch no. A653387 304; [0464]
  • NaOH (Sodium hydroxyde) from MERCK cat.no. 1.06498, batch no. C294798 404; [0465]
  • CMC (Carboxy Methyl Cellulose) supplied by Hercules (FMC)7LF (November 1989). [0466]
  • Cellulase resistance to anionic surfactants was measured as activity on PASC (phosphoric acid swollen cellulose) at neutral pH (pH 7.0) vs. activity on PASC at alkaline pH (pH 10.0). The reaction medium contained 5.0 g/l of a commercial regular powder detergent from the detergent manufacturer NOPA Denmark. The pH was adjusted to pH 7.0 and pH 10.0, respectively. Further the reaction medium included 0.5 g/l PASC, and the reaction proceeded at the temperature 30° C. for 30 minutes. Cellulase was dosed at 0.20 S-CEVU/l. After the 30 minutes of incubation the reaction was stopped with 2 N NaOH and the amount of reducing sugar ends determined through reduction of p-hydroxybenzoic acid hydrazide. The decrease in absorption of reduced p-hydroxybenzoic acid hydrazide relates to the cellulase activity. [0467]
  • Results: [0468]
  • The results are presented in the table below, the activity at pH10 relative to pH7 is compared to that of wild type [0469] Humicola insolens cellulase.
    PASC activity
    pH10/pH7 relative
    to wild type
    Variant [%]
    Humicola insolens 100
    Humicola insolens/S76K, S117D 120
    Humicola insolens/V129L 133
    Humicola insolens/R4H, A63R, N65R, D67R 120
    Humicola insolens/R252L, Y280F 115
    Humicola insolens/D161P, A162P 117
    Humicola insolens/A57C, A162C 110
    Humicola insolens/S76K 117
    Humicola insolens/D161P, A162P, R196E 113
    Humicola insolens/Q36T, D67T, A83T 111
    Humicola insolens/W62R 112
    Humicola insolens/D42Y 110
    Humicola insolens/S76K, A78K 114
    Humicola insolens/S76K, A78R 118
  • From the above table it is seen that the relative alkaline activity can be increased by creating variants involving potentially charged residues and/or by altering residues in the binding cleft less that 5 Å from the substrate. [0470]
  • Similarly the following table shows that the relative acidic activity can be increased by other mutations involving potentially charged residues and/or by altering residues in the binding cleft less than 5 Å from the substrate. [0471]
    PASC activity
    pH10/pH7 relative
    to wild type
    Variant [%]
    Humicola insolens 100 
    Humicola insolens/D58A 83
    Humicola insolens/Y280W 90
    Humicola insolens/D67R 89
    Humicola insolens/A63R 85
    Humicola insolens/Y8F 82
    Humicola insolens/W62E 82
    Humicola insolens/R37N, D58A 84
    Humicola insolens/K175G 81
    Humicola insolens/K175R 82
    Humicola insolens/Y8F, M104Q 83
    Humicola insolens/Y8F, W62E, R252L, Y280F 83
    Humicola insolens/W62E, A162P 87
    Humicola insolens/Y8F, W62E, A162P, 88
    Humicola insolens/Y147H 90
    Humicola insolens/Y147N 90
    Humicola insolens/Y147Q 85
    Humicola insolens/Y147W 85
    Humicola insolens/E192P 89
    Humicola insolens/R158G 83
    Humicola insolens/S152D 90
    Humicola insolens/K13Q 82
    Humicola insolens/R37P 82
    Humicola insolens/S45T 87
    Humicola insolens/E48D 86
    Humicola insolens/R7I 83
    Humicola insolens/P14A 84
    Humicola insolens/A19G 90
    Humicola insolens/A19T 90
    Humicola insolens/R4H, D161P, A162P, R196E 88
    Humicola insolens/D133N 80
    Humicola insolens/D40N 40
    Humicola insolens/Y90F 72
    Humicola insolens/A63D 78
    Humicola insolens/ 25
    G127S, I131A, A162P, Y280F, R252L
    Humicola insolens/Y147S 39
    Humicola insolens/Y147F 71
    Humicola insolens/T6S 44
    Humicola insolens/S55E 14
    Humicola insolens/N123D 35
    Humicola insolens/N123Y 71
    Humicola insolens/R158E 78
    Humicola insolens/T136D, G141R 57
    Humicola insolens/G127S, I131A, A162P 52
    Humicola insolens/ 35
    W62E, G127S, I131A, A162P, Y280F, R252L
    Humicola insolens/W62E, G127S, I131A, A162P 58
    Humicola insolens/W62E, G127S, I131A 64
    Humicola insolens/ 80
    W62E, G127S, I131A, Y280F, R252L
    Humicola insolens/H119Q 57
    Humicola insolens/Y8F, W62E 61
    Humicola insolens/W62E, A162P 76
    Humicola insolens/W62E, A162P 80
    Humicola insolens/R158E, A162P 80
    Humicola insolens/Y8F, Y147S 63
    Humicola insolens/Y147R 54
    Humicola insolens/Y147V 22
    Humicola insolens/Y147C 67
    Humicola insolens/Y147D 60
    Humicola insolens/N154D 74
    Humicola insolens/R158E, R196E 79
    Humicola insolens/R158E, D161P, A162P 70
    Humicola insolens/D67T, *143NGT 65
    Humicola insolens/Q36T, D67T, *143NGT 53
    Humicola insolens/143*NGW, Q145D 53
    Humicola insolens/L142P, 143*NGW, Q145E 42
    Humicola insolens/N65R, D67R, S76K 60
    Humicola insolens/A63R, N65R, D67R 77
    Humicola insolens/T93R 80
    Humicola insolens/S76R 70
    Humicola insolens/S117R, F120S 58
    Humicola insolens/N123Q 63
    Humicola insolens/N123M 49
    Humicola insolens/N123A 80
    Humicola insolens/E48D, P49* 66
    Humicola insolens/S55Y 61
    Humicola insolens/S55M 48
    Humicola insolens/W18F 54
    Humicola insolens/S45N 71
    Humicola insolens/R7W 58
    Humicola insolens/K13R 72
    Humicola insolens/R7L 74
    Humicola insolens/S15T 38
    Humicola insolens/W18Y 37
    Humicola insolens/C16M, C86G 67
    Humicola insolens/K13L 59
    Humicola insolens/C12M, C470 12
    Humicola insolens/W9F 62
    Humicola insolens/C47G 58
    Humicola insolens/C12G, C47M  0
    Humicola insolens/D10E  0
    Humicola insolens/R7K 49
  • Accordingly, this example demonstrates that the relative activity pH profile can be altered towards acidic or alkaline pH by creation of variants involving potentially charged residues and/or by altering residues in the binding cleft less that 5 Å from the substrate. [0472]
    • Example 10
  • Wash Performance of Cellulases made Resistant to Anionic Surfactants [0473]
  • Application effect of a cellulase made resistant to anionic surfactants vs. application effect of the native cellulase was measured as ‘color clarification’ of worn black cotton swatches laundered with cellulase in a 0.1 liter mini-Terg-o-Meter. Laundering was done in varying concentrations of anionic surfactant. [0474]
  • The reaction medium contained phosphate buffer pH 7.0 and varying concentrations of LAS in the range 0.2-1.0 g/L. Two swatches were laundered at 40° C. for 30 minutes, rinsed and then dried. This laundering cycle was repeated four times. All enzymes was tested at each LAS concentration. [0475]
  • Finally the black cotton swatches were graded against a standard of similar swatches washed with varying dosages of the native cellulase, the fungal ~43 kD endo-β-1,4-glucanase from [0476] Humicola insolens, DSM 1800, (commercially available under the tradename Carezyme®), and the effect expressed in PSU (panel score units).
    LAS concentration
    0.2 0.4 0.6 0.8 1.0
    Variant g/l g/l g/l g/l g/l
    Humicola insolens 15 0 0 0 0
    Humicola insolens/R158E 30 14 30 22 11
    Humicola insolens/R158G 20 18 20 33 28
  • [0477]
  • 1 26 1 202 PRT Cellulase variants 1 Ala Asp Gly Arg Ser Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Gly Trp Ala Lys Lys Ala Pro Val Asn Gln Pro Val Phe Ser Cys Asn 20 25 30 Ala Asn Phe Gln Arg Ile Thr Asp Phe Asp Ala Lys Ser Gly Cys Glu 35 40 45 Pro Gly Gly Val Ala Tyr Ser Cys Ala Asp Gln Thr Pro Trp Ala Val 50 55 60 Asn Asp Asp Phe Ala Leu Gly Phe Ala Ala Thr Ser Ile Ala Gly Ser 65 70 75 80 Asn Glu Ala Gly Trp Cys Cys Ala Cys Tyr Glu Leu Thr Phe Thr Ser 85 90 95 Gly Pro Val Ala Gly Lys Lys Met Val Val Gln Ser Thr Ser Thr Gly 100 105 110 Gly Asp Leu Gly Ser Asn His Phe Asp Leu Asn Ile Pro Gly Gly Gly 115 120 125 Val Gly Ile Phe Asp Gly Cys Thr Pro Gln Phe Gly Gly Leu Pro Gly 130 135 140 Gln Arg Tyr Gly Gly Ile Ser Ser Arg Asn Glu Cys Asp Arg Phe Pro 145 150 155 160 Asp Ala Leu Lys Pro Gly Cys Tyr Trp Arg Phe Asp Trp Phe Lys Asn 165 170 175 Ala Asp Asn Pro Ser Phe Ser Phe Arg Gln Val Gln Cys Pro Ala Glu 180 185 190 Leu Val Ala Arg Thr Gly Cys Arg Arg Ala 195 200 2 202 PRT Cellulase variants 2 Gly Ser Gly His Thr Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Ala Trp Asp Glu Lys Ala Ala Val Ser Arg Pro Val Thr Thr Cys Asp 20 25 30 Arg Asn Asn Ser Pro Leu Ser Pro Gly Ala Val Ser Gly Cys Asp Pro 35 40 45 Asn Gly Val Ala Phe Thr Cys Asn Asp Asn Gln Pro Trp Ala Val Asn 50 55 60 Asn Asn Val Ala Tyr Gly Phe Ala Ala Thr Ala Phe Pro Gly Gly Asn 65 70 75 80 Glu Ala Ser Trp Cys Cys Ala Cys Tyr Ala Leu Gln Phe Thr Ser Gly 85 90 95 Pro Val Ala Gly Lys Thr Met Val Val Gln Ser Thr Asn Thr Gly Gly 100 105 110 Asp Leu Ser Gly Thr His Phe Asp Ile Gln Met Pro Gly Gly Gly Leu 115 120 125 Gly Ile Phe Asp Gly Cys Thr Pro Gln Phe Gly Phe Thr Phe Pro Gly 130 135 140 Asn Arg Tyr Gly Gly Thr Thr Ser Arg Ser Gln Cys Ala Glu Leu Pro 145 150 155 160 Ser Val Leu Arg Asp Gly Cys His Trp Arg Tyr Asp Trp Phe Asn Asp 165 170 175 Ala Asp Asn Pro Asn Val Asn Trp Arg Arg Val Arg Cys Pro Ala Ala 180 185 190 Leu Thr Asn Arg Ser Gly Cys Val Arg Ala 195 200 3 202 PRT cellulase variants 3 Gly Thr Gly Arg Thr Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Gly Trp Asp Glu Lys Ala Ser Val Ser Gln Pro Val Lys Thr Cys Asp 20 25 30 Arg Asn Asn Asn Pro Leu Ala Ser Thr Ala Arg Ser Gly Cys Asp Ser 35 40 45 Asn Gly Val Ala Tyr Thr Cys Asn Asp Asn Gln Pro Trp Ala Val Asn 50 55 60 Asp Asn Leu Ala Tyr Gly Phe Ala Ala Thr Ala Phe Ser Gly Gly Ser 65 70 75 80 Glu Ala Ser Trp Cys Cys Ala Cys Tyr Ala Leu Gln Phe Thr Ser Gly 85 90 95 Pro Val Ala Gly Lys Thr Met Val Val Gln Ser Thr Asn Thr Gly Gly 100 105 110 Asp Leu Ser Gly Asn His Phe Asp Ile Leu Met Pro Gly Gly Gly Leu 115 120 125 Gly Ile Phe Asp Gly Cys Thr Pro Gln Trp Gly Val Ser Phe Pro Gly 130 135 140 Asn Arg Tyr Gly Gly Thr Thr Ser Arg Ser Gln Cys Ser Gln Ile Pro 145 150 155 160 Ser Ala Leu Gln Pro Gly Cys Asn Trp Arg Tyr Asp Trp Phe Asn Asp 165 170 175 Ala Asp Asn Pro Asp Val Ser Trp Arg Arg Val Gln Cys Pro Ala Ala 180 185 190 Leu Thr Asp Arg Thr Gly Cys Arg Arg Ala 195 200 4 201 PRT Cellulase variants 4 Gly Ser Gly Lys Ser Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Ala Trp Ser Gly Lys Ala Ser Val Asn Arg Pro Val Leu Ala Cys Asp 20 25 30 Ala Asn Asn Asn Pro Leu Asn Asp Ala Asn Val Lys Ser Gly Cys Asp 35 40 45 Gly Gly Ser Ala Tyr Thr Cys Ala Asn Asn Ser Pro Trp Ala Val Asn 50 55 60 Asp Asn Leu Ala Tyr Gly Phe Ala Ala Thr Lys Leu Ser Gly Gly Thr 65 70 75 80 Glu Ser Ser Trp Cys Cys Ala Cys Tyr Ala Leu Thr Phe Thr Ser Gly 85 90 95 Pro Val Ser Gly Lys Thr Leu Val Val Gln Ser Thr Ser Thr Gly Gly 100 105 110 Asp Leu Gly Ser Asn His Phe Asp Leu Asn Met Pro Gly Gly Gly Val 115 120 125 Gly Leu Phe Asp Gly Cys Lys Arg Glu Phe Gly Gly Leu Pro Gly Ala 130 135 140 Gln Tyr Gly Gly Ile Ser Ser Arg Ser Glu Cys Asp Ser Phe Pro Ala 145 150 155 160 Ala Leu Lys Pro Gly Cys Gln Trp Arg Phe Asp Trp Phe Lys Asn Ala 165 170 175 Asp Asn Pro Glu Phe Thr Phe Lys Gln Val Gln Cys Pro Ser Glu Leu 180 185 190 Thr Ser Arg Thr Gly Cys Lys Arg Ala 195 200 5 201 PRT Cellulase variants 5 Gly Ser Gly Gln Ser Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Ala Trp Pro Gly Lys Ala Ala Val Ser Gln Pro Val Tyr Ala Cys Asp 20 25 30 Ala Asn Phe Gln Arg Leu Ser Asp Phe Asn Val Gln Ser Gly Cys Asn 35 40 45 Gly Gly Ser Ala Tyr Ser Cys Ala Asp Gln Thr Pro Trp Ala Val Asn 50 55 60 Asp Asn Leu Ala Tyr Gly Phe Ala Ala Thr Ser Ile Ala Gly Gly Ser 65 70 75 80 Glu Ser Ser Trp Cys Cys Ala Cys Tyr Ala Leu Thr Phe Thr Ser Gly 85 90 95 Pro Val Ala Gly Lys Thr Met Val Val Gln Ser Thr Ser Thr Gly Gly 100 105 110 Asp Leu Gly Ser Asn Gln Phe Asp Ile Ala Met Pro Gly Gly Gly Val 115 120 125 Gly Ile Phe Asn Gly Cys Ser Ser Gln Phe Gly Gly Leu Pro Gly Ala 130 135 140 Gln Tyr Gly Gly Ile Ser Ser Arg Asp Gln Cys Asp Ser Phe Pro Ala 145 150 155 160 Pro Leu Lys Pro Gly Cys Gln Trp Arg Phe Asp Trp Phe Gln Asn Ala 165 170 175 Asp Asn Pro Thr Phe Thr Phe Gln Gln Val Gln Cys Pro Ala Glu Ile 180 185 190 Val Ala Arg Ser Gly Cys Lys Arg Ala 195 200 6 203 PRT Cellulase variants 6 Gly Ser Gly His Ser Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Ser Trp Ser Gly Lys Ala Ala Val Asn Ala Pro Ala Leu Thr Cys Asp 20 25 30 Lys Asn Asp Asn Pro Ile Ser Asn Thr Asn Ala Val Asn Gly Cys Glu 35 40 45 Gly Gly Gly Ser Ala Tyr Ala Cys Thr Asn Tyr Ser Pro Trp Ala Val 50 55 60 Asn Asp Glu Leu Ala Tyr Gly Phe Ala Ala Thr Lys Ile Ser Gly Gly 65 70 75 80 Ser Glu Ala Ser Trp Cys Cys Ala Cys Tyr Ala Leu Thr Phe Thr Thr 85 90 95 Gly Pro Val Lys Gly Lys Lys Met Ile Val Gln Ser Thr Asn Thr Gly 100 105 110 Gly Asp Leu Gly Asp Asn His Phe Asp Leu Met Met Pro Gly Gly Gly 115 120 125 Val Gly Ile Phe Asp Gly Cys Thr Ser Glu Phe Gly Lys Ala Leu Gly 130 135 140 Gly Ala Gln Tyr Gly Gly Ile Ser Ser Arg Ser Glu Cys Asp Ser Tyr 145 150 155 160 Pro Glu Leu Leu Lys Asp Gly Cys His Trp Arg Phe Asp Trp Phe Glu 165 170 175 Asn Ala Asp Asn Pro Asp Phe Thr Phe Glu Gln Val Gln Cys Pro Lys 180 185 190 Ala Leu Leu Asp Ile Ser Gly Cys Lys Arg Ala 195 200 7 205 PRT Cellulase variants 7 Gly Ile Gly Gln Thr Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Ala Trp Pro Gly Lys Gly Pro Ser Ser Pro Val Gln Ala Cys Asp Lys 20 25 30 Asn Asp Asn Pro Phe Asn Asp Gly Gly Ser Thr Arg Ser Gly Cys Asp 35 40 45 Ala Gly Gly Ser Ala Tyr Met Cys Ser Ser Gln Ser Pro Trp Ala Val 50 55 60 Ser Asp Glu Leu Ser Tyr Gly Trp Ala Ala Val Lys Leu Ala Gly Ser 65 70 75 80 Ser Glu Ser Gln Trp Cys Cys Ala Cys Tyr Glu Leu Thr Phe Thr Ser 85 90 95 Gly Pro Val Ala Gly Lys Lys Met Ile Val Gln Ala Thr Asn Thr Gly 100 105 110 Gly Asp Leu Gly Asp Asn His Phe Asp Leu Ala Ile Pro Gly Gly Gly 115 120 125 Val Gly Ile Phe Asn Ala Cys Thr Asp Gln Tyr Gly Ala Pro Pro Asn 130 135 140 Gly Trp Gly Asp Arg Tyr Gly Gly Ile His Ser Lys Glu Glu Cys Glu 145 150 155 160 Ser Phe Pro Glu Ala Leu Lys Pro Gly Cys Asn Trp Arg Phe Asp Trp 165 170 175 Phe Gln Asn Ala Asp Asn Pro Ser Val Thr Phe Gln Glu Val Ala Cys 180 185 190 Pro Ser Glu Leu Thr Ser Lys Ser Gly Cys Ser Arg Ala 195 200 205 8 203 PRT Cellulase variants 8 Thr Ala Gly Val Thr Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Gly Trp Ser Gly Lys Ala Ser Val Ser Ala Pro Val Arg Thr Cys Asp 20 25 30 Arg Asn Gly Asn Thr Leu Gly Pro Asp Val Lys Ser Gly Cys Asp Ser 35 40 45 Gly Gly Thr Ser Phe Thr Cys Ala Asn Asn Gly Pro Phe Ala Ile Asp 50 55 60 Asn Asn Thr Ala Tyr Gly Phe Ala Ala Ala His Leu Ala Gly Ser Ser 65 70 75 80 Glu Ala Ala Trp Cys Cys Gln Cys Tyr Glu Leu Thr Phe Thr Ser Gly 85 90 95 Pro Val Val Gly Lys Lys Leu Thr Val Gln Val Thr Asn Thr Gly Gly 100 105 110 Asp Leu Gly Asn Asn His Phe Asp Leu Met Ile Pro Gly Gly Gly Val 115 120 125 Gly Leu Phe Thr Gln Gly Cys Pro Ala Gln Phe Gly Ser Trp Asn Gly 130 135 140 Gly Ala Gln Tyr Gly Gly Val Ser Ser Arg Asp Gln Cys Ser Gln Leu 145 150 155 160 Pro Ala Ala Val Gln Ala Gly Cys Gln Phe Arg Phe Asp Trp Met Gly 165 170 175 Gly Ala Asp Asn Pro Asn Val Thr Phe Arg Pro Val Thr Cys Pro Ala 180 185 190 Gln Leu Thr Asn Ile Ser Gly Cys Val Arg Ala 195 200 9 203 PRT Cellulase variants 9 Thr Ser Gly Val Thr Thr Arg Tyr Trp Asp Cys Cys Lys Pro Ser Cys 1 5 10 15 Ala Trp Thr Gly Lys Ala Ser Val Ser Lys Pro Val Gly Thr Cys Asp 20 25 30 Ile Asn Asp Asn Ala Gln Thr Pro Ser Asp Leu Leu Lys Ser Ser Cys 35 40 45 Asp Gly Gly Ser Ala Tyr Tyr Cys Ser Asn Gln Gly Pro Trp Ala Val 50 55 60 Asn Asp Ser Leu Ser Tyr Gly Phe Ala Ala Ala Lys Leu Ser Gly Lys 65 70 75 80 Gln Glu Thr Asp Trp Cys Cys Gly Cys Tyr Lys Leu Thr Phe Thr Ser 85 90 95 Thr Ala Val Ser Gly Lys Gln Met Ile Val Gln Ile Thr Asn Thr Gly 100 105 110 Gly Asp Leu Gly Asn Asn His Phe Asp Ile Ala Met Pro Gly Gly Gly 115 120 125 Val Gly Ile Phe Asn Gly Cys Ser Lys Gln Trp Asn Gly Ile Asn Leu 130 135 140 Gly Asn Gln Tyr Gly Gly Phe Thr Asp Arg Ser Gln Cys Ala Thr Leu 145 150 155 160 Pro Ser Lys Trp Gln Ala Ser Cys Asn Trp Arg Phe Asp Trp Phe Glu 165 170 175 Asn Ala Asp Asn Pro Thr Val Asp Trp Glu Pro Val Thr Cys Pro Gln 180 185 190 Glu Leu Val Ala Arg Thr Gly Cys Ser Arg Ala 195 200 10 235 PRT Cellulase variants 10 Cys Asn Gly Tyr Ala Thr Arg Tyr Trp Asp Cys Cys Lys Pro His Cys 1 5 10 15 Gly Trp Ser Ala Asn Val Pro Ser Leu Val Ser Pro Leu Gln Ser Cys 20 25 30 Ser Ala Asn Asn Thr Arg Leu Ser Asp Val Ser Val Gly Ser Ser Cys 35 40 45 Asp Gly Gly Gly Gly Tyr Met Cys Trp Asp Lys Ile Pro Phe Ala Val 50 55 60 Ser Pro Thr Leu Ala Tyr Gly Tyr Ala Ala Thr Ser Ser Gly Asp Val 65 70 75 80 Cys Gly Arg Cys Tyr Gln Leu Gln Phe Thr Gly Ser Ser Tyr Asn Ala 85 90 95 Pro Gly Asp Pro Gly Ser Ala Ala Leu Ala Gly Lys Thr Met Ile Val 100 105 110 Gln Ala Thr Asn Ile Gly Tyr Asp Val Ser Gly Gly Gln Phe Asp Ile 115 120 125 Leu Val Pro Gly Gly Gly Val Gly Ala Phe Asn Ala Cys Ser Ala Gln 130 135 140 Trp Gly Val Ser Asn Ala Glu Leu Gly Ala Gln Tyr Gly Gly Phe Leu 145 150 155 160 Ala Ala Cys Lys Gln Gln Leu Gly Tyr Asn Ala Ser Leu Ser Gln Tyr 165 170 175 Lys Ser Cys Val Leu Asn Arg Cys Asp Ser Val Phe Gly Ser Arg Gly 180 185 190 Leu Thr Gln Leu Gln Gln Gly Cys Thr Trp Phe Ala Glu Trp Phe Glu 195 200 205 Ala Ala Asp Asn Pro Ser Leu Lys Tyr Lys Glu Val Pro Cys Pro Ala 210 215 220 Glu Leu Thr Thr Arg Ser Gly Met Asn Arg Ala 225 230 235 11 211 PRT Cellulase variants 11 Gly Met Ala Thr Arg Tyr Trp Asp Cys Cys Leu Ala Ser Ala Ser Trp 1 5 10 15 Glu Gly Lys Ala Pro Val Tyr Ala Pro Val Asp Ala Cys Lys Ala Asp 20 25 30 Gly Val Thr Leu Ile Asp Ser Lys Lys Asp Pro Ser Gly Gln Ser Gly 35 40 45 Cys Asn Gly Gly Asn Lys Phe Met Cys Ser Cys Met Gln Pro Phe Asp 50 55 60 Asp Glu Thr Asp Pro Thr Leu Ala Phe Gly Phe Gly Ala Phe Thr Thr 65 70 75 80 Gly Gln Glu Ser Asp Thr Asp Cys Ala Cys Phe Tyr Ala Glu Phe Glu 85 90 95 His Asp Ala Gln Gly Lys Ala Met Lys Arg Asn Lys Leu Ile Phe Gln 100 105 110 Val Thr Asn Val Gly Gly Asp Val Gln Ser Gln Asn Phe Asp Phe Gln 115 120 125 Ile Pro Gly Gly Gly Leu Gly Ala Phe Pro Lys Gly Cys Pro Ala Gln 130 135 140 Trp Gly Val Glu Ala Ser Leu Trp Gly Asp Gln Tyr Gly Gly Val Lys 145 150 155 160 Ser Ala Thr Glu Cys Ser Lys Leu Pro Lys Pro Leu Gln Glu Gly Cys 165 170 175 Lys Trp Arg Phe Ser Glu Trp Gly Asp Asn Pro Val Leu Lys Gly Ser 180 185 190 Pro Lys Arg Val Lys Cys Pro Lys Ser Leu Ile Asp Arg Ser Gly Cys 195 200 205 Gln Arg Ala 210 12 30 DNA Humicola grissea 12 gaatgacttg gttgacgcgt caccagtcac 30 13 30 DNA Humicola grissea 13 gaatgacttg gttgagtact caccagtcac 30 14 34 DNA Humicola grissea 14 cactggcggc gacctgggat ctaaccactt cgat 34 15 37 DNA Humicola grissea 15 atcgaagtgg ttagatccca ggtcgccgcc tgtgctc 37 16 20 DNA Humicola grissea 16 cgacttcaat gtccagtcgg 20 17 26 DNA Humicola grissea 17 gcgctctaga ggattaaagg cactgc 26 18 35 DNA Humicola grissea 18 cgacctggga tcgaacgact tcgatatcgc catgc 35 19 30 DNA Humicola grissea 19 cgactccagc ttccccgtct tcacgccccc 30 20 34 DNA Humicola grissea 20 cgagcttcta gatctcgact agaggcactg ggag 34 21 27 DNA Humicola grissea 21 ggatgccatg cttggaggat agcaacc 27 22 29 DNA Humicola grissea 22 gggggcgtga agacgggaag ctggagtcg 29 23 1261 DNA Humicola grissea 23 caagaacctc acactcattt tattcacgct catttattct aaaacttcaa tatgcgctct 60 gctcctattt tccgcacggc cctggcggct gcgctccccc ttgccgcact cgccgccgat 120 ggcaagtcga ccagatactg ggactgctgc aagccatcgt gctcttggcc cggaaaggca 180 ctcgtgaacc agcctgtctt cacttgcgac gccaaattcc agcgcatcac cgaccccaat 240 accaagtcgg gctgcgatgg cggctcggcc ttttcgtgtg ctgaccagac cccctgggct 300 ctgaacgacg atgtcgccta tggcttcgct gccacggcta tttcgggtgg atcggaagcc 360 tcgtggtgct gcgcatgcta cgctcttact ttcacctcgg gccctgtggc cggcaagacc 420 atggtcgtcc agtcgaccaa caccggcggc gatctcggca gcaaccattt cgacctccag 480 attccaggcg gcggtgtcgg catctttgat gggtgcaccc cccagttcgg aggtctcgct 540 ggcgaacgct acggtggcat ctcagaccgc agctcctgcg actcgttccc tgcggcgctc 600 aagcccggct gcctctggcg cttcgattgg ttcaagaacg ccgacaaccc gacctttacc 660 ttcaagcagg tgcagtgccc cgccgagctt gttgccagga ccggctgcaa gcgcgaggat 720 gacggcaact tccccgtctt cacgcccccc gcgggtagca acaccggcgg tagccagtcg 780 agctccacta tcgcttccag ctcgacctcc aaggctcaga cttcggccgc cagctccacc 840 tccaaggctg tcgtgactcc cgtctccagc tccacctcga aggccgctga ggtccccaaa 900 tccagctcga cctccaaggc tgccgaggtc gccaagccca gctcaacttc gacctcgacc 960 tcgacctcga ccaaggtcag ctgctctgcg accggtggct cctgcgtcgc tcagaagtgg 1020 gcgcagtgcg gcggcaatgg cttcaccggc tgcacgtcgt gcgtcagcgg caccacctgc 1080 cagaagcaaa atgactggta ctcccagtgc ctctaagtcg tttgtagtag cagtttgaag 1140 gatgtcaggg atgagggagg gaggagtggg ggaaaagtac gccgcagttt tttggtagac 1200 ttactgtatt gttgagtaat tacccattcg cttcttgtac gaaaaaaaaa aaaaaaaaaa 1260 a 1261 24 41 DNA Humicola grissea 24 gctgcaagcc gtcctgtggc tggagcgcta acgtgcccgc g 41 25 36 DNA Humicola grissea 25 cgatgtttcc ggaggccact ttgacattct ggttcc 36 26 30 DNA Humicola grissea 26 gaatgacttg gttgacgcgt caccagtcac 30

Claims (36)

What is claimed is:
1. An enzyme variant comprising a catalytic core domain exhibiting cellulolytic activity, which variant is derived from a naturally occurring parental cellulase by amino acid residue substitution, insertion or deletion or any combination thereof, and
at position 5 (cellulase numbering) holds an alanine residue (A), a serine residue (S), or a threonine residue (T);
at position 8 (cellulase numbering) holds a phenylalanine residue (F), or a tyrosine residue (Y);
at position 9 (cellulase numbering) holds a phenylalanine residue (F), a tryptophan residue (W), or a tyrosine residue (Y);
at position 10 (cellulase numbering) holds an aspartic acid residue (D); and
at position 121 (cellulase numbering) holds an aspartic acid residue (D).
2. The variant according to claim 1, which at position 119 (cellulase numbering) holds an amino acid residue selected from the group consisting of histidine (H), aspartic acid (D), asparagine (N), glutamine (Q), arginine (R), and phenylalanine (F).
3. The variant according to claim 1, which at position 6 (cellulase numbering) holds an amino acid residue selected from the group consisting of threonine (T) and serine (S).
4. The variant according to claim 1, which at position 7 (cellulase numbering) holds an amino acid residue selected from the group consisting of arginine (R), leucine (L), isoleucine (I), tryptophan (W), and lysine (K).
5. A cellulase variant, which variant holds 4 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering).
6. The cellulase variant according to claim 5, which variant holds 5 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-Cl99; C89-C189; and C156-C167 (cellulase numbering).
7. The cellulase variant according to claim 5, which variant holds 6 or more of the following disulfide bridges: C11-C135; C12-C47; C16-C86; C31-C56; C87-Cl99; C89-C189; and C156-C167 (cellulase numbering).
8. The cellulase variant according to claim 5, in which variant a cysteine residue has been replaced by a different natural amino acid residue at one or more of the positions 16, 86, 87, 89, 189, and/or 199 (cellulase numbering).
9. The cellulase variant according to claim 5 selected from the group consisting the following variants derived from Humicola insolens endoglucanase V (EGV): C12G/C47M, C47G, C87M/C199G and C16M/C86G.
10. A method of reducing the thermostability of a cellulase comprising removal, by amino acid substitution, deletion or insertion, of one or more disulfide bridges selected from the group consisting of C11-C135; C12-C47; C16-C86; C31-C56; C87-C199; C89-C189; and C156-C167 (cellulase numbering).
11. A cellulase variant derived from a parental cellulase by substitution, insertion and/or deletion at one or more amino acid residues located in the substrate binding cleft at a position within an enzyme-substrate interactive distance from the substrate.
12. The cellulase variant according to claim 11, which variant has been derived from a parental cellulases by substitution, insertion and/or deletion at one or more amino acid residues located in the substrate binding cleft at a distance of not more than 5 Å from the substrate.
13. The cellulase variant according to claim 12, which variant has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 21a, 42, 44, 45, 47, 48, 49, 49a, 49b, 74, 82, 95j, 110, 111, 112, 113, 114, 115, 116, 119, 121, 123, 127, 128, 129, 130, 131, 132, 132a, 133, 145, 146, 147, 148, 149, 150b, 178, and/or 179 (cellulase numbering).
14. The cellulase variant according to claim 12, which variant has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 4, 5, 13, 14, 15, 16, 19, 20, 21, 21a, 42, 44, 47, 48, 49, 49a, 49b, 74, 82, 95j, 110, 111, 113, 115, 116, 119, 123, 129, 131, 132a, 133, 145, 146, 150b, 178, and/or 179 (cellulase numbering).
15. The cellulase variant according to claim 13 selected from the group consisting the following variants derived from Humicola insolens endoglucanase V (EGV): T6S, R7I, R7W, Y8F, W9F, C12M/C47G, W18Y, W18F, S45T, S45N, D114N, F132D, Y147D, Y147C, Y147W, Y147V, Y147R, Y147G, Y147Q, Y147N, Y147K, Y147H, Y147F and Y147S.
16. The cellulase variant according to claim 13 selected from the group consisting the following variants derived from Humicola insolens endoglucanase V (EGV): R4H, R4Q, K13L, K13R, K13Q, P14A, P14T, S15T, S15H, C16M/C86G, A19P, A19T, A19G, A19S, K20G, D42Y, D42W, C47G, E48D, E48Q, E48D/P49*, E48N/P49*, S110N, L115I, G116D, H119R, H119Q, H119F, N123Å, N123M, N123Q, N123Y, N123D, V129L, D133N and D178N.
17. The cellulase variant according to claim 11, which variant has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more amino acid residues located in the substrate binding cleft at a distance of not more than 3 Å from the substrate.
18. The cellulase variant according to claim 17, which variant has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 6, 7, 8, 10, 12, 13, 14, 15, 18, 20, 21, 45, 48, 74, 110, 111, 112, 113, 114, 115, 119, 121, 127, 128, 129, 130, 131, 132, 132a, 146, 147, 148, 150b, 178, and/or 179 (cellulase numbering).
19. The cellulase variant according to claim 17, which variant has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 13, 14, 15, 20, 21, 48, 74, 110, 111, 113, 115, 119, 129, 131, 146, 150b, 178, and/or 179 (cellulase numbering).
20. A cellulase variant, in which variant an amino acid residue has been changed into a conserved amino acid residue at one or more positions according to Table 1, at which position(s) between 7 and 10 amino acid residues of the 11 residues identified in Table 1, are identical.
21. The cellulase variant according to claim 20, which variant has been derived from a parental cellulases by substitution, insertion and/or deletion at one or more of the following positions: 13, 14, 15, 20, 21, 22, 24, 28, 32, 34, 45, 48, 50, 53, 54, 62, 63, 64, 65, 66, 68, 69, 70, 71, 72, 73, 74, 75, 79, 85, 88, 90, 92, 93, 95, 96, 97, 98, 99, 104, 106, 110, 111, 113, 115, 116, 118, 119, 131, 134, 138, 140, 146, 152, 153, 163, 166, 169, 170, 171, 172, 173, 174, 174, 177, 178, 179, 180, 193, 196, and/or 197 (cellulase numbering).
22. A cellulase variant according to claim 21 comprising one or more of the following mutations (cellulase numbering):
K13L or L13K;
P14Å or A14P;
S15H or H15S;
K20E, K20G, K20A, E20K, G20K, A20K, E20G, E20A, G20E, A20E, G20A, or A20G;
K21N or N21K;
A22G, A22P, G22A, P22A, G22P, or P22G;
V24*, V24L, *24V, L24V, *24L, or L24*;
V28A, V28L, A28V, L28V, A28L, or L28A;
N32D, N32S, N32K, D32N, S32N, K32N, D32S, D32K, S32D, K32D, S32K, or K32S;
N34D or D34N;
I38L, I38F, I38Q, L38I, F38I, Q38I, L38F, L38Q, F38L, Q38L, F38Q, or Q38F;
S45N or N45S;
G46S or S46G;
E48D, E48N, D48E, N48E, D48N, or N48D;
G50N or N50G;
A53S, A53G, A53K, S53A, G53A, K53A, S53G, S53K, G53S, K53S, G53K, or K53G;
Y54F or F54Y;
W62F or F62W;
A63D or D63A;
V64I, V64D, I64V, D64V, I64D, or D64I;
N65S, N65D, N65E, S65N, D65N, E65N, S65D, S65E, D65S, E65S, D65E, or E65D;
D66N, D66P, D66T, N66D, P66D, T66D, N66P, N66T, P66N, T66N, P66T, or T66P;
F68V, F68L, F68T, F68P, V68F, L68F, T68F, P68F, V68L, V68T, V68P, L68V, T68V, P68V, L68T, L68P, T68L, P68L, T68P, or P68T;
A69S, A69T, S69A, T69A, S69T, or T69S;
L70Y or Y70L;
G71A or A71G;
F72W, F72Y, W72F, Y72F, W72Y, or Y72W;
A73G or G73A;
A74F or F74A;
T75V, T75A, T75G, V75T, A75T, G75T, V75A, V75G, A75V, G75V, A75G, or G75A;
G79T or T79G;
W85T or T85W;
A88Q, A88G, A88R, Q88A, G88A, R88A, Q88G, Q88R, G88Q, R88Q, G88R, or R88G;
Y90For F90 Y;
L92A or A92L;
T93Q, T93E, Q93T, E93T, Q93E, or E93Q;
T95E or E95T;
S96T or T96S;
G97T, G97A, T97G, A97G, T97A, or A97T;
P98A or A98P;
V99L or L99V;
M104L or L104M;
V106F or F106V;
S110N or N110S;
T111I, T111V, I111T, V111T, I111V, or V111I;
G113Y or Y113G;
L115V or V115L;
G116S, G116Q, S116G, Q116G, S116Q, or Q116S;
N118T, N118G, N118Q, T118N, G118N, Q118N, T118G, T118Q, G118T, Q118T, G118Q, or Q118G;
H119Q, H119N, Q119H, or N119H;
V129L or L129V;
I131L, I131A, L131I, A131I, L13:LA, or A131L;
G134A or A134G;
Q138E or E138Q;
G140N or N140G;
R146Q or Q146R;
S152D or D152S;
R153K, R153L, R153A, K153R, L153R, A153R, K153L, K153A, L153K, A153K, L153A, or A153L;
L163V, L163W, V163L, W163L, V163W, or W163V;
G166S or S166G;
W169F or F169W;
R170F or F170R;
F171Y, F171A, Y171F, A171F, Y171A, or A171Y;
D172E, D172S, E172D, S172D, E172S, or S172E;
W173E or E173W;
F174M, F174W, M174F, W174F, M174W, or W174M;
A177N or N177A;
D178P or P178D;
N179V or V179N;
P180L or L180P;
L193I or I193L;
R196I, R196K, I196R, K196R, I196K, or K196I; and/or T197S or S197T.
23. A cellulase variant, which variant has been derived from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions (cellulase numbering), and which variant:
in position 4 holds R, H, K, Q, V, Y, or M;
in position 5 holds S, T, or A;
in position 13 holds K, or L;
in position 14 holds P, or A;
in position 15 holds H, or S;
in position 16 holds C, or A;
in position 19 holds A, D, S, P, T, or E;
in position 20 holds A, E, G, or K;
in position 21 holds K, or N;
in position 21a holds V or *;
in position 22 holds A, G, or P;
in position 24 holds L, V, or *;
in position 28 holds A, L, or V;
in position 32 holds D, K, N, or S;
in position 34 holds D or N;
in position 38 holds F, I, L, or Q;
in position 42 holds D, G, T, N, S, K, or *;
in position 44 holds K, V, R, Q, G, or P;
in position 45 holds N, or S;
in position 46 holds G, or S;
in position 47 holds C, or Q;
in position 48 holds D, E, N, or S;
in position 49 holds P, S, A, G, or *;
in position 49a holds C, or *;
in position 49b holds N, or *;
in position 50 holds G, or N;
in position 53 holds A, G, K, or S;
in position 54 holds F, or Y;
in position 62 holds F, or W;
in position 63 holds A, or D;
in position 64 holds D, I, or V;
in position 65 holds D, I, N, or S;
in position 68 holds D, N, P, or T;
in position 69 holds A, S, or T;
in position 70 holds L, or Y;
in position 71 holds A, or G;
in position 72 holds F, W, or Y;
in position 73 holds A, or G;
in position 74 holds A, or F;
in position 75 holds A, G, T, or V;
in position 79 holds G, or T;
in position 82 holds F, or *;
in position 88 holds A, G, Q, or R;
in position 90 holds F, or Y;
in position 92 holds A, or L;
in position 93 holds E, Q, or T;
in position 95 holds E, or *;
in position 95j holds P, or *;
in position 96 holds S, or T;
in position 97 holds A, G, or T;
in position 98 holds A, or P;
in position 99 holds L, or V;
in position 104 holds L, or M;
in position 106 holds F, or V;
in position 110 holds N, or S;
in position 111 holds I, T, or V;
in position 113 holds G, or Y;
in position 115 holds L, or V;
in position 116 holds G, Q, or S;
in position 118 holds G, N, Q, or T;
in position 119 holds H, N, or Q;
in position 129 holds L, or V;
in position 131 holds A, I, or L;
in position 132 holds A, P, or T;
in position 133 holds D, K, N, or Q;
in position 134 holds A, or G;
in position 138 holds E, or Q;
in position 145 holds A, D, N, or Q;
in position 146 holds Q, or R;
in position 150b holds A, or *;
in position 152 holds D, or S;
in position 153 holds A, K, L, or R;
in position 163 holds L, V, or W;
in position 166 holds G, or S;
in position 169 holds F, or W;
in position 170 holds F, or R;
in position 171 holds A, F, or Y;
in position 172 holds D, E, or S;
in position 173 holds E, or W;
in position 174 holds F, V, or W;
in position 177 holds A, or N;
in position 178 holds D, or P;
in position 179 holds N, or V;
in position 180 holds L, or P;
in position 193 holds I, or L;
in position 196 holds I, K, or R; and/or
in position 197 holds S, or T.
24. A cellulase variant having an altered anion tenside sensitivity, and which variant is from a parental cellulase by substitution, insertion and/or deletion at one or more of the following positions: 2, 4, 7, 8, 10, 13, 15, 19, 20, 21, 25, 26, 29, 32, 33, 34, 35, 37, 40, 42, 42a, 43, 44, 48, 53, 54, 55, 58, 59, 63, 64, 65, 66, 67, 70, 72, 76, 79, 80, 82, 84, 86, 88, 90, 91, 93, 95, 95d, 95h, 95j, 97, 100, 101, 102, 103, 113, 114, 117, 119, 121, 133, 136, 137, 138, 139, 140a, 141, 143a, 145, 146, 147, 150e, 150j, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160c, 160e, 160k, 161, 162, 164, 165, 168, 170, 171, 172, 173, 175, 176, 178, 181, 183, 184, 185, 186, 188, 191, 192, 195, 196, 200, and/or 201 (cellulase numbering).
25. A cellulase variant, in which variant an amino acid residue has been substituted at one or more of the following positions: 17, 85, 86 87, 88, and/or 89 (cellulase numbering).
26. A Humicola insolens EGV variant, in which one or more of the following mutations have been introduced: D42W, D42Y, or L70Y.
27. A Thielavia terrestris cellulase variant, in which variant one or more of the following mutations have been introduced: P19A, G20K, Q44K, N48E, Q119H or Q146 R.
28. The Thielavia terrestris/Q119H variant.
29. A Pseudomonas fluorescens cellulase variant, in which variant one or more of the following mutations have been introduced: Y4R, H15S, N119Q or Q146R.
30. A Crinipellis scabella cellulase variant, in which one or more of the following mutations have been introduced: V4R, T132a*, Q133D or Q146R.
31. A method for improving the properties of a cellulolytic enzyme by amino acid substitution, deletion or insertion, the method comprising the steps of:
a. constructing a multiple alignment of at least two amino acid sequences known to have three-dimensional structures similar to endoglucanase V (EGV) from Humicola insolens known from Protein Data Bank entry 4ENG;
b. constructing a homology-built three-dimensional structure of the cellulolytic enzyme based on the structure of the EGV;
c. identifying amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å;
d. identifying surface-exposed amino acid residues of the enzyme;
e. identifying all charged or potentially charged amino acid residue positions of the enzyme;
f. choosing one or more positions wherein the amino acid residue is to be substituted, deleted or where an insertion is to be provided; and
g. carrying out the substitution, deletion or insertion by using conventional protein engineering techniques.
32. The method according to claim 31, wherein step f. is carried out by choosing positions which, as a result of the alignment of step a., carry the same amino acid residue in a majority of the aligned sequences.
33. The method according to claim 32, wherein step f is carried out by choosing positions which, in the aligned sequences, carries different amino acid residues.
34. A method of improving the specific activity of a naturally occurring parental cellulase by carrying out a substitution, deletion or insertion at amino acid residue positions present in a distance from the substrate binding cleft of not more than 5 Å.
35. A method of altering the pH activity profile, the pH activity optimum, the pH stability profile, or the pH stability optimum of a naturally occurring parental cellulase by altering the electrostatic environment either locally or globally by carrying out a substitution, deletion or insertion at amino acid residue positions present either in a distance from the substrate binding cleft of not more than 5 Å, or at surface-exposed amino acid residue positions of the enzyme; preferably by a substitution involving a charged or potentially charged residue, this residue either being the original residue or the replacement residue.
36. A method of altering the stability of a naturally occurring parental cellulase in the presence of an anionic tenside or anionic detergent component by altering the electrostatic environment either locally or globally by carrying out a substitution, deletion or insertion at one or more surface-exposed amino acid residue positions of the enzyme.
US09/261,329 1996-09-17 1999-03-03 Cellulase variants Abandoned US20030092097A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/919,195 US20050009166A1 (en) 1996-09-17 2004-08-16 Cellulase variants
US11/830,063 US8017372B2 (en) 1996-09-17 2007-07-30 Cellulase variants
US12/394,202 US7993898B2 (en) 1996-09-17 2009-02-27 Cellulase variants
US13/162,636 US20110250674A1 (en) 1996-09-17 2011-06-17 Cellulase variants
US13/471,757 US20120289450A1 (en) 1996-09-17 2012-05-15 Cellulase Variants

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK101396 1996-09-17
DK1013/96 1996-09-17
PCT/DK1997/000393 WO1998012307A1 (en) 1996-09-17 1997-09-17 Cellulase variants

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1997/000393 Continuation WO1998012307A1 (en) 1996-09-17 1997-09-17 Cellulase variants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/919,195 Continuation US20050009166A1 (en) 1996-09-17 2004-08-16 Cellulase variants

Publications (1)

Publication Number Publication Date
US20030092097A1 true US20030092097A1 (en) 2003-05-15

Family

ID=8100020

Family Applications (6)

Application Number Title Priority Date Filing Date
US09/261,329 Abandoned US20030092097A1 (en) 1996-09-17 1999-03-03 Cellulase variants
US10/919,195 Abandoned US20050009166A1 (en) 1996-09-17 2004-08-16 Cellulase variants
US11/830,063 Expired - Fee Related US8017372B2 (en) 1996-09-17 2007-07-30 Cellulase variants
US12/394,202 Expired - Fee Related US7993898B2 (en) 1996-09-17 2009-02-27 Cellulase variants
US13/162,636 Abandoned US20110250674A1 (en) 1996-09-17 2011-06-17 Cellulase variants
US13/471,757 Abandoned US20120289450A1 (en) 1996-09-17 2012-05-15 Cellulase Variants

Family Applications After (5)

Application Number Title Priority Date Filing Date
US10/919,195 Abandoned US20050009166A1 (en) 1996-09-17 2004-08-16 Cellulase variants
US11/830,063 Expired - Fee Related US8017372B2 (en) 1996-09-17 2007-07-30 Cellulase variants
US12/394,202 Expired - Fee Related US7993898B2 (en) 1996-09-17 2009-02-27 Cellulase variants
US13/162,636 Abandoned US20110250674A1 (en) 1996-09-17 2011-06-17 Cellulase variants
US13/471,757 Abandoned US20120289450A1 (en) 1996-09-17 2012-05-15 Cellulase Variants

Country Status (10)

Country Link
US (6) US20030092097A1 (en)
EP (2) EP0937138B1 (en)
JP (2) JP3532576B2 (en)
CN (2) CN100362100C (en)
AT (1) ATE324437T1 (en)
AU (1) AU4200797A (en)
BR (1) BR9711479B1 (en)
CA (1) CA2265914C (en)
DE (1) DE69735767T2 (en)
WO (1) WO1998012307A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030051836A1 (en) * 2001-05-21 2003-03-20 Novozymes A/S Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer
US20070111278A1 (en) * 2003-12-03 2007-05-17 Jinichiro Koga Endoglucanase stce and cellulase preparation containing the same
US20110087470A1 (en) * 2007-11-02 2011-04-14 Ceres, Inc. Material and methods for use in biomass processing
WO2013138288A1 (en) 2012-03-16 2013-09-19 Monosol, Llc. Water soluble compositions incorporating enzymes, and method of making same
WO2013158364A1 (en) 2012-04-16 2013-10-24 Monosol, Llc Powdered pouch and method of making same
US8927481B2 (en) 2011-04-18 2015-01-06 Henkel Ag & Co. Kgaa Detergents or cleaning agents having a solid enzyme formulation
CN104583394A (en) * 2012-08-16 2015-04-29 诺维信公司 Method for treating textile with endoglucanase
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
US11104867B2 (en) 2011-06-16 2021-08-31 Henkel IP & Holding GmbH Dishwashing liquid having bleaching catalyst and protease
US11104497B2 (en) 2014-10-03 2021-08-31 Monosol, Llc Degradable materials and packaging made from same
CN114250214A (en) * 2020-09-21 2022-03-29 南京工业大学 Persistent endo-cellulase mutant and application thereof

Families Citing this family (750)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271295B1 (en) * 1996-09-05 2001-08-07 General Electric Company Emulsions of silicones with non-aqueous hydroxylic solvents
WO1998012307A1 (en) * 1996-09-17 1998-03-26 Novo Nordisk A/S Cellulase variants
EP1002061A1 (en) * 1997-07-04 2000-05-24 Novo Nordisk A/S FAMILY 6 ENDO-1,4-$g(b)-GLUCANASE VARIANTS AND CLEANING COMPOSIT IONS CONTAINING THEM
WO2000014208A1 (en) * 1998-09-03 2000-03-16 Genencor International, Inc. Egiii-like cellulase compositions, dna encoding such egiii compositions and methods for obtaining same
US6407046B1 (en) 1998-09-03 2002-06-18 Genencor International, Inc. Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
US6187732B1 (en) * 1998-09-03 2001-02-13 Genencor International, Inc. Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
US6921655B1 (en) 1998-10-23 2005-07-26 Meiji Seika Kaisha, Ltd. Endoglucanases and cellulase preparations containing the same
DK2290059T3 (en) 1998-11-27 2016-02-22 Novozymes As Lipolytic enzyme VERSIONS
US6579841B1 (en) 1998-12-18 2003-06-17 Genencor International, Inc. Variant EGIII-like cellulase compositions
US6268328B1 (en) * 1998-12-18 2001-07-31 Genencor International, Inc. Variant EGIII-like cellulase compositions
ATE504651T1 (en) 1998-12-18 2011-04-15 Novozymes As SUBTILASE ENZYMES OF THE I-S1 AND I-S2 SUBGROUPS WITH AN ADDITIONAL AMINO ACID RESIDUE IN AN ACTIVE LOOP REGION
AU3419200A (en) 1999-03-31 2000-10-23 Novozymes A/S Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same
CN1234854C (en) 1999-03-31 2006-01-04 诺维信公司 Polypeptide with alkaline α-amylase activity and nucleic acid encoding the polypeptide
AU5279100A (en) * 1999-05-19 2000-12-05 Midwest Research Institute E1 endoglucanase variants y245g, y82r and w42r
DE60040282D1 (en) 1999-05-20 2008-10-30 Novozymes As SUBTILASE ENZYMES OF I-S1 AND I-S2 SUB-GROUPS WITH AT LEAST ONE ADDITIONAL AMINO ACID BETWEEN POSITIONS 132 AND 133
WO2000071688A1 (en) 1999-05-20 2000-11-30 Novozymes A/S Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 126 and 127
DE60040284D1 (en) 1999-05-20 2008-10-30 Novozymes As SUBTILASE ENZYMES OF I-S1 AND I-S2 SUB-GROUPS WITH AT LEAST ONE ADDITIONAL AMINO ACID BETWEEN POSITIONS 129 AND 130
ATE408679T1 (en) 1999-05-20 2008-10-15 Novozymes As SUBTILASE ENZYMES OF THE I-S1 AND I-S2 SUBGROUPS WITH AT LEAST ONE ADDITIONAL AMINO ACID BETWEEN POSITIONS 127 AND 128
DE60040287D1 (en) 1999-05-20 2008-10-30 Novozymes As SUBTILASE ENZYMS OF I-S1 AND I-S2 SUB-GROUPS WITH AT LEAST ONE ADDITIONAL AMINO ACID BETWEEN POSITIONS 128 AND 129
AU4393100A (en) 1999-05-20 2000-12-12 Novozymes A/S Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additionalamino acid residue between positions 125 and 126
EP2336331A1 (en) 1999-08-31 2011-06-22 Novozymes A/S Novel proteases and variants thereof
WO2001096382A2 (en) 2000-06-15 2001-12-20 Prokaria Ehf. Thermostable cellulase
CN100591763C (en) 2000-08-21 2010-02-24 诺维信公司 Subtilase enzymes
EP1975229A3 (en) 2000-10-13 2009-03-18 Novozymes A/S Alpha-amylase variant with altered properties
EP1326966B2 (en) 2000-10-13 2015-03-18 Novozymes A/S Subtilase variants
EP1423513B1 (en) 2001-05-15 2009-11-25 Novozymes A/S Alpha-amylase variant with altered properties
DK1421224T3 (en) 2001-06-26 2013-01-21 Novozymes As Polypeptides with cellobiohydrolase I activity and polynucleotides encoding the same
DK200101090A (en) 2001-07-12 2001-08-16 Novozymes As Subtilase variants
EP1490485B1 (en) 2002-03-27 2015-03-04 Novozymes A/S Granules with filamentous coatings
JP4897186B2 (en) * 2002-03-27 2012-03-14 花王株式会社 Mutant alkaline cellulase
DK1520012T3 (en) 2002-07-01 2009-04-27 Novozymes As Monopropylene glycol added to fermentation medium
AU2003266941A1 (en) 2002-10-01 2004-04-23 Novozymes A/S Family gh 61 polypeptides
WO2004039969A1 (en) 2002-10-31 2004-05-13 Meiji Seika Kaisha, Ltd. Novel cellulase tolerant to surfactants
TWI319007B (en) 2002-11-06 2010-01-01 Novozymes As Subtilase variants
EP1572996B1 (en) * 2002-12-11 2014-06-11 Novozymes A/S Detergent composition comprising endo-glucanase
DE10260903A1 (en) 2002-12-20 2004-07-08 Henkel Kgaa New perhydrolases
US7348168B2 (en) 2002-12-20 2008-03-25 Novozymes A/S Polypeptides having cellobiohydrolase II activity and polynucleotides encoding same
EP1590455B1 (en) 2003-01-27 2010-03-17 Novozymes A/S Stabilization of granules
CN1751116A (en) 2003-02-18 2006-03-22 诺和酶股份有限公司 Detergent compositions
ES2393058T3 (en) 2003-05-02 2012-12-18 Novozymes Inc. Beta glucosidase variants
EP1675941B1 (en) 2003-06-25 2013-05-22 Novozymes A/S Polypeptides having alpha-amylase activity and polynucleotides encoding same
EP2377931B1 (en) 2003-08-25 2013-05-08 Novozymes Inc. Variants of glycoside hydrolases
DE602004030595D1 (en) 2003-10-10 2011-01-27 Novozymes As PROTEASE VARIANTS
ATE516347T1 (en) 2003-10-23 2011-07-15 Novozymes As PROTEASE WITH IMPROVED STABILITY IN DETERGENTS
CN1902310B (en) 2003-10-28 2011-09-21 诺维信股份有限公司 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
DE10360805A1 (en) 2003-12-23 2005-07-28 Henkel Kgaa New alkaline protease and detergents containing this novel alkaline protease
EP1709165B1 (en) 2004-01-06 2014-04-23 Novozymes A/S Polypeptides of alicyclobacillus
DK2314605T3 (en) 2004-01-30 2014-06-16 Novozymes Inc Polypeptides with cellulolytic enhancing activity and polynucleotides encoding them
EP2325318A1 (en) 2004-02-13 2011-05-25 Novozymes A/S Protease variants
US7148404B2 (en) 2004-05-04 2006-12-12 Novozymes A/S Antimicrobial polypeptides
MXPA06014649A (en) 2004-06-21 2007-03-12 Novozymes As Proteases.
ES2554635T3 (en) 2004-07-05 2015-12-22 Novozymes A/S Variants of alpha-amylase with altered properties
DE602005026541D1 (en) 2004-09-21 2011-04-07 Novozymes As SUBTILASES
WO2006032278A1 (en) 2004-09-21 2006-03-30 Novozymes A/S Subtilases
US7741095B2 (en) 2004-09-21 2010-06-22 Novozymes A/S Subtilases
EP1799819B1 (en) 2004-09-30 2011-03-23 Novozymes Inc. Polypeptides having lipase activity and polynucleotides encoding same
DE102004047777B4 (en) 2004-10-01 2018-05-09 Basf Se Alpha-amylase variants with increased solvent stability, process for their preparation and their use
DE102004047776B4 (en) 2004-10-01 2018-05-09 Basf Se Stabilized against di- and / or multimerization alpha-amylase variants, processes for their preparation and their use
ATE447013T1 (en) 2005-04-27 2009-11-15 Novozymes Inc POLYPEPTIDES WITH ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES CODING THEREFOR
US7741093B2 (en) 2005-04-29 2010-06-22 Ab Enzymes Oy Cellulases and their uses
FI118340B (en) * 2005-04-29 2007-10-15 Ab Enzymes Oy Cellulus fusion proteins, their preparation and use
PT1874927E (en) * 2005-04-29 2014-04-23 Ab Enzymes Oy Improved cellulases
WO2007006305A1 (en) 2005-07-08 2007-01-18 Novozymes A/S Subtilase variants
EP1967584B1 (en) 2005-08-16 2011-03-23 Novozymes A/S Polypeptides of strain bacillus SP. P203
JP5329958B2 (en) 2005-08-16 2013-10-30 ノボザイムス アクティーゼルスカブ Subtilase
EP1934342B1 (en) 2005-09-30 2014-12-10 Novozymes A/S Immobilization of enzymes
EP2385110A3 (en) 2005-09-30 2011-11-16 Novozymes, Inc. Methods for enhancing the degradation or conversion of cellulosic material
DE102005053529A1 (en) 2005-11-08 2007-06-21 Henkel Kgaa System for the enzymatic generation of hydrogen peroxide
FI120045B (en) * 2005-12-22 2009-06-15 Roal Oy Treatment of cellulose materials and enzymes useful therein
FI119325B (en) * 2005-12-22 2008-10-15 Ab Enzymes Oy New endoglucanase polypeptides and their preparation and use
EP1969123B1 (en) * 2005-12-22 2017-07-12 AB Enzymes Oy Novel enzymes
US7256032B2 (en) 2005-12-22 2007-08-14 Ab Enzymes Oy Enzymes
DE102006038448A1 (en) 2005-12-28 2008-02-21 Henkel Kgaa Enzyme-containing cleaning agent
EP1994130A1 (en) 2006-03-02 2008-11-26 Novozymes A/S High capacity encapsulation process
US7883711B2 (en) 2006-03-22 2011-02-08 Novozymes A/S Use of polypeptides having antimicrobial activity
EP2004789B1 (en) 2006-03-31 2012-08-29 Novozymes A/S A stabilized liquid enzyme composition
CN101516906B (en) 2006-07-21 2013-11-06 诺维信股份有限公司 Methods of increasing secretion of polypeptides having biological activity
CA2660645C (en) 2006-08-11 2016-04-05 Novozymes Biologicals, Inc. Bacillus cultures for use in washing, cleaning, stain removal, or degrading waste materials
ES2419234T5 (en) 2006-10-06 2017-05-05 Novozymes A/S Detergent compositions and use of enzyme combinations in them
DE102006055669A1 (en) 2006-11-23 2008-07-17 Henkel Kgaa Enzyme preparation with carrier-bound antioxidants
CA2673527A1 (en) 2006-12-21 2008-07-24 Danisco Us Inc. Compositions and uses for an alpha-amylase polypeptide of bacillus species 195
DE102007003143A1 (en) 2007-01-16 2008-07-17 Henkel Kgaa New alkaline protease from Bacillus gibsonii and detergents and cleaners containing this novel alkaline protease
DE102007008655A1 (en) 2007-02-20 2008-08-21 Henkel Ag & Co. Kgaa Siderophore-metal complexes as bleach catalysts
DE102007010785A1 (en) 2007-03-02 2008-09-04 Henkel Ag & Co. Kgaa Use of superoxide dismutases to cleave and/or remove Amadori and/or Maillard products, especially as components of detergent, cosmetic or pharmaceutical products
EP2126089A2 (en) 2007-03-09 2009-12-02 Danisco US, INC., Genencor Division Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
WO2008118749A2 (en) 2007-03-23 2008-10-02 Novozymes Biologicals, Inc. Preventing and reducing biofilm formation and planktonic proliferation
DE102007016139A1 (en) 2007-03-30 2008-10-02 Jenabios Gmbh Method for regioselective oxygenation of N-heterocycles
DE102007017654A1 (en) 2007-04-12 2008-10-16 Henkel Ag & Co. Kgaa Bis (hydroxyquinoline) metal complexes as bleaching catalysts
DE102007017657A1 (en) 2007-04-12 2008-10-16 Henkel Ag & Co. Kgaa Tris / heterocyclyl) metal complexes as bleach catalysts
DE102007017656A1 (en) 2007-04-12 2008-10-16 Henkel Ag & Co. Kgaa Biheteroaryl metal complexes as bleaching catalysts
SG148934A1 (en) 2007-06-11 2009-01-29 Novozymes As A process for combined biopolishing and bleach clean-up
DE102007040326A1 (en) 2007-08-24 2009-02-26 Henkel Ag & Co. Kgaa Laundry pre-treatment agent and method
DE102007047433A1 (en) * 2007-10-04 2009-04-09 Lanxess Deutschland Gmbh Liquid washing and liquid cleaning agents
DE102007049830A1 (en) 2007-10-16 2009-04-23 Henkel Ag & Co. Kgaa New protein variants by circular permutation
DE102007051092A1 (en) 2007-10-24 2009-04-30 Henkel Ag & Co. Kgaa Subtilisin from Becillus pumilus and detergents and cleaners containing this new subtilisin
BRPI0821230A2 (en) 2007-12-19 2019-09-24 Novozymes As "nucleic acid construct, recombinant host microbial banknote, methods for producing a polypeptide having cellulolytic enhancing activity, for producing a precursor banknote mutant, for inhibiting expression of a cellulolytic enhancing activity polypeptide in a cell, for producing a protein" , to degrade or convert a cellulosic material, and to ferment a cellulosic material "
WO2009107091A2 (en) * 2008-02-29 2009-09-03 The Procter & Gamble Company Detergent composition comprising lipase
US20090217464A1 (en) * 2008-02-29 2009-09-03 Philip Frank Souter Detergent composition comprising lipase
EP2283136A2 (en) 2008-04-30 2011-02-16 Danisco US Inc. New chimeric alpha-amylase variants
CA2726803A1 (en) 2008-06-06 2009-12-10 Danisco Us Inc. Variant alpha-amylases from bacillus subtilis and methods of use, thereof
DK2291526T3 (en) 2008-06-06 2014-10-06 Danisco Us Inc SACCHARIFICATION OF ENZYME COMPOSITION WITH BACILLUS SUBTILIS ALPHA AMYLASE
EP2698434A1 (en) 2008-06-06 2014-02-19 Danisco US Inc. Uses of an alpha-amylase from Bacillus subtilis
RU2545721C2 (en) * 2008-06-06 2015-04-10 Новозимс А/С Versions of family consisting of 44 xyloglucanases
AU2009256171B2 (en) 2008-06-06 2013-11-07 Danisco Us Inc. Compositions and methods comprising cellulase variants with reduced affinity to non-cellulosic materials
DE102008027375A1 (en) 2008-06-09 2009-12-10 Henkel Ag & Co. Kgaa Bacitracin-metal complexes as bleaching catalysts
GB0810881D0 (en) 2008-06-16 2008-07-23 Unilever Plc Improvements relating to fabric cleaning
EP2149786A1 (en) 2008-08-01 2010-02-03 Unilever PLC Improvements relating to detergent analysis
ES2691384T3 (en) 2008-09-02 2018-11-27 Basf Se Procedure for manufacturing paper, cardboard and cardboard using endo-beta-1,4-glucanases as a drainage agent
CN202181298U (en) 2008-09-12 2012-04-04 荷兰联合利华有限公司 Dispenser and preconditioner for viscous liquids
WO2010059413A2 (en) 2008-11-20 2010-05-27 Novozymes, Inc. Polypeptides having amylolytic enhancing activity and polynucleotides encoding same
CA2745760A1 (en) 2008-12-04 2010-06-10 Novozymes A/S Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
US20110296557A1 (en) 2008-12-12 2011-12-01 Novozymes, Inc. Polypeptides Having Lipase Activity And Polynucleotides Encoding Same
WO2010080527A1 (en) 2008-12-19 2010-07-15 Novozymes, Inc. Methods for determining cellulolytic enhancing activity of a polypeptide
EP2379712B1 (en) 2008-12-19 2017-02-22 Novozymes Inc. Methods for increasing hydrolysis of cellulosic material in the presence of cellobiose dehydrogenase
EP2379733A2 (en) 2008-12-19 2011-10-26 Novozymes Inc. Methods for increasing hydrolysis of cellulosic material
US8426158B2 (en) 2008-12-19 2013-04-23 Novozymes, Inc. Methods for increasing enzymatic hydrolysis of cellulosic material in the presence of a peroxidase
EP2202290A1 (en) 2008-12-23 2010-06-30 Unilever PLC A flowable laundry composition and packaging therefor
CN102388134A (en) 2009-01-28 2012-03-21 诺维信股份有限公司 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
US8629324B2 (en) 2009-01-30 2014-01-14 Novozymes, Inc. Polypeptides having expansin activity and polynucleotides encoding same
WO2010097436A1 (en) 2009-02-27 2010-09-02 Novozymes A/S Mutant cells having reduced expression of metallopeptidase, suitable for recombinant polypeptide production
WO2010104675A1 (en) 2009-03-10 2010-09-16 Danisco Us Inc. Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof
CN102365360A (en) 2009-03-24 2012-02-29 诺维信公司 Polypeptides having acetyl xylan esterase activity and polynucleotides encoding same
EP2417254B1 (en) 2009-04-08 2014-05-21 Danisco US Inc. Halomonas strain wdg195-related alpha-amylases, and methods of use, thereof
EP2427540B1 (en) 2009-05-05 2015-11-25 Unilever PLC Shading composition
DK2435561T3 (en) 2009-05-29 2018-11-05 Novozymes Inc PROCEDURES FOR IMPROVING THE DEGRADATION OR CONVERSION OF CELLULOSE SUBSTANCES
EP2438163B1 (en) 2009-06-02 2015-01-21 Novozymes Inc. Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
WO2011005867A1 (en) 2009-07-07 2011-01-13 Novozymes, Inc. Polypeptides having cellulolytic enhancing activity activity and polynucleotides encoding same
EP2451914A1 (en) 2009-07-09 2012-05-16 The Procter & Gamble Company A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte
WO2011005905A1 (en) 2009-07-09 2011-01-13 The Procter & Gamble Company A mildly alkaline, low-built, solid fabric treatment detergent composition comprising phthalimido peroxy caproic acid
CN102471729A (en) 2009-07-09 2012-05-23 宝洁公司 A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte
WO2011005911A1 (en) 2009-07-09 2011-01-13 The Procter & Gamble Company Method of laundering fabric using a compacted liquid laundry detergent composition
ES2581916T5 (en) 2009-08-13 2022-11-07 Procter & Gamble Method for washing fabrics at low temperature
WO2011035027A2 (en) 2009-09-17 2011-03-24 Novozymes, Inc. Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
CN102712916B (en) 2009-09-18 2015-11-25 诺维信股份有限公司 There are the polypeptide of beta-glucosidase activity and the polynucleotide of this polypeptide of coding
AU2010299799B2 (en) 2009-09-25 2015-10-29 Novozymes A/S Subtilase variants
MX2012003387A (en) 2009-09-25 2012-04-10 Novozymes As Use of protease variants.
MX2012003473A (en) 2009-09-29 2012-05-22 Novozymes Inc Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same.
EP2483403B1 (en) 2009-09-29 2017-11-15 Novozymes Inc. Polypeptides having xylanase activity and polynucleotides encoding same
EP2977382A3 (en) 2009-09-30 2016-05-11 Novozymes Inc. Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
CN102666846A (en) 2009-09-30 2012-09-12 诺维信公司 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
MX2012004091A (en) 2009-10-08 2012-04-20 Unilever Nv Shading composition.
BR112012007757B1 (en) 2009-10-13 2019-08-27 Unilever Nv fabric wash treatment composition and domestic method of fabric treatment
CN102597228A (en) 2009-10-23 2012-07-18 诺维信股份有限公司 Cellobiohydrolase variants and polynucleotides encoding same
VN30996A1 (en) 2009-10-23 2012-09-25 Unilever Nv Dye polymers
MX356389B (en) 2009-10-23 2018-05-28 Danisco Us Inc Methods for reducing blue saccharide.
US20120260371A1 (en) 2009-10-29 2012-10-11 Novozymes A/S Polypeptides Having Cellobiohydrolase Activity and Polynucleotides Encoding Same
ES2574054T3 (en) 2009-11-06 2016-06-14 Novozymes, Inc. Polypeptides with xylanase activity and polynucleotides that encode them
BR112012008260A2 (en) 2009-11-06 2015-09-15 Novozymes Inc E Novozymes As polypeptide, polynucleotide, methods for making the polypeptide, for producing a precursor cell mutant, for inhibiting expression of a polypeptide, for producing a protein, for degrading or converting a cellulosic material, for producing a fermentation product, for fermenting a cellulosic material, transgenic plant, part of the plant or plant cell, and double stranded inhibitory rna molecule.
WO2011080267A2 (en) 2009-12-29 2011-07-07 Novozymes A/S Polypetides having detergency enhancing effect
CN102753672B (en) 2010-01-07 2014-11-12 荷兰联合利华有限公司 natural toner
WO2011089561A1 (en) 2010-01-22 2011-07-28 Danisco A/S Methods for producing amino-substituted glycolipid compounds
EP2534206B1 (en) 2010-02-09 2014-04-02 Unilever PLC Dye polymers
EP2357220A1 (en) 2010-02-10 2011-08-17 The Procter & Gamble Company Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent
CN102869759B (en) 2010-02-10 2015-07-15 诺维信公司 Variants having high stability in the presence of chelating agents and compositions comprising the variants
EP2534237B1 (en) 2010-02-12 2014-11-12 Unilever PLC Laundry treatment composition comprising bis-azo shading dyes
US8815559B2 (en) 2010-02-18 2014-08-26 Danisco Us Inc. Amylase from nesterenkonia and methods of use, thereof
WO2011104339A1 (en) 2010-02-25 2011-09-01 Novozymes A/S Variants of a lysozyme and polynucleotides encoding same
EP2365054A1 (en) 2010-03-01 2011-09-14 The Procter & Gamble Company Solid laundry detergent composition comprising secondary alcohol-based detersive surfactant
EP2363456A1 (en) 2010-03-01 2011-09-07 The Procter & Gamble Company Solid laundry detergent composition comprising brightener in micronized particulate form
EP2365059A1 (en) 2010-03-01 2011-09-14 The Procter & Gamble Company Solid laundry detergent composition comprising C.I. fluorescent brightener 260 in alpha-crystalline form
EP2377914B1 (en) 2010-04-19 2016-11-09 The Procter & Gamble Company Mildly alkaline, low-built, solid fabric treatment detergent composition comprising perhydrolase
EP2365058A1 (en) 2010-03-01 2011-09-14 The Procter & Gamble Company Solid laundry detergent composition having an excellent anti-encrustation profile
EP2380957A1 (en) 2010-04-19 2011-10-26 The Procter & Gamble Company Solid laundry detergent composition having a dynamic in-wash ph profile
US20110257069A1 (en) 2010-04-19 2011-10-20 Stephen Joseph Hodson Detergent composition
US20110257060A1 (en) 2010-04-19 2011-10-20 Robert Richard Dykstra Laundry detergent composition comprising bleach particles that are suspended within a continuous liquid phase
US20110257062A1 (en) 2010-04-19 2011-10-20 Robert Richard Dykstra Liquid laundry detergent composition comprising a source of peracid and having a ph profile that is controlled with respect to the pka of the source of peracid
MX349735B (en) 2010-04-26 2017-08-10 Novozymes As Enzyme granules.
CN102892875A (en) 2010-04-29 2013-01-23 荷兰联合利华有限公司 Bis-heterocyclic azo dyes
HUE045202T2 (en) 2010-05-06 2019-12-30 Procter & Gamble Consumer goods with protease variants
EP2395071A1 (en) 2010-06-10 2011-12-14 The Procter & Gamble Company Solid detergent composition comprising lipase of bacterial origin
PL2399980T3 (en) 2010-06-24 2013-01-31 Procter & Gamble Stable compositions comprising cationic cellulose polymer and cellulase
US8581042B2 (en) 2010-06-30 2013-11-12 Novozymes A/S Polypeptides having beta-glucosidase activity and polynucleotides encoding same
MX2013001540A (en) 2010-08-12 2013-04-24 Novozymes Inc Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof.
US20130111677A1 (en) 2010-08-30 2013-05-09 Novozymes A/S Concentrated Soak Wash
BR112013003845A2 (en) 2010-08-30 2016-07-05 Novozymes As "two-immersion object cleaning method"
WO2012035103A1 (en) 2010-09-16 2012-03-22 Novozymes A/S Lysozymes
CN107345226A (en) 2010-09-30 2017-11-14 诺维信股份有限公司 Polypeptide variants and its coded polynucleotide with cellulolytic enhancing activity
ES2594528T3 (en) 2010-09-30 2016-12-20 Novozymes, Inc. Variants of polypeptides with cellulolytic enhancement activity and polynucleotides that encode them
WO2012049033A1 (en) 2010-10-14 2012-04-19 Unilever Plc Top-loading laundry vessel method
BR112013009131B1 (en) 2010-10-14 2018-06-12 Unilever N.V. PACKED PRODUCT
PH12013500621A1 (en) 2010-10-14 2013-05-06 Unilever Ip Holdings B V Packaged particulate detergent composition
WO2012049034A1 (en) 2010-10-14 2012-04-19 Unilever Plc Packaging and dispensing of detergent compositions
ES2591003T3 (en) 2010-10-14 2016-11-24 Unilever N.V. Package comprising a composition for laundry and washing procedure using said package
PH12013500623A1 (en) 2010-10-14 2017-07-28 Unilever Ip Holdings B V Laundry detergent particle
EP2627749B1 (en) 2010-10-14 2015-03-04 Unilever PLC Laundry detergent particles
EP2441822A1 (en) 2010-10-14 2012-04-18 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Laundry detergent particles
WO2012049055A1 (en) 2010-10-14 2012-04-19 Unilever Plc Transparent packaging of detergent compositions
CN103201373B (en) 2010-10-14 2016-06-08 荷兰联合利华有限公司 Cloth-washing detergent granule
PL2627748T3 (en) 2010-10-14 2015-04-30 Unilever Nv Particulate detergent compositions containing a fluorescer
CN103154229B (en) 2010-10-14 2016-03-16 荷兰联合利华有限公司 The granular detergent composition of packaging
EP2441820A1 (en) 2010-10-14 2012-04-18 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Laundry detergent particles
AU2011315793B2 (en) 2010-10-14 2014-03-06 Unilever Plc Laundry detergent particles
WO2012049032A1 (en) 2010-10-14 2012-04-19 Unilever Plc Refill and refillable packages of concentrated particulate detergent compositions
IN2013MN00624A (en) 2010-10-14 2015-06-12 Unilever Plc
EP2627754B1 (en) 2010-10-14 2016-11-30 Unilever PLC Laundry detergent particles
MY162810A (en) 2010-10-14 2017-07-14 Unilever Nv Laundry detergent particles
EP2441825A1 (en) 2010-10-14 2012-04-18 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Process for preparing laundry detergent particles
BR112013009456B1 (en) 2010-10-22 2021-11-30 Unilever Ip Holdings B.V. STRUCTURED AQUEOUS LIQUID DETERGENT COMPOSITION AND PROCESS TO MANUFACTURE A STRUCTURED AQUEOUS LIQUID DETERGENT
EP2640833B1 (en) 2010-11-18 2016-08-24 Novozymes, Inc. Chimeric polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
WO2012078656A1 (en) 2010-12-06 2012-06-14 Novozymes North America, Inc. Methods of hydrolyzing oligomers in hemicellulosic liquor
DE102010063457A1 (en) 2010-12-17 2012-06-21 Henkel Ag & Co. Kgaa Storage stable liquid washing or cleaning agent containing protease and cellulase
DE102010063743A1 (en) 2010-12-21 2012-06-21 Henkel Ag & Co. Kgaa Liquid surfactant preparation containing lipase and phosphonate
US8802423B2 (en) 2010-12-30 2014-08-12 Novozymes A/S Method for treating textile with endoglucanase
CN103429736A (en) * 2010-12-30 2013-12-04 诺维信公司 Method for treating textile with endoglucanase
WO2012098046A1 (en) 2011-01-17 2012-07-26 Unilever Plc Dye polymer for laundry treatment
WO2012103322A1 (en) 2011-01-26 2012-08-02 Novozymes A/S Polypeptides having endoglucanase activity and polynucleotides encoding same
DK2668267T3 (en) 2011-01-26 2018-01-29 Novozymes Inc POLYPEPTIDES WITH CELLOBIO HYDROASE ACTIVITY AND POLYNUCLEOTIDES CODING THEM
PH12013501439A1 (en) 2011-01-31 2019-09-02 Unilever Nv Alkaline liquid detergent compositions
BR112013019324B1 (en) 2011-01-31 2021-06-08 Novozymes North America, Inc processes for enzymatic refinement of a pretreated cellulosic material
WO2012112718A1 (en) 2011-02-15 2012-08-23 Novozymes Biologicals, Inc. Mitigation of odor in cleaning machines and cleaning processes
JP2014511409A (en) 2011-02-16 2014-05-15 ノボザイムス アクティーゼルスカブ Detergent composition containing metalloprotease
CN103476916A (en) 2011-02-16 2013-12-25 诺维信公司 Detergent compositions comprising M7 or M35 metalloproteases
EP2675883A2 (en) 2011-02-16 2013-12-25 Novozymes A/S Detergent compositions comprising metalloproteases
WO2012113340A1 (en) 2011-02-23 2012-08-30 Novozymes Inc. Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
BR112013022989A2 (en) 2011-03-10 2016-12-06 Unilever Nv dye polymer, laundry treatment composition and domestic method of treating a textile material
WO2012130492A1 (en) 2011-03-25 2012-10-04 Unilever Plc Dye polymer
DK2689011T3 (en) 2011-03-25 2018-01-22 Novozymes As PROCEDURE FOR DEGRADATION OR CONVERSION OF CELLULOSE-SUBSTANCING MATERIAL
WO2012135659A2 (en) 2011-03-31 2012-10-04 Novozymes A/S Methods for enhancing the degradation or conversion of cellulosic material
ES2421162T3 (en) 2011-04-04 2013-08-29 Unilever Nv Fabric washing procedure
MX2013011617A (en) 2011-04-08 2013-11-21 Danisco Us Inc Compositions.
DE102011007313A1 (en) 2011-04-13 2012-10-18 Henkel Ag & Co. Kgaa expression methods
DE102011007695A1 (en) 2011-04-19 2012-10-25 Henkel Ag & Co. Kgaa Phosphate-free dishwashing detergent
MX2013011827A (en) 2011-04-29 2014-01-08 Novozymes Inc Methods for enhancing the degradation or conversion of cellulosic material.
EP2522714A1 (en) 2011-05-13 2012-11-14 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Aqueous concentrated laundry detergent compositions
BR112013028716A2 (en) 2011-05-13 2017-01-24 Unilever Nv aqueous concentrated liquid laundry detergent, composition, method of washing polyester fabrics and their use
EP2522715A1 (en) 2011-05-13 2012-11-14 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Aqueous concentrated laundry detergent compositions
EP2714878B2 (en) 2011-05-26 2021-06-02 Unilever PLC, a company registered in England and Wales under company no. 41424 Liquid laundry composition
DE102011118032A1 (en) 2011-05-31 2012-12-06 Henkel Ag & Co. Kgaa Expression vectors for improved protein secretion
EP4134424A1 (en) 2011-06-01 2023-02-15 Unilever IP Holdings B.V. Liquid detergent composition containing dye polymer
EP2537918A1 (en) 2011-06-20 2012-12-26 The Procter & Gamble Company Consumer products with lipase comprising coated particles
US10829721B2 (en) 2011-06-20 2020-11-10 Novozymes A/S Particulate composition
US20140206594A1 (en) 2011-06-24 2014-07-24 Martin Simon Borchert Polypeptides Having Protease Activity and Polynucleotides Encoding Same
KR20140041801A (en) 2011-06-30 2014-04-04 노보자임스 에이/에스 Method for screening alpha-amylases
RU2635355C2 (en) 2011-07-01 2017-11-13 Новозимс А/С Composition with stabilised subtitlisin
WO2013011071A1 (en) 2011-07-21 2013-01-24 Unilever Plc Liquid laundry composition
EP2551335A1 (en) 2011-07-25 2013-01-30 The Procter & Gamble Company Enzyme stabilized liquid detergent composition
JP2014531895A (en) 2011-08-15 2014-12-04 ノボザイムス アクティーゼルスカブ Polypeptide having cellulase activity and polynucleotide encoding the same
CN103764822B (en) 2011-08-19 2016-11-23 诺维信公司 Polypeptides with protease activity
US9670510B2 (en) 2011-09-13 2017-06-06 Novozymes A/S Methods of hydrolyzing and fermenting cellulosic material
WO2013041689A1 (en) 2011-09-22 2013-03-28 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
EP3572505A3 (en) 2011-10-28 2019-12-11 Danisco US Inc. Variant maltohexaose-forming alpha-amylase variants
CA2855451A1 (en) 2011-11-21 2013-08-15 Novozymes, Inc. Gh61 polypeptide variants and polynucleotides encoding same
CN103958657A (en) 2011-11-25 2014-07-30 诺维信公司 Subtilase variants and polynucleotides encoding same
DK2782592T3 (en) 2011-11-25 2017-06-19 Novozymes As Polypeptides with lysozyme activity and polynucleotides encoding them
WO2013087027A1 (en) 2011-12-16 2013-06-20 Novozymes, Inc. Polypeptides having laccase activity and polynucleotides encoding same
EP2607468A1 (en) 2011-12-20 2013-06-26 Henkel AG & Co. KGaA Detergent compositions comprising subtilase variants
WO2013092052A1 (en) 2011-12-20 2013-06-27 Unilever Plc Isotropic liquid detergents comprising soil release polymer
BR112014015030A2 (en) * 2011-12-20 2017-06-13 Codexis Inc endoflucanase variants 1b (eg1b)
WO2013092635A1 (en) 2011-12-20 2013-06-27 Novozymes A/S Subtilase variants and polynucleotides encoding same
WO2013096653A1 (en) 2011-12-22 2013-06-27 Danisco Us Inc. Compositions and methods comprising a lipolytic enzyme variant
WO2013096305A1 (en) 2011-12-22 2013-06-27 Danisco Us Inc. Variant alpha-amylases and methods of use, thereof
AU2012360992B2 (en) 2011-12-28 2018-08-09 Novozymes A/S Polypeptides having protease activity
JP2015507675A (en) 2011-12-29 2015-03-12 ノボザイムス アクティーゼルスカブ Detergent composition
ES2644007T3 (en) 2012-01-26 2017-11-27 Novozymes A/S Use of polypeptides with protease activity in animal feed and in detergents
DE102012201297A1 (en) 2012-01-31 2013-08-01 Basf Se expression methods
US10093911B2 (en) 2012-02-17 2018-10-09 Novozymes A/S Subtilisin variants and polynucleotides encoding same
ES2582608T3 (en) 2012-02-17 2016-09-14 Henkel Ag & Co. Kgaa Detergent compositions comprising subthylase variants
EP2639291A1 (en) 2012-03-13 2013-09-18 Unilever PLC Packaged particulate detergent composition
WO2013139702A1 (en) 2012-03-21 2013-09-26 Unilever Plc Laundry detergent particles
EP2831215B1 (en) 2012-03-29 2018-08-08 Novozymes A/S Use of enzymes for preparing water soluble films
BR112014021493B1 (en) 2012-04-03 2021-05-11 Unilever Ip Holdings B.V coated detergent particle and packaged detergent formulation
MX2014011527A (en) 2012-04-03 2015-01-16 Unilever Nv Laundry detergent particles.
MX2014011547A (en) 2012-04-03 2014-11-14 Unilever Nv Laundry detergent particles.
MY167809A (en) 2012-04-03 2018-09-26 Unilever Plc Laundry Detergent Particle
DE102012206571A1 (en) 2012-04-20 2013-10-24 Henkel Ag & Co. Kgaa Storage-stable washing or cleaning agent with increased cleaning performance
EP2841570B1 (en) 2012-04-23 2017-12-20 Novozymes A/S Polypeptides having glucuronyl esterase activity and polynucleotides encoding same
WO2013160025A1 (en) 2012-04-23 2013-10-31 Unilever Plc Structured aqueous liquid detergent
WO2013160248A2 (en) 2012-04-23 2013-10-31 Novozymes A/S Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same
WO2013163590A2 (en) 2012-04-27 2013-10-31 Novozymes, Inc. Gh61 polypeptide variants and polynucleotides encoding same
US9458441B2 (en) 2012-05-07 2016-10-04 Novozymes A/S Polypeptides having xanthan degrading activity and polynucleotides encoding same
MX2014013402A (en) 2012-05-11 2014-11-26 Danisco Inc Use of alpha-amylase from aspergillus clavatus for saccharification.
CN104302753A (en) 2012-05-16 2015-01-21 诺维信公司 Compositions comprising lipase and methods of use thereof
EP4026902B1 (en) 2012-06-08 2025-04-16 Danisco US Inc. Variant alpha amylases with enhanced activity on starch polymers
WO2013189802A1 (en) 2012-06-19 2013-12-27 Novozymes A/S Enzymatic reduction of hydroperoxides
WO2013189972A2 (en) 2012-06-20 2013-12-27 Novozymes A/S Use of polypeptides having protease activity in animal feed and detergents
US9328456B2 (en) 2012-08-16 2016-05-03 Novozymes A/S Method for treating textile with endoglucanase
CA2878988A1 (en) 2012-08-16 2014-02-20 Danisco Us Inc. Method of using alpha-amylase from aspergillus clavatus and pullulanase for saccharification
PT2885405T (en) * 2012-08-16 2019-07-19 Novozymes As Method for treating textile with endoglucanase
US9315791B2 (en) 2012-08-22 2016-04-19 Novozymes A/S Metalloproteases from alicyclobacillus
US20160145540A1 (en) 2012-08-22 2016-05-26 Novozymes A/S Detergent Compositions Comprising Metalloproteases
MX2015002211A (en) 2012-08-22 2015-05-08 Novozymes As Metalloprotease from exiguobacterium.
DE102012215107A1 (en) 2012-08-24 2014-02-27 Basf Se Solid dishwashing detergent with improved protease performance
EP2900799B1 (en) 2012-09-25 2016-11-02 Unilever PLC Laundry detergent particles
WO2014068083A1 (en) 2012-11-01 2014-05-08 Novozymes A/S Method for removal of dna
US20180112203A1 (en) 2012-11-20 2018-04-26 Danisco Us Inc. Amylase with maltogenic properties
WO2014086659A2 (en) 2012-12-06 2014-06-12 Ahmedabad Textile Industry's Research Association Method for enzymatical preparation of textiles
CN104837979B (en) 2012-12-07 2019-09-03 诺维信公司 Prevent bacterial adhesion
CA2893270C (en) 2012-12-11 2024-01-02 Danisco Us Inc. Trichoderma reesei host cells expressing a glucoamylase from aspergillus fumigatus and methods of use thereof
WO2014090940A1 (en) 2012-12-14 2014-06-19 Novozymes A/S Removal of skin-derived body soils
EP2931911A1 (en) 2012-12-14 2015-10-21 Danisco US Inc. Method of using alpha-amylase from aspergillus fumigatus and isoamylase for saccharification
US20160010128A1 (en) 2012-12-20 2016-01-14 Danisco Us Inc. Method of using alpha-amylase from aspergillus terreus and pullulanase for saccharification
DE102012224038A1 (en) 2012-12-20 2014-06-26 Henkel Ag & Co. Kgaa Enzyme-containing granular composition, used to prepare particulate washing/cleaning agents for textiles, carpets or natural fibers, comprises enzyme containing granular particles, and enzyme free granular particles with water-soluble salt
DK2935575T3 (en) 2012-12-21 2018-07-23 Danisco Us Inc ALPHA-amylase variants
WO2014099525A1 (en) 2012-12-21 2014-06-26 Danisco Us Inc. Paenibacillus curdlanolyticus amylase, and methods of use, thereof
US9551042B2 (en) 2012-12-21 2017-01-24 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
US9902946B2 (en) 2013-01-03 2018-02-27 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
MX2015010348A (en) * 2013-02-14 2015-10-29 Novozymes As Industrial and institutional laundering using multi-enzyme compositions.
WO2014164800A1 (en) 2013-03-11 2014-10-09 Danisco Us Inc. Alpha-amylase combinatorial variants
EP2970830B1 (en) 2013-03-14 2017-12-13 Novozymes A/S Enzyme and inhibitor contained in water-soluble films
EP2976416B1 (en) 2013-03-21 2018-05-16 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2014177709A1 (en) 2013-05-03 2014-11-06 Novozymes A/S Microencapsulation of detergent enzymes
MY192746A (en) 2013-05-14 2022-09-06 Novozymes As Detergent compositions
WO2014183921A1 (en) 2013-05-17 2014-11-20 Novozymes A/S Polypeptides having alpha amylase activity
EP3786269A1 (en) 2013-06-06 2021-03-03 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
PE20160799A1 (en) 2013-06-12 2016-09-03 Earth Alive Clean Tech Inc DUST SUPPRESSOR
WO2014200658A1 (en) 2013-06-13 2014-12-18 Danisco Us Inc. Alpha-amylase from promicromonospora vindobonensis
WO2014200656A1 (en) 2013-06-13 2014-12-18 Danisco Us Inc. Alpha-amylase from streptomyces umbrinus
WO2014200657A1 (en) 2013-06-13 2014-12-18 Danisco Us Inc. Alpha-amylase from streptomyces xiamenensis
WO2014204596A1 (en) 2013-06-17 2014-12-24 Danisco Us Inc. Alpha-amylase from bacillaceae family member
WO2014207224A1 (en) 2013-06-27 2014-12-31 Novozymes A/S Subtilase variants and polynucleotides encoding same
RU2016102045A (en) 2013-06-27 2017-08-01 Новозимс А/С SUBTILASE OPTIONS AND THE POLYNUCLEOTIDES ENCODING THEM
JP2016523098A (en) 2013-07-04 2016-08-08 ノボザイムス アクティーゼルスカブ Polypeptide having anti-reattachment effect and polynucleotide encoding the same
US20160160196A1 (en) 2013-07-09 2016-06-09 Novozymes A/S Polypeptides with Lipase Activity And Polynucleotides Encoding Same
EP2824170B1 (en) 2013-07-12 2018-11-14 The Procter & Gamble Company Structured liquid compositions
ES2797483T3 (en) 2013-07-19 2020-12-02 Danisco Us Inc Compositions and Methods Comprising a Lipolytic Enzyme Variant
EP3339436B1 (en) 2013-07-29 2021-03-31 Henkel AG & Co. KGaA Detergent composition comprising protease variants
CN117904081A (en) 2013-07-29 2024-04-19 诺维信公司 Protease variants and polynucleotides encoding the same
US9926550B2 (en) 2013-07-29 2018-03-27 Novozymes A/S Protease variants and polynucleotides encoding same
US20160186102A1 (en) 2013-10-03 2016-06-30 Danisco Us Inc. Alpha-amylases from exiguobacterium, and methods of use, thereof
WO2015049370A1 (en) 2013-10-03 2015-04-09 Novozymes A/S Detergent composition and use of detergent composition
EP3060659B1 (en) 2013-10-03 2019-05-29 Danisco US Inc. Alpha-amylases from exiguobacterium, and methods of use, thereof
US20160272957A1 (en) 2013-11-20 2016-09-22 Danisco Us Inc. Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof
WO2015095046A1 (en) 2013-12-16 2015-06-25 E. I. Du Pont De Nemours And Company Use of poly alpha-1,3-glucan ethers as viscosity modifiers
AU2014364772B2 (en) 2013-12-18 2018-07-26 Nutrition & Biosciences USA 4, Inc. Cationic poly alpha-1,3-glucan ethers
WO2015094809A1 (en) 2013-12-19 2015-06-25 Danisco Us Inc. Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof
DE102013226835A1 (en) 2013-12-20 2015-06-25 Henkel Ag & Co. Kgaa Detergents or cleaners with reduced surfactant content
EP3083954B1 (en) 2013-12-20 2018-09-26 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
EP3097112B1 (en) 2014-01-22 2020-05-13 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
US20150232785A1 (en) 2014-02-14 2015-08-20 E I Du Pont De Nemours And Company Polysaccharides for viscosity modification
EP3114272A1 (en) 2014-03-05 2017-01-11 Novozymes A/S Compositions and methods for improving properties of cellulosic textile materials with xyloglucan endotransglycosylase
CN106062270A (en) 2014-03-05 2016-10-26 诺维信公司 Compositions and methods for improving the properties of non-cellulosic textile materials using endo-xyloglucan glycosyltransferases
US9695253B2 (en) 2014-03-11 2017-07-04 E I Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan
EP3521434A1 (en) 2014-03-12 2019-08-07 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
JP6340647B2 (en) 2014-03-13 2018-06-13 本田技研工業株式会社 Super thermostable cellobiohydrolase
WO2015150457A1 (en) 2014-04-01 2015-10-08 Novozymes A/S Polypeptides having alpha amylase activity
CA2943029C (en) 2014-04-11 2022-09-20 Novozymes A/S Detergent composition
CN106715465B (en) 2014-04-15 2021-10-08 诺维信公司 Polypeptides with lipase activity and polynucleotides encoding them
WO2015181118A1 (en) 2014-05-27 2015-12-03 Novozymes A/S Methods for producing lipases
US10023852B2 (en) 2014-05-27 2018-07-17 Novozymes A/S Lipase variants and polynucleotides encoding same
EP3155097A1 (en) 2014-06-12 2017-04-19 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US9771548B2 (en) 2014-06-19 2017-09-26 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US10626388B2 (en) 2014-07-04 2020-04-21 Novozymes A/S Subtilase variants and polynucleotides encoding same
EP3878960A1 (en) 2014-07-04 2021-09-15 Novozymes A/S Subtilase variants and polynucleotides encoding same
CN107207999B (en) 2014-09-18 2019-09-27 荷兰联合利华有限公司 whitening composition
FI127093B (en) 2014-10-27 2017-11-15 Ab Enzymes Oy Fungal endoglucanase variants, preparation and use thereof
WO2016079110A2 (en) 2014-11-19 2016-05-26 Novozymes A/S Use of enzyme for cleaning
WO2016079305A1 (en) 2014-11-20 2016-05-26 Novozymes A/S Alicyclobacillus variants and polynucleotides encoding same
MX2017006695A (en) 2014-12-04 2017-08-21 Novozymes As SUBTILASS AND POLYNUCLEOTID VARIANTS CODING THEM.
WO2016087401A1 (en) 2014-12-05 2016-06-09 Novozymes A/S Lipase variants and polynucleotides encoding same
DE102014225475A1 (en) 2014-12-10 2016-06-16 Henkel Ag & Co. Kgaa Washing or cleaning agent with special a-amylase and defined viscosity
DE102014225478A1 (en) 2014-12-10 2016-06-16 Henkel Ag & Co. Kgaa Washing or cleaning agent with special a-amylase and defined water activity aw
EP3234121A1 (en) 2014-12-15 2017-10-25 Henkel AG & Co. KGaA Detergent composition comprising subtilase variants
US20180000076A1 (en) 2014-12-16 2018-01-04 Novozymes A/S Polypeptides Having N-Acetyl Glucosamine Oxidase Activity
DE102014226293A1 (en) 2014-12-17 2016-06-23 Henkel Ag & Co. Kgaa Detergent with improved stain removal
WO2016097352A1 (en) 2014-12-19 2016-06-23 Novozymes A/S Protease variants and polynucleotides encoding same
CN107002061A (en) 2014-12-19 2017-08-01 诺维信公司 Protease variants and polynucleotides encoding them
DE102014226681A1 (en) 2014-12-19 2016-06-23 Henkel Ag & Co. Kgaa Liquid surfactant composition with special surfactant combination and enzyme
CN107109307B (en) 2015-01-09 2020-04-17 荷兰联合利华有限公司 Laundry treatment compositions comprising dyes
US10487296B2 (en) 2015-02-13 2019-11-26 Conopco, Inc. Laundry liquid composition
BR112017019942A2 (en) 2015-04-02 2018-06-12 Unilever Nv liquid laundry detergent composition and polymer release for dirt release
WO2016162507A1 (en) 2015-04-08 2016-10-13 Novozymes A/S Process for extraction of palm oil using enzymes
WO2016162510A1 (en) 2015-04-08 2016-10-13 Novozymes A/S Process for extraction of palm oil using enzymes
WO2016162558A1 (en) 2015-04-10 2016-10-13 Novozymes A/S Detergent composition
CN107567489A (en) 2015-04-10 2018-01-09 诺维信公司 The purposes of laundry process, DNA enzymatic and detergent composition
CN104789543B (en) * 2015-04-25 2017-11-07 上海康地恩生物科技有限公司 A kind of color protection cellulase and its mutant
US10336971B2 (en) 2015-05-19 2019-07-02 Novozymes A/S Odor reduction
CN107995923B (en) 2015-06-01 2021-11-02 营养与生物科学美国4公司 Structured liquid composition comprising colloidal dispersion of poly alpha-1,3-glucan
EP3310908B1 (en) 2015-06-16 2020-08-05 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
CN107922095A (en) 2015-06-17 2018-04-17 诺维信公司 Container
US11162089B2 (en) 2015-06-18 2021-11-02 Novozymes A/S Subtilase variants and polynucleotides encoding same
EP3106508B1 (en) 2015-06-18 2019-11-20 Henkel AG & Co. KGaA Detergent composition comprising subtilase variants
CN107922896A (en) 2015-06-30 2018-04-17 诺维信公司 Laundry detergent composition, for washing method and composition purposes
EP3317407B1 (en) 2015-07-01 2021-05-19 Novozymes A/S Methods of reducing odor
CN114292829A (en) 2015-07-06 2022-04-08 诺维信公司 Lipase variants and polynucleotides encoding them
DE102015215158A1 (en) 2015-08-07 2017-02-09 Henkel Ag & Co. Kgaa New, whiteness-enhancing detergent
DE102015215160A1 (en) 2015-08-07 2017-02-09 Henkel Ag & Co. Kgaa New whitening-enhancing detergent
DE102015215163A1 (en) 2015-08-07 2017-02-09 Henkel Ag & Co. Kgaa Detergent with ironing aid
DE102015215591A1 (en) 2015-08-14 2017-02-16 Henkel Ag & Co. Kgaa Low-water, two-phase liquid detergent with acidic pH
US20190016996A1 (en) 2015-08-28 2019-01-17 Conopco, Inc., D/B/A Unilever Liquid detergency composition comprising lipase and protease
CA2991114A1 (en) 2015-09-17 2017-03-23 Novozymes A/S Polypeptides having xanthan degrading activity and polynucleotides encoding same
ES2794837T3 (en) 2015-09-17 2020-11-19 Henkel Ag & Co Kgaa Detergent Compositions Comprising Polypeptides Having Xanthan Degrading Activity
WO2017060505A1 (en) 2015-10-07 2017-04-13 Novozymes A/S Polypeptides
US20180171318A1 (en) 2015-10-14 2018-06-21 Novozymes A/S Polypeptides Having Protease Activity and Polynucleotides Encoding Same
EP3362556B1 (en) 2015-10-14 2024-07-10 Novozymes A/S Polypeptide variants
US10675589B2 (en) 2015-10-14 2020-06-09 Novozymes A/S Cleaning of water filtration membranes
MX388896B (en) 2015-10-28 2025-03-20 Novozymes As DETERGENT COMPOSITION INCLUDING VARIANTS OF AMYLASE AND PROTEASE.
WO2017083229A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
US10876074B2 (en) 2015-11-13 2020-12-29 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
WO2017083228A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
EP3380608A1 (en) 2015-11-24 2018-10-03 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
EP3384019B1 (en) 2015-12-01 2020-06-24 Novozymes A/S Methods for producing lipases
JP2018537099A (en) 2015-12-07 2018-12-20 ノボザイムス アクティーゼルスカブ Polypeptides having beta-glucanase activity, polynucleotides encoding the same, and their use in cleaning compositions and in detergent compositions
EP3387124B1 (en) 2015-12-09 2021-05-19 Danisco US Inc. Alpha-amylase combinatorial variants
MX2018007067A (en) 2015-12-09 2018-08-01 Basf Se Method of purifying a protein from fermentation solids under desorbing conditions.
EP3397061A1 (en) 2015-12-28 2018-11-07 Novozymes BioAG A/S Heat priming of bacterial spores
CA3006607A1 (en) 2015-12-30 2017-07-06 Novozymes A/S Enzyme variants and polynucleotides encoding the same
EP3190167B1 (en) 2016-01-07 2018-06-06 Unilever PLC Bitter pill
EP3402868B1 (en) 2016-01-15 2020-04-08 Unilever PLC Laundry treatment composition
JP2019504625A (en) 2016-01-29 2019-02-21 ノボザイムス アクティーゼルスカブ β-glucanase variant and polynucleotide encoding the same
WO2017133879A1 (en) 2016-02-04 2017-08-10 Unilever Plc Detergent liquid
EP3417040B1 (en) 2016-02-17 2019-09-04 Unilever PLC Whitening composition
WO2017140391A1 (en) 2016-02-17 2017-08-24 Unilever Plc Whitening composition
BR112018068068B1 (en) 2016-03-21 2023-04-18 Unilever Ip Holdings B.V. LIQUID AQUEOUS COMPOSITION OF DETERGENT FOR WASHING CLOTHES AND DOMESTIC METHOD OF TREATMENT OF A FABRIC
BR112018069220A2 (en) 2016-03-23 2019-01-22 Novozymes As use of polypeptide that has dnase activity for tissue treatment
WO2017173190A2 (en) 2016-04-01 2017-10-05 Danisco Us Inc. Alpha-amylases, compositions & methods
WO2017173324A2 (en) 2016-04-01 2017-10-05 Danisco Us Inc. Alpha-amylases, compositions & methods
EP3440180B1 (en) 2016-04-08 2020-11-11 Novozymes A/S Detergent compositions and uses of the same
AU2017253501B2 (en) 2016-04-22 2022-01-20 Novozymes A/S Enzyme assisted palm oil extraction with continuous sterilizer
MY197025A (en) 2016-04-22 2023-05-22 Novozymes As Use of phospholipase c in palm oil milling
EP3693449A1 (en) 2016-04-29 2020-08-12 Novozymes A/S Detergent compositions and uses thereof
EP3452497B1 (en) 2016-05-03 2021-02-17 Novozymes A/S Alpha-amylase variants and polynucleotides encoding the same
CN109312319B (en) 2016-05-09 2023-05-16 诺维信公司 Variant polypeptides with improved properties and uses thereof
CN109715792A (en) 2016-06-03 2019-05-03 诺维信公司 Subtilase variants and the polynucleotides that it is encoded
CN109312259A (en) 2016-06-09 2019-02-05 荷兰联合利华有限公司 laundry products
US11001787B2 (en) 2016-06-23 2021-05-11 Novozymes A/S Use of enzymes, composition and method for removing soil
CN109563495A (en) 2016-06-30 2019-04-02 诺维信公司 Lipase variants and compositions comprising surfactants and lipase variants
WO2018002261A1 (en) 2016-07-01 2018-01-04 Novozymes A/S Detergent compositions
CA3028535A1 (en) 2016-07-05 2018-01-11 Novozymes A/S Pectate lyase variants and polynucleotides encoding same
WO2018007573A1 (en) 2016-07-08 2018-01-11 Novozymes A/S Detergent compositions with galactanase
CA3027272C (en) 2016-07-13 2022-06-21 The Procter & Gamble Company Bacillus cibi dnase variants and uses thereof
WO2018011242A1 (en) 2016-07-14 2018-01-18 Basf Se Fermentation medium comprising chelating agent
WO2018015295A1 (en) 2016-07-18 2018-01-25 Novozymes A/S Lipase variants, polynucleotides encoding same and the use thereof
DE102016213568A1 (en) 2016-07-25 2018-01-25 Henkel Ag & Co. Kgaa Polymers of vinylpyrrolidone and / or vinyl acetate as textilpflegende ingredients
DE102016213567A1 (en) 2016-07-25 2018-01-25 Henkel Ag & Co. Kgaa Propylene glycol esters as textilpflegende ingredients
DE102016213569A1 (en) 2016-07-25 2018-01-25 Henkel Ag & Co. Kgaa Acylglutamate as textilpflegende ingredients
CN109844110B (en) 2016-08-24 2023-06-06 诺维信公司 Xanthan gum lyase variants and polynucleotides encoding same
US11001827B2 (en) 2016-08-24 2021-05-11 Henkel Ag & Co. Kgaa Detergent compositions comprising xanthan lyase variants I
KR102507692B1 (en) 2016-08-24 2023-03-09 헨켈 아게 운트 코. 카게아아 Detergent composition comprising GH9 endoglucanase variant I
EP3504330A1 (en) 2016-08-24 2019-07-03 Novozymes A/S Gh9 endoglucanase variants and polynucleotides encoding same
DE102016216014A1 (en) 2016-08-25 2018-03-01 Henkel Ag & Co. Kgaa Method for evaluating cellulases for fiber care
CN110023474A (en) 2016-09-29 2019-07-16 诺维信公司 Purposes, washing methods and utensil washing composition of the enzyme for washing
US20190284647A1 (en) 2016-09-29 2019-09-19 Novozymes A/S Spore Containing Granule
CN109844083B (en) 2016-10-18 2021-11-09 联合利华知识产权控股有限公司 Whitening composition
US20210284933A1 (en) 2016-10-25 2021-09-16 Novozymes A/S Detergent compositions
CN110072986B (en) 2016-11-01 2023-04-04 诺维信公司 Multi-core particles
DE102016221849A1 (en) 2016-11-08 2018-05-09 Henkel Ag & Co. Kgaa A surfactant composition containing an amylase
BR112019010622A2 (en) 2016-12-01 2019-10-22 Basf Se composition, methods for preparing the composition, removing stains and cleaning, microcapsule, and use of pentane-1,2-diol.
US20190292493A1 (en) 2016-12-12 2019-09-26 Novozymes A/S Use of polypeptides
CN110023469A (en) 2016-12-15 2019-07-16 荷兰联合利华有限公司 Laundry detergent composition
US10047321B2 (en) 2016-12-22 2018-08-14 Henkel Ag & Co. Kgaa Liquid surfactant compositions having a modified oxo-alcohol derivative
US10385291B2 (en) 2016-12-22 2019-08-20 Henkel Ag & Co. Kgaa Liquid surfactant compositions and associated methods
ES2969518T3 (en) 2017-02-13 2024-05-21 Unilever Ip Holdings B V Garment washing system
GB201705186D0 (en) * 2017-03-31 2017-05-17 Innovia Films Ltd Fibre
WO2018177936A1 (en) 2017-03-31 2018-10-04 Novozymes A/S Polypeptides having dnase activity
EP3601550A1 (en) 2017-03-31 2020-02-05 Novozymes A/S Polypeptides having dnase activity
WO2018177203A1 (en) 2017-03-31 2018-10-04 Novozymes A/S Polypeptides having dnase activity
CN110651039A (en) 2017-03-31 2020-01-03 诺维信公司 Polypeptides with RNase activity
CA3057713A1 (en) 2017-03-31 2018-10-04 Danisco Us Inc Alpha-amylase combinatorial variants
EP3607040A1 (en) 2017-04-04 2020-02-12 Novozymes A/S Polypeptide compositions and uses thereof
US20200109354A1 (en) 2017-04-04 2020-04-09 Novozymes A/S Polypeptides
WO2018185181A1 (en) 2017-04-04 2018-10-11 Novozymes A/S Glycosyl hydrolases
EP3385362A1 (en) 2017-04-05 2018-10-10 Henkel AG & Co. KGaA Detergent compositions comprising fungal mannanases
DK3385361T3 (en) 2017-04-05 2019-06-03 Ab Enzymes Gmbh Detergent compositions comprising bacterial mannanases
US20200032170A1 (en) 2017-04-06 2020-01-30 Novozymes A/S Cleaning compositions and uses thereof
US10968416B2 (en) 2017-04-06 2021-04-06 Novozymes A/S Cleaning compositions and uses thereof
CN110709499A (en) 2017-04-06 2020-01-17 诺维信公司 Cleaning composition and use thereof
EP3607038A1 (en) 2017-04-06 2020-02-12 Novozymes A/S Cleaning compositions and uses thereof
US11499121B2 (en) 2017-04-06 2022-11-15 Novozymes A/S Detergent compositions and uses thereof
WO2018184818A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
CN110662829B (en) 2017-04-06 2022-03-01 诺维信公司 Cleaning compositions and their uses
EP3607043A1 (en) 2017-04-06 2020-02-12 Novozymes A/S Cleaning compositions and uses thereof
WO2018202846A1 (en) 2017-05-05 2018-11-08 Novozymes A/S Compositions comprising lipase and sulfite
EP3622064B1 (en) 2017-05-08 2025-05-14 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP3401385A1 (en) 2017-05-08 2018-11-14 Henkel AG & Co. KGaA Detergent composition comprising polypeptide comprising carbohydrate-binding domain
WO2018206535A1 (en) 2017-05-08 2018-11-15 Novozymes A/S Carbohydrate-binding domain and polynucleotides encoding the same
EP4570894A3 (en) 2017-05-08 2025-09-03 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP3412761A1 (en) 2017-06-07 2018-12-12 Henkel AG & Co. KGaA Anti-pilling laundry sheet
WO2018234056A1 (en) 2017-06-20 2018-12-27 Unilever N.V. PARTICULATE DETERGENT COMPOSITION COMPRISING A FRAGRANCE
WO2018234003A1 (en) 2017-06-21 2018-12-27 Unilever Plc PACKAGING AND DISTRIBUTION OF DETERGENT COMPOSITIONS
US20200181542A1 (en) 2017-06-30 2020-06-11 Novozymes A/S Enzyme Slurry Composition
CN110892053A (en) 2017-07-07 2020-03-17 荷兰联合利华有限公司 Laundry cleaning compositions
CN110869480B (en) 2017-07-07 2021-08-13 联合利华知识产权控股有限公司 whitening composition
CN111032856A (en) 2017-08-07 2020-04-17 诺维信公司 Use of FCA control based on pH
MX2020001606A (en) 2017-08-18 2020-08-03 Danisco Us Inc Alpha-amylase variants.
US20210130744A1 (en) 2017-08-24 2021-05-06 Henkel Ag & Co. Kgaa Detergent composition comprising xanthan lyase variants ii
CA3070749A1 (en) 2017-08-24 2019-02-28 Novozymes A/S Gh9 endoglucanase variants and polynucleotides encoding same
WO2019038186A1 (en) 2017-08-24 2019-02-28 Unilever Plc Improvements relating to fabric cleaning
WO2019038059A1 (en) 2017-08-24 2019-02-28 Henkel Ag & Co. Kgaa Detergent compositions comprising gh9 endoglucanase variants ii
WO2019038057A1 (en) 2017-08-24 2019-02-28 Novozymes A/S Xanthan lyase variants and polynucleotides encoding same
WO2019038187A1 (en) 2017-08-24 2019-02-28 Unilever Plc Improvements relating to fabric cleaning
DE102017215015A1 (en) 2017-08-28 2019-02-28 Henkel Ag & Co. Kgaa Method for improved expression of enzymes
WO2019057758A1 (en) 2017-09-20 2019-03-28 Novozymes A/S Use of enzymes for improving water absorption and/or whiteness
US11414814B2 (en) 2017-09-22 2022-08-16 Novozymes A/S Polypeptides
BR112020006224A2 (en) 2017-09-27 2020-10-13 Novozymes A/S lipase variants and microcapsule compositions comprising such lipase variants
CN111108195A (en) 2017-09-27 2020-05-05 宝洁公司 Detergent compositions comprising lipase
GB2567010A (en) 2017-10-02 2019-04-03 Univ Strathclyde Apparatus for the rehabilitation, assistance and/or augmentation of arm strength in a user
WO2019068713A1 (en) 2017-10-02 2019-04-11 Novozymes A/S Polypeptides having mannanase activity and polynucleotides encoding same
BR112020006621A2 (en) 2017-10-02 2020-10-06 Novozymes A/S polypeptides with mannanase activity and polynucleotides encoding the same
WO2019076833A1 (en) 2017-10-16 2019-04-25 Novozymes A/S Low dusting granules
WO2019076834A1 (en) 2017-10-16 2019-04-25 Novozymes A/S Low dusting granules
WO2019076800A1 (en) 2017-10-16 2019-04-25 Novozymes A/S Cleaning compositions and uses thereof
US11866748B2 (en) 2017-10-24 2024-01-09 Novozymes A/S Compositions comprising polypeptides having mannanase activity
EP3476936B1 (en) 2017-10-27 2022-02-09 The Procter & Gamble Company Detergent compositions comprising polypeptide variants
WO2019081724A1 (en) 2017-10-27 2019-05-02 Novozymes A/S Dnase variants
WO2019086530A1 (en) 2017-11-01 2019-05-09 Novozymes A/S Polypeptides and compositions comprising such polypeptides
DE102017125559A1 (en) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa CLEANSING COMPOSITIONS CONTAINING DISPERSINE II
DE102017125558A1 (en) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa CLEANING COMPOSITIONS CONTAINING DISPERSINE I
EP3704220A1 (en) 2017-11-01 2020-09-09 Novozymes A/S Methods for cleaning medical devices
US20200291330A1 (en) 2017-11-01 2020-09-17 Novozymes A/S Polypeptides and Compositions Comprising Such Polypeptides
DE102017125560A1 (en) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa CLEANSING COMPOSITIONS CONTAINING DISPERSINE III
MX2020004831A (en) 2017-11-09 2020-10-16 Basf Se Coatings of enzyme particles comprising organic white pigments.
EP3717616B1 (en) 2017-11-30 2021-10-13 Unilever IP Holdings B.V. Detergent composition comprising protease
US11725197B2 (en) 2017-12-04 2023-08-15 Novozymes A/S Lipase variants and polynucleotides encoding same
EP3728579A4 (en) * 2017-12-21 2021-12-01 AB Enzymes Oy VARIANTS OF MUSHROOM CELLULASE
US10570383B2 (en) 2017-12-21 2020-02-25 Ab Enzymes Oy Variants of fungal cellulase
CN113717864B (en) * 2018-01-30 2023-03-31 青岛蔚蓝生物集团有限公司 Cellulase high-yield strain and application thereof
EP3749761A1 (en) 2018-02-08 2020-12-16 Novozymes A/S Lipases, lipase variants and compositions thereof
EP3749758A1 (en) 2018-02-08 2020-12-16 Novozymes A/S Lipase variants and compositions thereof
WO2019162000A1 (en) 2018-02-23 2019-08-29 Henkel Ag & Co. Kgaa Detergent composition comprising xanthan lyase and endoglucanase variants
CN111770788B (en) 2018-03-13 2023-07-25 诺维信公司 Microencapsulation using amino sugar oligomers
CN111868328A (en) * 2018-03-15 2020-10-30 巴克曼实验室国际公司 Method and system for producing commercial pulp and products thereof
EP3768835A1 (en) 2018-03-23 2021-01-27 Novozymes A/S Subtilase variants and compositions comprising same
US11535837B2 (en) 2018-03-29 2022-12-27 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP3781660A1 (en) 2018-04-17 2021-02-24 Novozymes A/S Polypeptides comprising carbohydrate binding activity in detergent compositions and their use in reducing wrinkles in textile or fabric
WO2019201785A1 (en) 2018-04-19 2019-10-24 Novozymes A/S Stabilized cellulase variants
CN112272701B (en) 2018-04-19 2024-05-14 诺维信公司 Stabilized cellulase variants
US11732250B2 (en) 2018-04-26 2023-08-22 Basf Se Lipase enzymes
WO2019219302A1 (en) 2018-05-17 2019-11-21 Unilever Plc Cleaning composition comprising rhamnolipid and alkyl ether carboxylate surfactants
CN112119147B (en) 2018-05-17 2023-09-29 联合利华知识产权控股有限公司 cleaning composition
CN112368363A (en) 2018-06-28 2021-02-12 诺维信公司 Detergent composition and use thereof
US20210071116A1 (en) 2018-06-29 2021-03-11 Novozymes A/S Detergent Compositions and Uses Thereof
WO2020002255A1 (en) 2018-06-29 2020-01-02 Novozymes A/S Subtilase variants and compositions comprising same
EP3818139A1 (en) 2018-07-02 2021-05-12 Novozymes A/S Cleaning compositions and uses thereof
WO2020007875A1 (en) 2018-07-03 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
WO2020008024A1 (en) 2018-07-06 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
WO2020008043A1 (en) 2018-07-06 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
EP3824057B1 (en) 2018-07-17 2023-10-18 Unilever Global IP Limited Use of a rhamnolipid in a surfactant system
EP3775137A1 (en) 2018-07-27 2021-02-17 Unilever N.V. Laundry detergent
JP7530884B2 (en) 2018-07-31 2024-08-08 ダニスコ・ユーエス・インク Mutant alpha-amylases with amino acid substitutions that reduce general acid PKA
BR112021004507A2 (en) 2018-09-17 2021-06-08 Unilever Ip Holdings B.V. detergent composition, method of treating a substrate with a detergent composition and use of a bacterial lipase enzyme
WO2020070063A2 (en) 2018-10-01 2020-04-09 Novozymes A/S Detergent compositions and uses thereof
WO2020070014A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition comprising anionic surfactant and a polypeptide having rnase activity
WO2020070209A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition
EP3861094A1 (en) 2018-10-02 2021-08-11 Novozymes A/S Cleaning composition
US11993762B2 (en) 2018-10-03 2024-05-28 Novozymes A/S Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same
WO2020070249A1 (en) 2018-10-03 2020-04-09 Novozymes A/S Cleaning compositions
EP3864123A1 (en) 2018-10-09 2021-08-18 Novozymes A/S Cleaning compositions and uses thereof
WO2020074498A1 (en) 2018-10-09 2020-04-16 Novozymes A/S Cleaning compositions and uses thereof
DE102018217393A1 (en) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Detergent composition with catechol metal complex compound
CN112996894A (en) 2018-10-11 2021-06-18 诺维信公司 Cleaning composition and use thereof
DE102018217392A1 (en) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Multi-component detergent with catechol metal complex
DE102018217397A1 (en) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Use of transition metal-free tinting dyes in combination with catechol derivatives
DE102018217398A1 (en) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Liquid detergent with dihydroxy terephthalic acid diamide compound
DE102018217399A1 (en) 2018-10-11 2020-04-16 Henkel Ag & Co. Kgaa Liquid composition with dihydroxy terephthalic acid diamide compound and high amount of surfactant
CA3116128A1 (en) 2018-10-12 2020-04-16 Danisco Us Inc Alpha-amylases with mutations that improve stability in the presence of chelants
EP3647398B1 (en) 2018-10-31 2024-05-15 Henkel AG & Co. KGaA Cleaning compositions containing dispersins v
EP3647397A1 (en) 2018-10-31 2020-05-06 Henkel AG & Co. KGaA Cleaning compositions containing dispersins iv
BR112021009785A2 (en) 2018-11-20 2021-08-17 Unilever Ip Holdings B.V. detergent composition, method of treating a fabric substrate and use of an enzyme
BR112021009828A2 (en) 2018-11-20 2021-08-17 Unilever Ip Holdings B.V. liquid detergent composition, method of treating a fabric substrate and use of a sterol esterase enzyme
CN113056549B (en) 2018-11-20 2023-03-10 联合利华知识产权控股有限公司 detergent composition
WO2020104156A1 (en) 2018-11-20 2020-05-28 Unilever Plc Detergent composition
BR112021009789A2 (en) 2018-11-20 2021-08-17 Unilever Ip Holdings B.V. detergent composition, method of treating a fabric substrate and use of an esterase enzyme
CN113302270A (en) 2018-12-03 2021-08-24 诺维信公司 Low pH powder detergent compositions
CN113302295A (en) 2018-12-03 2021-08-24 诺维信公司 Powder detergent composition
EP3666872B1 (en) 2018-12-12 2021-08-11 Henkel AG & Co. KGaA Phosphonated acrylic copolymers for surface hydrophilization
EP3898962A2 (en) 2018-12-21 2021-10-27 Novozymes A/S Polypeptides having peptidoglycan degrading activity and polynucleotides encoding same
EP3898919A1 (en) 2018-12-21 2021-10-27 Novozymes A/S Detergent pouch comprising metalloproteases
CN113330102B (en) 2019-01-22 2023-06-02 联合利华知识产权控股有限公司 laundry detergent
CN113330103B (en) 2019-01-22 2023-05-16 联合利华知识产权控股有限公司 Laundry detergents
EP3702452A1 (en) 2019-03-01 2020-09-02 Novozymes A/S Detergent compositions comprising two proteases
WO2020188095A1 (en) 2019-03-21 2020-09-24 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
CN113785039B (en) 2019-04-03 2024-06-18 诺维信公司 Polypeptides having beta-glucanase activity, polynucleotides encoding the same, and their use in cleaning and detergent compositions
DE102019204792A1 (en) 2019-04-04 2020-10-08 Henkel Ag & Co. Kgaa Use of mannanase enzyme in combination with catechol derivatives
US12247237B2 (en) 2019-04-10 2025-03-11 Novozymes A/S Polypeptide variants
CN113795576A (en) 2019-04-12 2021-12-14 诺维信公司 Stabilized glycoside hydrolase variants
BR112021022167A2 (en) 2019-05-16 2022-01-18 Unilever Ip Holdings B V Laundry auxiliary composition, method of delivering enzymes to fabrics, method of enhancing the softening benefit of a fabric conditioner, and use of an auxiliary laundry composition
CN113874484A (en) 2019-05-16 2021-12-31 联合利华知识产权控股有限公司 Laundry compositions
US20220364022A1 (en) 2019-06-28 2022-11-17 Conopco, Inc., D/B/A Unilever Detergent composition
CN113891930A (en) 2019-06-28 2022-01-04 联合利华知识产权控股有限公司 Detergent composition
US20220372397A1 (en) 2019-06-28 2022-11-24 Conopco, Inc., D/B/A Unilever Detergent composition
WO2020259949A1 (en) 2019-06-28 2020-12-30 Unilever Plc Detergent composition
WO2020260006A1 (en) 2019-06-28 2020-12-30 Unilever Plc Detergent compositions
US20220364020A1 (en) 2019-06-28 2022-11-17 Conopco, Inc., D/B/A Unilever Detergent composition
MX2021015894A (en) 2019-07-01 2022-02-03 Basf Se Peptide acetals for stabilising enzymes.
EP3994255A1 (en) 2019-07-02 2022-05-11 Novozymes A/S Lipase variants and compositions thereof
US20220403298A1 (en) 2019-07-12 2022-12-22 Novozymes A/S Enzymatic emulsions for detergents
WO2021037895A1 (en) 2019-08-27 2021-03-04 Novozymes A/S Detergent composition
EP4022020A1 (en) 2019-08-27 2022-07-06 Novozymes A/S Composition comprising a lipase
AR119874A1 (en) 2019-09-02 2022-01-19 Unilever Nv COMPOSITION DETERGENT WITH A DERIVATIVE OF ESTER OF CITRIC ACID OF A MONOGLYCERIDE
US20220372399A1 (en) 2019-09-19 2022-11-24 Conopco, Inc., D/B/A Unilever Detergent compositions
CN114616312A (en) 2019-09-19 2022-06-10 诺维信公司 Detergent composition
WO2021064068A1 (en) 2019-10-03 2021-04-08 Novozymes A/S Polypeptides comprising at least two carbohydrate binding domains
AR120142A1 (en) 2019-10-07 2022-02-02 Unilever Nv DETERGENT COMPOSITION
US20220403359A1 (en) 2019-10-24 2022-12-22 Danisco Us Inc Variant maltopentaose/maltohexaose-forming alpha-amylases
WO2021105336A1 (en) 2019-11-29 2021-06-03 Basf Se Compositions comprising polymer and enzyme
US20220411726A1 (en) 2019-12-20 2022-12-29 Novozymes A/S Stabilized liquid boron-free enzyme compositions
US20230040230A1 (en) 2019-12-20 2023-02-09 Henkel Ag & Co. Kgaa Cleaning composition comprising a dispersin and a carbohydrase
EP4077656A2 (en) 2019-12-20 2022-10-26 Novozymes A/S Polypeptides having proteolytic activity and use thereof
KR20220119608A (en) 2019-12-20 2022-08-30 헨켈 아게 운트 코. 카게아아 Cleaning Composition Comprising Dispersin VIII
AU2020404593A1 (en) 2019-12-20 2022-08-18 Henkel Ag & Co. Kgaa Cleaning compositions comprising dispersins VI
CA3160579A1 (en) 2019-12-23 2021-07-01 Neil Joseph Lant Compositions comprising enzymes
WO2021130167A1 (en) 2019-12-23 2021-07-01 Novozymes A/S Enzyme compositions and uses thereof
EP4093842A1 (en) 2020-01-23 2022-11-30 Novozymes A/S Enzyme compositions and uses thereof
JP7731360B2 (en) 2020-01-31 2025-08-29 ノボザイムス アクティーゼルスカブ Mannanase variants and polynucleotides encoding same
US12497606B2 (en) 2020-01-31 2025-12-16 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP3892708A1 (en) 2020-04-06 2021-10-13 Henkel AG & Co. KGaA Cleaning compositions comprising dispersin variants
EP4133066A1 (en) 2020-04-08 2023-02-15 Novozymes A/S Carbohydrate binding module variants
EP4139431A1 (en) 2020-04-21 2023-03-01 Novozymes A/S Cleaning compositions comprising polypeptides having fructan degrading activity
WO2021249927A1 (en) 2020-06-08 2021-12-16 Unilever Ip Holdings B.V. Method of improving protease activity
WO2021259099A1 (en) 2020-06-24 2021-12-30 Novozymes A/S Use of cellulases for removing dust mite from textile
EP3936593A1 (en) 2020-07-08 2022-01-12 Henkel AG & Co. KGaA Cleaning compositions and uses thereof
PH12023550203A1 (en) 2020-07-27 2024-06-24 Unilever Ip Holdings B V Use of an enzyme and surfactant for inhibiting microorganisms
MX2023001888A (en) 2020-08-25 2023-03-10 Novozymes As VARIANTS OF A XYLOGLUCANASE FROM FAMILY 44.
WO2022043042A1 (en) 2020-08-28 2022-03-03 Unilever Ip Holdings B.V. Detergent composition
US20230287302A1 (en) 2020-08-28 2023-09-14 Conopco, Inc., D/B/A Unilever Detergent composition
US20230303951A1 (en) 2020-08-28 2023-09-28 Conopco, Inc., D/B/A Unilever Detergent composition
US20230287300A1 (en) 2020-08-28 2023-09-14 Conopco, Inc., D/B/A Unilever Surfactant and detergent composition
EP4204526B1 (en) 2020-08-28 2024-04-24 Unilever IP Holdings B.V. Surfactant and detergent composition
CN116096731A (en) 2020-09-22 2023-05-09 巴斯夫欧洲公司 Improved combinations of protease and protease inhibitor with a second enzyme
EP4225905A2 (en) 2020-10-07 2023-08-16 Novozymes A/S Alpha-amylase variants
WO2022084303A2 (en) 2020-10-20 2022-04-28 Novozymes A/S Use of polypeptides having dnase activity
JP2023547450A (en) 2020-10-29 2023-11-10 ノボザイムス アクティーゼルスカブ Lipase variants and compositions comprising such lipase variants
CN116670261A (en) 2020-11-13 2023-08-29 诺维信公司 Detergent composition comprising lipase
CN116529351A (en) 2020-12-07 2023-08-01 联合利华知识产权控股有限公司 Detergent composition
WO2022122481A1 (en) 2020-12-07 2022-06-16 Unilever Ip Holdings B.V. Detergent compositions
US20240002751A1 (en) 2020-12-17 2024-01-04 Conopco, Inc., D/B/A Unilever Cleaning composition
EP4263771B1 (en) 2020-12-17 2025-02-12 Unilever IP Holdings B.V. Use of a cleaning composition to improve cold cleaning performance
DE102021100563A1 (en) 2021-01-13 2022-07-14 Henkel Ag & Co. Kgaa COMPOSITION CONTAINING PERFUMES AND ENZYMES
EP4032966A1 (en) 2021-01-22 2022-07-27 Novozymes A/S Liquid enzyme composition with sulfite scavenger
EP4039806A1 (en) 2021-02-04 2022-08-10 Henkel AG & Co. KGaA Detergent composition comprising xanthan lyase and endoglucanase variants with im-proved stability
US20250075152A1 (en) 2021-02-12 2025-03-06 Novozymes A/S Stabilized biological detergents
CN116829709A (en) 2021-02-12 2023-09-29 诺维信公司 Alpha-amylase variants
EP4053256A1 (en) 2021-03-01 2022-09-07 Novozymes A/S Use of enzymes for improving fragrance deposition
WO2022189521A1 (en) 2021-03-12 2022-09-15 Novozymes A/S Polypeptide variants
EP4060036A1 (en) 2021-03-15 2022-09-21 Novozymes A/S Polypeptide variants
US20240060061A1 (en) 2021-03-15 2024-02-22 Novozymes A/S Dnase variants
CN117083370A (en) 2021-03-26 2023-11-17 诺维信公司 Detergent compositions with reduced polymer content
EP4347772A1 (en) 2021-05-25 2024-04-10 Unilever IP Holdings B.V. Laundry method
WO2022268885A1 (en) 2021-06-23 2022-12-29 Novozymes A/S Alpha-amylase polypeptides
KR20240027620A (en) 2021-06-30 2024-03-04 헨켈 아게 운트 코. 카게아아 Cleaning composition with improved anti-gray performance and/or anti-fluffing performance
WO2023274923A1 (en) 2021-06-30 2023-01-05 Henkel Ag & Co. Kgaa Composition with improved moisture management performance
EP4405450B1 (en) 2021-09-20 2025-01-29 Unilever IP Holdings B.V. Detergent composition
CN113684198B (en) * 2021-10-27 2022-02-25 中国农业科学院北京畜牧兽医研究所 Method for improving cellulase catalytic efficiency and mutant 5I77-M2
CN118647716A (en) 2021-12-16 2024-09-13 丹尼斯科美国公司 Maltopentaose/maltohexaose variant α-amylase
CN118871559A (en) 2021-12-21 2024-10-29 诺维信公司 Composition comprising lipase and a enhancer
EP4454213A1 (en) 2021-12-21 2024-10-30 Basf Se Chemical product passport
EP4206309A1 (en) 2021-12-30 2023-07-05 Novozymes A/S Protein particles with improved whiteness
CN118591614A (en) 2022-01-28 2024-09-03 联合利华知识产权控股有限公司 Laundry composition
CN118647704A (en) 2022-01-28 2024-09-13 联合利华知识产权控股有限公司 Laundry composition
EP4234664A1 (en) 2022-02-24 2023-08-30 Evonik Operations GmbH Composition comprising glucolipids and enzymes
EP4486859A1 (en) 2022-03-02 2025-01-08 Novozymes A/S Use of xyloglucanase for improvement of sustainability of detergents
EP4486876A1 (en) 2022-03-04 2025-01-08 Novozymes A/S Dnase variants and compositions
US20250207116A1 (en) 2022-04-08 2025-06-26 Novozymes A/S Hexosaminidase variants and compositions
AU2023272468A1 (en) 2022-05-14 2024-11-14 Novonesis Plant Biosolutions A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
WO2023227331A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Composition comprising a specific methyl ester ethoxylate surfactant and a lipase
CN119365577A (en) 2022-05-27 2025-01-24 联合利华知识产权控股有限公司 Compositions comprising enzymes
WO2023227335A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Liquid composition comprising linear alkyl benzene sulphonate, methyl ester ethoxylate and alkoxylated zwitterionic polyamine polymer
WO2023227332A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Laundry liquid composition comprising a surfactant, an alkoxylated zwitterionic polyamine polymer and a protease
EP4532662B8 (en) 2022-05-27 2025-10-29 Unilever IP Holdings B.V. Laundry liquid composition comprising a surfactant, an alkoxylated zwitterionic polyamine polymer, and a fragrance
CN119301230A (en) 2022-05-27 2025-01-10 联合利华知识产权控股有限公司 Laundry liquid composition comprising surfactant, aminocarboxylate, organic acid and perfume
DE102022205588A1 (en) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa DETERGENT AND CLEANING AGENTS WITH IMPROVED ENZYME STABILITY
DE102022205593A1 (en) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa DETERGENT AND CLEANING AGENTS WITH IMPROVED ENZYME STABILITY
DE102022205594A1 (en) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa PERFORMANCE-IMPROVED AND STORAGE-STABLE PROTEASE VARIANTS
DE102022205591A1 (en) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa DETERGENT AND CLEANING AGENTS WITH IMPROVED ENZYME STABILITY
WO2023247348A1 (en) 2022-06-21 2023-12-28 Novozymes A/S Mannanase variants and polynucleotides encoding same
US20250368924A1 (en) 2022-06-24 2025-12-04 Novozymes A/S Lipase variants and compositions comprising such lipase variants
WO2024028161A1 (en) 2022-08-04 2024-02-08 Unilever Ip Holdings B.V. Packaged homecare product
WO2024028159A1 (en) 2022-08-04 2024-02-08 Unilever Ip Holdings B.V. Packaged homecare product
WO2024028160A1 (en) 2022-08-04 2024-02-08 Unilever Ip Holdings B.V. Packaged homecare product
JP2025526738A (en) 2022-08-11 2025-08-15 ビーエーエスエフ ソシエタス・ヨーロピア Amylase variants
WO2024033136A1 (en) 2022-08-11 2024-02-15 Basf Se Amylase variants
EP4324900A1 (en) 2022-08-17 2024-02-21 Henkel AG & Co. KGaA Detergent composition comprising enzymes
WO2024046952A1 (en) 2022-08-30 2024-03-07 Novozymes A/S Improvements in or relating to organic compounds
EP4587546A1 (en) 2022-09-13 2025-07-23 Unilever IP Holdings B.V. Washing machine and washing method
EP4587545A1 (en) 2022-09-13 2025-07-23 Unilever IP Holdings B.V. Washing machine and washing method
WO2024056278A1 (en) 2022-09-13 2024-03-21 Unilever Ip Holdings B.V. Washing machine and washing method
WO2024056333A1 (en) 2022-09-13 2024-03-21 Unilever Ip Holdings B.V. Washing machine and washing method
EP4349944A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Laundry liquid composition
EP4349943A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Laundry liquid composition
EP4349948A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Laundry liquid composition
EP4349942A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Laundry liquid composition
EP4349946A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Unit dose fabric treatment product
EP4349947A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Laundry liquid composition
EP4349945A1 (en) 2022-10-05 2024-04-10 Unilever IP Holdings B.V. Laundry liquid composition
EP4361239A1 (en) 2022-10-25 2024-05-01 Unilever IP Holdings B.V. Laundry liquid composition
EP4608958A1 (en) 2022-10-25 2025-09-03 Unilever IP Holdings B.V. Composition
EP4608955A1 (en) 2022-10-25 2025-09-03 Unilever IP Holdings B.V. Composition
DE102022211482A1 (en) 2022-10-28 2024-05-08 Henkel Ag & Co. Kgaa Natural dye coloring with improved color intensity
CN120153068A (en) 2022-11-04 2025-06-13 巴斯夫欧洲公司 Polypeptides having protease activity for use in detergent compositions
EP4612285A1 (en) 2022-11-04 2025-09-10 Basf Se Polypeptides having protease activity for use in detergent compositions
CN120693402A (en) 2022-11-04 2025-09-23 巴斯夫欧洲公司 Polypeptides having protease activity for use in detergent compositions
DE102022211856A1 (en) 2022-11-09 2024-05-16 Henkel Ag & Co. Kgaa Two-stage dyeing process with natural dyes with improved color intensity
CN120202283A (en) 2022-11-29 2025-06-24 联合利华知识产权控股有限公司 Composition
DE102022131732A1 (en) 2022-11-30 2024-06-06 Henkel Ag & Co. Kgaa Improved washing performance through the use of a protease fused with a special adhesion promoter peptide
WO2024121057A1 (en) 2022-12-05 2024-06-13 Novozymes A/S A composition for removing body grime
EP4630528A1 (en) 2022-12-05 2025-10-15 Novozymes A/S Protease variants and polynucleotides encoding same
CN120265743A (en) 2022-12-14 2025-07-04 诺维信公司 Improved lipase (GCL1) variants
EP4389864A1 (en) 2022-12-20 2024-06-26 Basf Se Cutinases
KR20250130619A (en) 2022-12-23 2025-09-02 노보자임스 에이/에스 Detergent composition comprising catalase and amylase
DE102023200106A1 (en) 2023-01-10 2024-07-11 Henkel Ag & Co. Kgaa ENZYME-CONTAINING WASHING AND CLEANING AGENTS
CN120435539A (en) 2023-01-23 2025-08-05 诺维信公司 Cleaning compositions and uses thereof
EP4414443A1 (en) 2023-02-09 2024-08-14 Henkel AG & Co. KGaA Cleaning composition comprising polyesterase
DE102023201696A1 (en) 2023-02-24 2024-08-29 Henkel Ag & Co. Kgaa WASHING AND CLEANING PRODUCTS WITH DISPERSIN
DE102023201692A1 (en) 2023-02-24 2024-08-29 Henkel Ag & Co. Kgaa WASHING AND CLEANING PRODUCTS WITH DISPERSIN AND FRAGRANCE
DE102023201695A1 (en) 2023-02-24 2024-08-29 Henkel Ag & Co. Kgaa WASHING AND CLEANING PRODUCTS WITH DISPERSIN
CN120813673A (en) 2023-03-17 2025-10-17 联合利华知识产权控股有限公司 Composition
WO2024194098A1 (en) 2023-03-21 2024-09-26 Unilever Ip Holdings B.V. Detergent unit dose
EP4683990A1 (en) 2023-03-21 2026-01-28 Novozymes A/S Detergent compositions based on biosurfactants
CN120882844A (en) 2023-04-11 2025-10-31 联合利华知识产权控股有限公司 Composition
CN120835924A (en) 2023-04-11 2025-10-24 联合利华知识产权控股有限公司 Composition
CN121100170A (en) 2023-04-11 2025-12-09 联合利华知识产权控股有限公司 Composition
CN121358835A (en) 2023-04-11 2026-01-16 联合利华知识产权控股有限公司 Composition and method for producing the same
WO2024213428A1 (en) 2023-04-11 2024-10-17 Unilever Ip Holdings B.V. Composition
WO2024213513A1 (en) 2023-04-12 2024-10-17 Novozymes A/S Compositions comprising polypeptides having alkaline phosphatase activity
WO2024223218A1 (en) 2023-04-25 2024-10-31 Unilever Ip Holdings B.V. Composition
WO2024226828A2 (en) 2023-04-26 2024-10-31 Novozymes A/S Cleaning composition and cleaning method
EP4461796A1 (en) 2023-05-10 2024-11-13 Novozymes A/S Detergent composition comprising laccase
EP4461795A1 (en) 2023-05-10 2024-11-13 Novozymes A/S Detergent composition comprising laccase
WO2024231483A1 (en) 2023-05-11 2024-11-14 Novozymes A/S Automatic dishwashing detergent compositions comprising a lipase
WO2024250142A1 (en) 2023-06-05 2024-12-12 The Procter & Gamble Company Laundry detergent composition containing cellulase and graft copolymer
DE102023205632A1 (en) 2023-06-15 2024-12-19 Henkel Ag & Co. Kgaa PEPTIDES WITH DIRT-REMOVING EFFECT FOR WASHING AND CLEANING AGENTS
WO2025011933A1 (en) 2023-07-07 2025-01-16 Novozymes A/S Washing method for removing proteinaceous stains
DE24728530T1 (en) 2023-07-11 2025-11-27 Unilever Global Ip Limited METHOD FOR TISSUE TREATMENT
DE24732329T1 (en) 2023-07-11 2025-11-27 Unilever Global Ip Limited METHOD FOR TISSUE TREATMENT
WO2025012293A1 (en) 2023-07-13 2025-01-16 Unilever Ip Holdings B.V. Washing machine and method
WO2025016669A1 (en) 2023-07-19 2025-01-23 Unilever Ip Holdings B.V. Laundry capsule
WO2025026734A1 (en) 2023-08-02 2025-02-06 Unilever Ip Holdings B.V. Composition
WO2025031925A1 (en) 2023-08-04 2025-02-13 Unilever Ip Holdings B.V. Composition
WO2025031752A1 (en) 2023-08-04 2025-02-13 Unilever Ip Holdings B.V. Composition
WO2025036643A1 (en) 2023-08-15 2025-02-20 Evonik Operations Gmbh Biosurfactant for washing wool
EP4509589A1 (en) 2023-08-16 2025-02-19 Unilever IP Holdings B.V. Unit dose product
WO2025045955A1 (en) 2023-08-30 2025-03-06 Unilever Ip Holdings B.V. Solid laundry composition
WO2025088003A1 (en) 2023-10-24 2025-05-01 Novozymes A/S Use of xyloglucanase for replacement of optical brightener
WO2025093368A1 (en) 2023-11-02 2025-05-08 Basf Se Enzyme stabilization in compositions containing a protease inhibitor
DE102023211746A1 (en) 2023-11-24 2025-05-28 Henkel Ag & Co. Kgaa WASHING AND CLEANING AGENTS CONTAINING ANTIMICROBIAL PEPTIDE
WO2025114053A1 (en) 2023-11-30 2025-06-05 Novozymes A/S Biopolymers for use in detergent
DE102023212456A1 (en) 2023-12-11 2025-06-12 Henkel Ag & Co. Kgaa Improved textile care through detergents containing copolymers
EP4570890A1 (en) 2023-12-14 2025-06-18 Unilever IP Holdings B.V. Composition
WO2025124811A1 (en) 2023-12-14 2025-06-19 Unilever Ip Holdings B.V. Composition
WO2025132258A1 (en) 2023-12-20 2025-06-26 Basf Se Stabilized enzyme composition comprising a protease
WO2025129507A1 (en) 2023-12-20 2025-06-26 The Procter & Gamble Company Liquid detergent compositions
WO2025153644A1 (en) 2024-01-18 2025-07-24 Unilever Ip Holdings B.V. Composition
WO2025153645A1 (en) 2024-01-18 2025-07-24 Unilever Ip Holdings B.V. Use for fabric shape retention
WO2025153046A1 (en) 2024-01-19 2025-07-24 Novozymes A/S Detergent compositions and uses thereof
WO2025202369A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
EP4624572A1 (en) 2024-03-27 2025-10-01 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202374A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202379A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202370A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025202372A1 (en) 2024-03-27 2025-10-02 Basf Se Polypeptides having protease activity for use in detergent compositions
WO2025214659A1 (en) 2024-04-11 2025-10-16 Unilever Ip Holdings B.V. Washing method
WO2025214720A1 (en) 2024-04-11 2025-10-16 Unilever Ip Holdings B.V. Washing machine and washing method
WO2025257254A1 (en) 2024-06-12 2025-12-18 Novozymes A/S Lipases and lipase variants and the use thereof
EP4663737A1 (en) 2024-06-13 2025-12-17 Unilever IP Holdings B.V. Laundry unit dose product
EP4663738A1 (en) 2024-06-13 2025-12-17 Unilever IP Holdings B.V. Laundry unit dose product
EP4663729A1 (en) 2024-06-13 2025-12-17 Unilever IP Holdings B.V. Method for treating fabrics
EP4663728A1 (en) 2024-06-13 2025-12-17 Unilever IP Holdings B.V. Method for treating fabrics
WO2026012789A1 (en) 2024-07-08 2026-01-15 Unilever Ip Holdings B.V. Composition
WO2026012788A1 (en) 2024-07-08 2026-01-15 Unilever Ip Holdings B.V. Composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
US5520838A (en) * 1991-01-16 1996-05-28 The Procter & Gamble Company Compact detergent compositions with high activity cellulase
US5792641A (en) * 1992-10-06 1998-08-11 Novo Nordisk A/S Cellulase variants and detergent compositions containing cellulase variants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK16490D0 (en) 1990-01-19 1990-01-19 Novo Nordisk As ENZYME
WO1991017243A1 (en) * 1990-05-09 1991-11-14 Novo Nordisk A/S A cellulase preparation comprising an endoglucanase enzyme
DK115890D0 (en) 1990-05-09 1990-05-09 Novo Nordisk As ENZYME
EP0707640A4 (en) * 1993-07-07 2000-10-11 Biomolecular Res Inst Ltd (1 $ m (7) 3, 1 $ m (7) 4) - $ 9 (b) -GLUCANOX WITH INCREASED STABILITY
ES2251717T3 (en) * 1994-03-08 2006-05-01 Novozymes A/S NEW ALKALINE CELLS.
EP0796365B1 (en) * 1994-12-05 2010-03-10 Novozymes A/S A method of obtaining a cellulosic textile fabric with reduced tendency to pilling formation
DK2199378T3 (en) * 1995-02-03 2012-10-29 Novozymes As alpha-amylase mutants
CA2214116C (en) * 1995-03-17 2011-05-24 Novo Nordisk A/S Novel endoglucanases
US5520638A (en) 1995-03-28 1996-05-28 Arthrex, Inc. Main pump tubing for arthroscopy infusion pump
WO1998012307A1 (en) * 1996-09-17 1998-03-26 Novo Nordisk A/S Cellulase variants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
US5520838A (en) * 1991-01-16 1996-05-28 The Procter & Gamble Company Compact detergent compositions with high activity cellulase
US5792641A (en) * 1992-10-06 1998-08-11 Novo Nordisk A/S Cellulase variants and detergent compositions containing cellulase variants
US6114296A (en) * 1992-10-06 2000-09-05 Novo Nordisk A/S Cellulase variants

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040226672A1 (en) * 2001-05-21 2004-11-18 Novozymes A/S Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer
US20080023160A1 (en) * 2001-05-21 2008-01-31 Novozymes A/S Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer
US7951267B2 (en) 2001-05-21 2011-05-31 Kim Borch Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer
US20110198048A1 (en) * 2001-05-21 2011-08-18 Novozymes A/S Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer
US20030051836A1 (en) * 2001-05-21 2003-03-20 Novozymes A/S Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer
US20070111278A1 (en) * 2003-12-03 2007-05-17 Jinichiro Koga Endoglucanase stce and cellulase preparation containing the same
US7595182B2 (en) 2003-12-03 2009-09-29 Meiji Seika Kaisha, Ltd., Endoglucanase STCE and cellulase preparation containing the same
US20110087470A1 (en) * 2007-11-02 2011-04-14 Ceres, Inc. Material and methods for use in biomass processing
US8489340B2 (en) 2007-11-02 2013-07-16 Ceres, Inc. Method for predicting the amount of accessible carbohydrate in a feedstock sample using a near-infrared model
US8927481B2 (en) 2011-04-18 2015-01-06 Henkel Ag & Co. Kgaa Detergents or cleaning agents having a solid enzyme formulation
US11104867B2 (en) 2011-06-16 2021-08-31 Henkel IP & Holding GmbH Dishwashing liquid having bleaching catalyst and protease
US10087401B2 (en) 2012-03-16 2018-10-02 Monosol, Llc Water soluble compositions incorporating enzymes, and method of making same
EP3354716A1 (en) 2012-03-16 2018-08-01 Monosol, LLC Water soluble compositions incorporating enzymes, and method of making same
WO2013138288A1 (en) 2012-03-16 2013-09-19 Monosol, Llc. Water soluble compositions incorporating enzymes, and method of making same
WO2013158364A1 (en) 2012-04-16 2013-10-24 Monosol, Llc Powdered pouch and method of making same
US9908675B2 (en) 2012-04-16 2018-03-06 Monosol, Llc Powdered pouch and method of making same
US10696460B2 (en) 2012-04-16 2020-06-30 Monosol, Llc Powdered pouch and method of making same
US9394092B2 (en) 2012-04-16 2016-07-19 Monosol, Llc Powdered pouch and method of making same
US11753222B2 (en) 2012-04-16 2023-09-12 Monosol, Llc Powdered pouch and method of making same
CN104583394A (en) * 2012-08-16 2015-04-29 诺维信公司 Method for treating textile with endoglucanase
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects
US11104497B2 (en) 2014-10-03 2021-08-31 Monosol, Llc Degradable materials and packaging made from same
US11884467B2 (en) 2014-10-03 2024-01-30 Monosol, Llc Degradable materials and packaging made from same
US12434891B2 (en) 2014-10-03 2025-10-07 Monosol, Llc Degradable materials and packaging made from same
CN114250214A (en) * 2020-09-21 2022-03-29 南京工业大学 Persistent endo-cellulase mutant and application thereof

Also Published As

Publication number Publication date
CN101085985B (en) 2012-05-16
DE69735767D1 (en) 2006-06-01
CA2265914C (en) 2011-05-03
EP1726644A1 (en) 2006-11-29
BR9711479A (en) 1999-08-24
JP3532576B2 (en) 2004-05-31
DE69735767T2 (en) 2007-04-05
ATE324437T1 (en) 2006-05-15
JP2000514311A (en) 2000-10-31
US20080206836A1 (en) 2008-08-28
CA2265914A1 (en) 1998-03-26
BR9711479B1 (en) 2009-08-11
CN1230987A (en) 1999-10-06
JP2004065255A (en) 2004-03-04
US20090170747A1 (en) 2009-07-02
CN101085985A (en) 2007-12-12
US7993898B2 (en) 2011-08-09
AU4200797A (en) 1998-04-14
US20120289450A1 (en) 2012-11-15
US20050009166A1 (en) 2005-01-13
WO1998012307A1 (en) 1998-03-26
EP0937138A1 (en) 1999-08-25
CN100362100C (en) 2008-01-16
EP0937138B1 (en) 2006-04-26
US8017372B2 (en) 2011-09-13
US20110250674A1 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
EP0937138B1 (en) Cellulase variants
US6207436B1 (en) Endo-B-1,4-glucanases from saccharothrix
EP0882123B1 (en) Process for removal or bleaching of soiling or stains from cellulosic fabric
DE69833197T2 (en) ALKALIC XYLOGLUCANASE
WO1998008940A1 (en) A novel endoglucanase
US6268197B1 (en) Xyloglucan-specific alkaline xyloglucanase from bacillus
WO1997001629A1 (en) A cellulase with reduced mobility
US20060035800A1 (en) Detergent composition
US5997584A (en) Method of treating polyester fabrics
US5968883A (en) Peroxidase variants
WO2002077242A2 (en) Family 74 xyloglucanases
JP2003507039A (en) Alkaline xyloglucanase from Malbranchea spp.
DE69838910T2 (en) ENDO-BETA-1,4-GLUCANASES OF SACCHAROTHRIX

Legal Events

Date Code Title Description
AS Assignment

Owner name: NOVO NORDISK A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ANDERSON, KIM VILBOUR;SCHULEIN, MARTIN;CHRISTIANSEN, LARS;AND OTHERS;REEL/FRAME:009960/0861;SIGNING DATES FROM 19990324 TO 19990422

AS Assignment

Owner name: NOVOZYMES A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NOVO NORDISK A/S;REEL/FRAME:012366/0350

Effective date: 20011029

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION